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Mandate 
To advise on the establishment of European Recommended Dietary Allowances for a 
number of purposes, including nutrition labelling and Community programmes on 
research and nutrition, and to make recommendations. 
Policy of the Committee 
Almost all countries of the European Community have independently convened 
committees of experts to derive values for nutritional recommendations. These experts, 
drawing from a common pool of data, have used physiological and biochemical 
knowledge to estimate nutrient requirements. In many cases the data are limited and the 
expert committees have had to make decisions on the balance of evidence. 
For most nutrients the derived requirements are fairly similar across the Community '. 
Not surprisingly, however, committees can assess the evidence from slightly divergent 
viewpoints and arrive at different values for nutrient requirements. This can raise 
problems for food manufacturers, food regulators and consumers. The Committee set up 
a working group, representative of various views on the interpretation of the available 
evidence, to compile a set of recommendations that could be used across the 
Community for a variety of purposes. 
The working group consisted of 19 experts who operated in four sub-groups covering 
(i) energy and protein, (ii) water-soluble vitamins, (iii) fat-soluble vitamins, and (iv) 
minerals and trace elements. The sub-groups met several times, and the full working 
group met on seven occasions. 
The Committee debated at length how to present their recommendations in the most 
helpful way. Their decisions are described in the section below on Recommendations 
and Nomenclature. The Committee drew on the experience of a number of expert 
committees, of member countries, of non-member countries
 2-
3, and of international 
agencies
 4·
5. They did not, however, just try to harmonise existing national reports of 
member states, but sought instead to consider the data afresh, including the most recent, 
and sometimes still unpublished, work. Reports of the Scientific Committee for Food: 31st scries 
Fig 1.1 The frequency distribution of individual requirements for a nutrient 
Nutrient requirement 
Point b is the mean requirement of the group. Point c (mean + 2 SD) is the intake that will meet 
the needs of nearly all healthy people in a group. Point a (mean - 2 SD) is the intake below 
which nearly all individuals will be unable to maintain metabolic integrity according to the 
criterion chosen. 
In this report, point b will be called the Average Requirement (AR). Points c and a will 
roughly correspond to the Population Reference Intake (PRI) and the Lowest Threshold 
Intake (LTI) respectively. Nutrition. Chapter 1: Introduction 11-12-1992 
Recommendations and nomenclature 
Many countries in the world have produced quantitative dietary recommendations 
under a variety of names such as recommended daily amounts, recommended daily 
allowances, recommended daily intakes, recommended dietary intakes and 
recommended nutrient intakes, among others. In this report they will be referred to 
by the generic term RDA. 
A major problem in formulating a RDA is that nutrient requirements differ between 
individuals. They are conventionally assumed to have a normal Gaussian 
distribution, as depicted in Figure 1.1, with a peak at the mean requirement (point b 
in Fig. 1.1). Experimental evidence supporting this for humans is scanty, and a clear 
exception is known in the iron requirements of menstruating women, which are 
skewed, with a long tail of higher values. Nevertheless the basic assumption serves 
as a useful concept on which to base discussions of variations between individuals. 
The policy adopted for most nutrients over many years by bodies promulgating 
RDAs was to choose a single value at, or more likely beyond, the top end of the 
distribution range, i.e. to give an intake that would cover the needs of all or almost 
all members of the group. Notionally this is often described as the mean requirement 
of the group plus two standard deviations (SD), i.e. covering at least 97.5 % of the 
population (point c in Fig. 1.1). 
This approach had great merits for the original use of RDAs - to set a standard for 
an adequate diet for groups of the population; it is simple, and one can check by 
observation if the RDA has been set high enough. A single value RDA however is 
often misinterpreted or misused; it is sometimes regarded as the lowest acceptable 
intake, despite being clearly defined as substantially more than individual needs for 
the great majority of the population. 
The more recent extensions of the use of RDAs to other purposes highlight the 
shortcomings of the single RDA. Reviewing bodies are therefore tending to move 
away from single RDA values. Agreeing with that view, this Committee is 
attempting to give, as far as possible, three values to indicate the spread of needs, 
corresponding to points c, b and a in Figure 1.1. 
Point c, that intake which will meet the needs of virtually all healthy people in a 
group, corresponds conceptually with the traditional RDA. Since the Committee is 
producing more than one value, it seems inappropriate to retain a term such as 
recommended dietary allowance for this value alone. The use of the adjective 
'recommended' has been criticised as potentially misleading, for intakes can be 
recommended only on a basis of probability. Even though always clearly stated, this Repons of the Scientific Committee for Food: 31st scries 
is not always recognised by users, perhaps because of the prescriptive overtones of 
'recommended', and reviewing bodies have been introducing other terms. This 
Committee will call the intake that is enough for virtually all healthy people in a 
group the Population Reference Intake (PRI). 
Point b in Figure 1.1 is the Average Requirement (AR) for the group, according to 
the criterion chosen. 
Point a in Figure 1.1 is the intake below which, on the basis of our current 
knowledge, almost all individuals will be unlikely to maintain metabolic integrity 
according to the criterion chosen for each nutrient. The Committee will call this the 
Lowest Threshold Intake (LTI). 
As mentioned previously, the schematic Figure 1.1 represents a conceptual 
framework, which may be adjusted to deal with the information available on specific 
nutrients. For example, the PRI is set notionally as the mean requirement plus two 
standard deviations, and thus about 2.5 % of the population would be inadequately 
supplied by that intake. In practice, this is not so; the mean and the standard 
deviation cannot be established reliably, and it is common to incorporate a safety 
factor by fixing the PRI at the lowest level above which all subjects appear to be 
adequately supplied. 
In the absence of more reliable information, the LTI values in this report have been 
calculated as the mean minus two standard deviations. If more direct evidence is 
available to provide other figures, this has been used. Because deficiencies of most 
nutrients are fortunately relatively rare, data from which to estimate the LTI are 
often very inadequate, and the criteria chosen as indicators of deficiency may vary 
somewhat in stringency. In this report LTIs are often set on the prudent side, being 
not those intakes below which frank deficiency is almost certain, but rather those 
intakes below which there may be cause for concern for a substantial section of the 
population. 
Consequently, the PRI and LTI values are not always the means plus and minus two 
standard deviations. Furthermore, there is much uncertainty about what the 
standard deviation should be. Many biological characteristics have a coefficient of 
variation of 15 %, and this is often assumed in this report. Nevertheless for some 
nutrients other coefficients of variation have been used, because there is direct 
evidence to that effect, or to allow a larger safety factor, or where the calculated 
values fit uneasily with observations. 
The Committee has given only one value for increases during pregnancy or lactation; 
it considers it has inadequate information to give more with any confidence. Nutrition. Chapter 1 : Introduction 11-12-1992 
For nutrients where the requirements are given in terms of energy intake, there is 
the problem of how to give meaningful PRIs and LTIs as a weight of nutrient per day. 
The convention adopted in this report is to give the PRIs and LTIs for average 
energy intakes. 
Use of values proposed 
Multiple values are of greater utility than just a single RDA. For any particular use, 
one or other of the values may be appropriate: 
Assessing the diets of individuals 
Any individual who habitually has an intake equal to or greater than the PRI will 
almost certainly be provided for adequately. As the habitual intake falls below the 
PPJ towards the LTI, the chances of being inadequately provided for increase. If the 
habitual intake falls below the LTI, further investigation of the nutritional status of 
the individuals being studied may need to be carried out. 
Considerable caution should be exercised in judging an individual's diet in this way. 
Measurements of habitual intake of a nutrient are often not very accurate and the 
proposed reference values in this report are subject to some uncertainties. 
Assessing the diets of groups 
The risk of deficiency in a group can be estimated from the numbers and the intakes 
of those in the group habitually consuming less than the PRI. As the number of 
individuals with intakes below the PRI increases, so does the likelihood of the group 
being inadequately provided for. 
For prescribing diets or provisions of food supplies 
When diets are being devised or food supplied, they should contain nutrients at the 
level of the PRI (and adequate energy), over a period of time, to ensure negligible 
risk of deficiency in any person. Most individuals would therefore receive in excess 
or well in excess of their nutrient needs. 
For food labelling purposes 
This is discussed in detail in chapter 36 of this report. Reports of the Scientific Committee for Food: 31 si scries 
Energy recommendations 
The above considerations cannot apply to recommendations for energy. PRIs for 
other nutrients are set at the top end of the distribution of requirements to eliminate 
any cases of deficiency. The fact that most people will consume more than they need 
is of relatively little importance and will do no harm. That is not true for energy 
intakes. These are therefore given as average requirements for a group; they cannot 
be used for individuals, but are important for catering and food supply programmes. 
Acceptable ranges of intakes 
For some nutrients known to be essential, the data are inadequate for making 
recommendations. For these nutrients, an acceptable range of intakes is given, 
based on observations that individual consumptions within these limits appears 
satisfactory in that neither deficiency nor signs of excess are seen. 
High levels of nutrient intakes 
Most individuals aim at a nutrient intake that is not less than the PRI. Many 
habitually consume more. This may be due to the composition of the customary diet 
(e.g. a high consumption of meat may lead to a diet rich in protein; a high 
consumption of fruit and vegetables may produce a diet rich in folate), or to the 
deliberate consumption of some nutrient-rich foods (e.g. consumption of liver leading 
to a high intake of iron and vitamin A). Nutrient intakes may also be high due to 
consumption of dietary supplements or fortified foodstuffs. 
Intentional consumption of nutrients considerably above the PRI is not uncommon. 
This is in part due to the well-publicised claims which have been made that some 
nutrients have extra health benefits at intakes very much higher than those needed 
to prevent recognised deficiency signs
 6. The Committee considers the evidence 
insufficient at present to justify making quantitative recommendations in this regard, 
but the results of current research are awaited with interest. For most nutrients 
however, there is little reason to expect any advantage from intakes that are greatly 
in excess of the PRI. 
For most nutrients, the PRI can be exceeded several fold without causing adverse 
effects and although any additional benefits are unlikely, there is no harm in 
individuals consuming amounts of these nutrients that are much higher than the PRI. Nutrition. Chapter 1 : Introduction 11-12-1992 
For some nutrients however, undesirable effects can occur at levels relatively close 
to the PRI. In some cases, there may be consequences that are not directly harmful, 
but are undesirable - for example, high intakes of folate may have the effect of 
masking the effects of vitamin B]2 deficiency, thus preventing its diagnosis early 
enough to avoid damage to the nervous system. In a few cases, high amounts of a 
nutrient are toxic, notably vitamin A after persistent intakes of a little over ten times 
the PRI. High intakes of these nutrients are likely to cause undesirable effects and 
should not therefore be encouraged. 
This report gives for individual nutrients levels above which there is concern about 
undesirable or harmful effects. Where there is no hard evidence of adverse effects, 
then indications are given of intakes that have been reported as producing no 
apparent adverse effects. However while for many nutrients there is no reason to 
believe that intakes well above the PRI will be harmful, the Committee counsels 
caution; for example, vitamin BQ was thought for a long time to be non-toxic, but 
recent evidence suggests that intakes above 50 mg per day are potentially toxic. 
Age groups reviewed 
The main emphasis of this report is placed on values for adults, as the quality of the 
data on which decisions have to be based is higher than for other groups of the 
population. 
The report deals also with the requirements of children down to six months. For 
most nutrients the requirements of infants below that age were not considered, as 
they would be either breast- or formula- fed. The composition of infant formulas is a 
complex matter raising problems of bioavailability etc. that are better dealt with by a 
more specialist expert group. 
Only for energy and protein have values been given for infants below the age of six 
months. It seems reasonable to do this because they are based on more solid 
calculations than are values for other nutrients, they can be calculated for narrower 
age groups, and the information should be of value for many purposes. 
For most nutrients, children have been divided arbitrarily into age groups: 6-11 
months, 1-3 years, 4-6 years and 7-10 years. From 11 years onwards, the sexes 
have been divided into age groups of 11-14 years and 15-17 years. (The convention 
being used in this report is that, for example, the 1-3 year group covers children from 
their first birthday to the day before their fourth birthday). Reports of the Scientific Committee for Food: 31st scries 
Individuals aged 18 years or more are considered as adults. Adults are broken down 
further into age groups only for consideration of energy requirements. 
Children 
Experimental data on the nutrient needs of children are more sparse and in general 
less reliable than for adults. The Committee considers that information is inadequate 
to give Average Requirements or Lowest Threshold Intakes for children and is 
limiting itself to giving Population Reference Intakes. For most nutrients the 
experimental data are frequently insufficient even for that restricted purpose. Most 
committees have tackled the problem by interpolating between the values for young 
adults and those for infants, based on the composition of breast milk. Some 
committees have based recommendations, usually for minerals, on calculations and 
assumptions using factorial approaches based on tissue composition, basal losses 
and the changing size of body compartments. 
In this report, where no specific statement has been made, the PRIs for children of 
one year and over have been derived, in the absence of reliable data, by 
extrapolation from the PRI of young adults on the basis of energy expenditure. The 
energy expenditure of a growing child includes the energy cost of growth and the 
increase in body mass, as well as basal metabolic rate and physical activity. It thus 
appears to provide a basis on which to estimate the requirement for other nutrients 
above the maintenance level. For infants 6-11 months, the values are usually derived 
by interpolation between those known for infants below 6 months, and those 
calculated for the 1-3 years group. 
The PRIs given for children are therefore best estimates, but they are similar to 
values proposed by committees in a number of countries. They should perhaps be 
regarded as serviceable values for food labelling and planning purposes, rather than 
definite statements of need. 
The elderly 
Because of demographic developments in Europe, more attention now has to be paid 
to the nutrition of the elderly. 
With increasing age, there is usually progressive loss of lean tissue, energy needs 
tend to decline, and energy intake to fall. The deficiency of some nutrients, seen not 
infrequently, can arise from a greatly reduced food intake in the elderly. It is Nutrition. Chapter 1: Introduction 11-12-1992 
desirable for the elderly to remain active and to keep up their intake with foods of a 
high nutrient density. 
Dietary deficiencies can also occur because of the inability of some old people to care 
properly for themselves, or because of illness which is the primary cause of 
malnutrition. 
There is no evidence that the nutrient requirements (as distinct from the energy 
requirements) of the elderly differ from those of middle-aged adults, and except for 
vitamin D, no different values are given. 
Bioavailability 
Dietary nutrients have to be absorbed and utilised by the body to exert their 
physiological effect. The extent to which this occurs is referred to as the 
bioavailability of the nutrient, usually expressed as a percentage. 
For some nutrients the bioavailability is high and does not raise a problem. For 
others the bioavailability is much lower, and this has been allowed for when making 
recommendations. 
Many factors affect the bioavailability of a nutrient. It may be the chemical form in 
which it occurs in the diet, for example, folate in the monoglutamate and 
polyglutamate forms, haem iron and inorganic iron. There may be interactions with 
other dietary constituents which reduce (or enhance) bioavailability. 
The absorptive capacity of the intestine may be limited and may be influenced by 
systemic factors. It may be dependent on the need for the nutrient in the body; 
adaptation can occur to change bioavailability. 
Because of the many factors influencing it, the bioavailability of a nutrient may vary 
substantially with circumstances, and it is often poorly predictable. No single value 
can be given with any reliability, yet in drawing up recommendations it is usually 
necessary to select one. Some compromise has to be arrived at, usually based on 
common dietary patterns. The problems are discussed in more detail in the sections 
on the nutrients where they raise difficulties, notably among the minerals and some 
of the vitamins. IO Reports of the Scientific Committee for Food: 31st series 
General considerations 
The recommendations are expressed per person per day. This does not mean that 
those amounts should be taken every day; conceptually they represent the average 
intake over a period of time. 
The values are proposed for groups of healthy people, and may not apply to those 
with different needs arising from disease, medication or adherence to a special diet. 
The values put forward for any one nutrient assume that the requirements for energy 
and all other nutrients are met. 
Research needs 
The Committee is acutely aware that there are many gaps in the data it had to use to 
produce the variety of values presented in this report. Some are mentioned 
specifically in sections dealing with individual nutrients; others are implicit in that 
some decisions clearly have had to be made on the basis of inadequate evidence. In 
the Committee's view this unsatisfactory situation is in part a consequence of the 
limited amount of nutritional research that has been carried out in the Community 
and in the world at large. The nutritional needs of the normal healthy individual are 
commonly classified as a low priority for medical research. 
The Committee recommends that the EC reconsider the importance of research on 
the nutritional needs of the European consumer, to provide more reliable information 
to serve as the basis for better advice across the wide variety of dietary patterns in 
Europe. Nutrition. Chapter 1: Introduction 11-12-1992 11 
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Definition 
Energy requirement has recently been defined '-
2 in terms of the energy expenditure 
rather than the intake of an individual or group. Previous definitions described 
requirements on the basis of an assessment of energy intakes but this is now 
considered unacceptable because intakes may not match the energy demands of the 
body and the intake may also be incompatible with the long term maintenance of 
desirable levels of body weight and physical activity. Several EC member countries 
have now adopted the use of energy expenditure values. In this report energy 
requirements of adults are therefore defined as the levels of energy intake from food 
which will balance energy expenditure when individuals have a body size and 
composition and a level of physical activity which are consistent with long-term good 
health. The requirement also allows for the maintenance of economically necessary 
and socially desirable physical activities. 
Glossary 
BMR: Basal metabolic rate, is the rate of energy used in the postabsorptive state 
under highly standardised conditions of thermal neutrality, with the individual 
awake but at complete psychological and physical rest
 3. 
PAR: Physical activity ratio, is the energy cost of specific tasks, expressed as a ratio 
of the BMR. The task may include a variety of movements and activities. For 
example, shopping includes the walking and standing required to choose from 
shelves, to pay, and carry the purchased goods. PARs are considered on a 
daily basis, which means that they are not weighted on a weekly or yearly 
basis. 
IEI: Integrated energy index, describes the energy cost of specific occupations as a 
ratio of the BMR. This value is weighted for the pauses in activity and 
integrates the cost of various tasks. Thus a domestic helper's IEI specifies the 
energy spent over the whole work shift, while carrying out the appropriate 
variety of specific tasks (cooking, ironing, washing etc.) and having a number of 
interspersed periods of rest. Nutrition. Chapter 2: Energy 11-12-1992 13 
PAL: Physical activity level integrates on a 24 hours basis the energy spent on all 
types of activities, i.e. the IEIs specific to various occupations, and the cost of 
inactive periods such as sleep. Strictly speaking, both IEI and PAL are 
calculated so that they refer to typical days. 
It is possible to calculate average yearly IEIs and PALs, accounting for the 
average number of hours worked per day, the number of days worked per week, 
and weeks per year. It is important to distinguish between the two series of 
values. The yearly weighted averages are expressed as IEI and PAL, and 
assume that the number of occupational hours correspond to 40 hrs/week for 48 
weeks/year. 
BMI: Body Mass Index (Quetelet's Index). Body weight (kg) divided by square of 
body height (m). 
Physiology and metabolism 
Three major components contribute to the energy expenditure of adults. The first and 
largest component is the basal metabolic rate, BMR, which is the energy used in 
maintaining the body in a fasting, relaxed and physically inactive state in a 
thermoneutral environment. This component usually accounts for 50 - 60 % of the 
total energy expended. The second component is the energy used in processing and 
storing the nutrients eaten. This cost usually amounts to about 10 % of the energy 
ingested but the value depends on the balance of the diet, on individual differences in 
response and on the extent to which individuals are being underfed or overfed. The 
third major component is the energy expended in undertaking the variety of physical 
activities involved in living, working and in social activities. 
The BMR of an adult is determined principally by body size, body composition and 
age. Men have on average more lean tissue than women and it is the lean tissue and 
the relative sizes of different organs which determine the BMR. The taller and 
heavier the individual the greater the amount of lean tissue and therefore the higher 
the BMR. With age there is usually a progressive loss of lean tissue and an increase 
in body fat. These differences and changes in body composition account for the lower 
BMR per kg body weight of women than men and for the declining BMR with age 
even when body weight is taken into account. 
The level of physical activity must obviously be considered in detail when assessing 
the energy needs of an individual or group. Some activities involve the minimum of 
movement compatible with the individuals' needs at home whereas other activities 
involve the energy expended at work in a variety of different tasks. Further energy is 14 Reports of the Scientific Committee for Food: 31st scries 
expended in discretionary activities which include many useful contributions to the 
well-being of the individual and society; these can therefore be considered as socially 
desirable energy costs. There is also increasing recognition that maintaining physical 
fitness, promoting a sense of well-being by exercise and helping to prevent chronic 
diseases such as coronary heart disease, osteoporosis and muscle wasting in old 
age, may involve additional desirable physical activity if the physical cost of 
occupational work is modest. These additional needs are difficult to quantitate but it 
is recognised that physical activity is important for health and an allowance may 
need to be made for these additional exercise costs. 
The basis for variation in energy requirements 
The energy requirement of an individual is difficult to predict even when account is 
taken of the sex, age, body size and degree of physical activity. This is because of 
the substantial differences between individuals in their basal metabolism, in the 
efficiency with which they store food and in the muscle tone and physical cost of 
movement. Thus there remains a variation between individuals under standardised 
conditions with a range of values which extend to ± 15 % of the mean. A group of 
men or women of the same age and weight who engage in a variety of physical 
activities may show a range of individual needs which amounts to ± 20 % of the 
average for the group. It is therefore not possible to predict individual energy needs 
with any accuracy without special measurements of, for example, the BMR and 
physical activity patterns. 
The traditional approach to deriving nutrient recommended dietary allowances has 
never been appropriate to estimating energy requirements because a sustained 
intake of energy either below or above the individual's specific needs has deleterious 
effects. This is in contrast to the effects of other nutrients where the provision of an 
ample amount of the nutrient ensures the whole population's needs are covered; 
individuals who receive more than they need are unlikely to suffer deleterious effects 
unless the nutrient is taken in very large amounts. It is therefore usual to calculate 
the average energy needs of a group. 
Effects of energy excess 
Adults have only a modest ability to dissipate excess dietary energy by altering 
their metabolic efficiency and thereby increasing their energy expenditure
 4. Weight 
is readily gained with fat and protein being deposited in adipose and lean tissue 
respectively. About 30 % of the excess weight gain is lean tissue so the BMR Nutrition. Chapter 2: Energy 11-12-1992 15 
slowly increases
 5-
6. This increase and the energy cost of moving a heavier body 
during physical activity means that an individual or group eventually comes back into 
equilibrium at a higher energy intake and expenditure but at the cost of being 
overweight. The increases in morbidity and mortality associated with excess weight 
are well documented and include greater risk of arthritis, gallbladder disease, 
diabetes, coronary heart disease, hypertension, stroke and an increased risk of some 
cancers
 7. These risks can be avoided if energy intakes and expenditure are matched 
within a desirable weight range. This has been defined as equivalent to a BMI of 
about 20-25 8.9,10. On a population basis, however, the risk of having individuals who 
have either chronic energy deficiency with a BMI below 18.5 or overweight with a 
BMI above 25 is minimised when the median BMI of the population is between 20 
and 22. This may therefore be taken as the optimal population BMI range. 
Estimation of energy requirement 
To estimate energy requirement at the individual or group level it is necessary to 
establish the habitual level of energy expenditure. This is done in two steps. First 
the basic expenditure, BMR, is estimated. This can be predicted accurately on a 
group basis with a standard error of about 2 %, by the set of regressive equations 
developed for WHO/FAO/UNU '. These equations are based on age and weight for 
males and females separately. Recently new data on BMR of European elderly men 
and women have been collected so that a more extensive and relevant set of values 
is now available 'U2 . (See Appendix, Table A. 1). 
The next step consists in defining the level of activity which the individual or group 
engages in habitually. This is defined as the physical activity level (PAL) and 
expressed as a multiple of BMR. This PAL figure integrates in one single value the 
total energy expended over the whole day. While it is possible to derive the PAL 
from actual measurement of the energy spent in all the activities during a day, in 
most cases it is estimated from a knowledge of the type of occupation and 
recreational activity; these types are then linked to the energy cost of the activity 
defined as the physical activity ratio (PAR). Thus the total energy cost per minute of 
each task can be calculated. There are published tables of PARs for various 
activities and also estimates of the daily PALs of various life styles
 13. 
The energy cost of different occupations integrated over the working day is also 
given in specially designed tables which classify the occupations into various activity 
levels L13. This cost is explained as the integrated energy index (IEI), and 
integrates the energy costs of a variety of activities carried out in performing a 
specific task. It is, however, appropriate to reclassify a group's lifestyle if it is 
apparent that modern living conditions have changed the energy demands. Thus a 16 Reports of the Scientific Committee for Food: 31st scries 
domestic helper may be classified as holding a "moderately" active job in some 
European countries where there are short working weeks and appliances designed 
to save human energy are available. The same occupation may involve heavy work 
when performed with little mechanisation and for many hours per day or with more 
days worked per year in other European countries. 
It is now advisable to group daily activities not only in terms of occupation but also 
to take account of discretionary activities, the latter being further subdivided into 
socially desirable activities and activity intended for the maintenance of a healthy 
cardiovascular and muscular system '. This health maintenance activity may be 
totally absent from the life style of modem sedentary populations in Europe. If it is 
considered desirable, the cost associated with these activities for a given minimum 
time each day may be provided as an extra energy allowance. This approach implies 
a prescriptive or normative scheme rather than simply taking the observed patterns 
of activity and then specifying the energy needs accordingly. 
Therefore when attempting to estimate the energy requirement of an individual or 
group, the following information is needed: 
1) age, sex and body weight; 
2) type of occupation, the time involved and its energy costs; 
3) type of discretionary activity, the time involved and its energy costs; 
4) hours of sleep. 
The BMR is then calculated from the observed body weight provided the body mass 
index is between 20 and 25 for an individual. If the body mass index exceeds 25 then 
a desirable weight should be defined as that corresponding to a BMI of 25. For 
estimating the BMI of groups, however, a BMI of 22 should be chosen as desirable if 
the observed average BMI exceeds this value. 
The energy cost of the various activities is usually established on the basis of tables 
of PARs (physical activity ratios), i.e. as a ratio of the cost to BMR. By knowing the 
time involved in each activity and with the use of tables it is possible to build up a 
picture of the total 24 hour energy expenditure, which may also be expressed as a 
ratio of the estimated 24 hr BMR of the individual. This is then the individual's PAL 
for that day. Experts conversant with the problems of establishing these PAL values 
are needed in developing this approach to energy requirements since serious errors 
and misinterpretations are readily made by the untrained analyst. Nutrition. Chapter 2: Energy 11-12-1992 17 
Simplifying the estimates of energy requirements 
The various occupational activities can be grouped, on the basis of their mean IEI, 
into four major intensity levels. These are set out in Table 2.1 separately for men and 
women. 
These values result from an integration of the energy spent on the actual work and of 
the interspersed pauses; the heavier the work the longer the pauses. The job 
specifications of the IEI categories are shown in Table 2.1, but this is meant to 
provide only general guidance; better definitions may eventually become available. 
Table A.2 (Appendix) shows how the differences in body weight and in physical 
activity levels affect the average daily energy requirements of groups of men and 
women. There is over a threefold variation in needs. This emphasises the importance 
of establishing the characteristics of the group whose energy needs are to be met. 
Therefore, in developing the European average energy requirement, weights and 
heights and physical activity patterns (as IEI and/or as PAL) within the community 
are needed. Very little suitable information is available currently, but extensive and 
representative data are likely to become available as part of current or planned 
nutritional surveillance surveys. 
Developing individual or group requirement values 
Table 2.2 provides an example of how the energy requirement of a domestic helper is 
estimated. She is considered to work in a Southern European country with a 
relatively low level of mechanisation. She is aged 25 and weighs 60 kg, so that from 
Table A. 1 (Appendix) her BMR can be estimated as 5.8 MJ per day. To illustrate the 
need to integrate all her activities it is assumed that for two months of the year she 
also engages in harvesting a crop as part of the regular summer work in the area. In 
addition she has commitments to maintaining her own household. Three types of 
activity patterns therefore need to be considered: (a) her regular domestic work 
combined with her own household duties for three days per week, (b) an average 
pattern of activity for four week and weekend days when she copes predominantly 
with her household duties and (c) the two months weekday work picking crops. In 
this latter period it is assumed that she also works as a domestic for one weekend 
day to maintain her regular employment. Thus it is possible to obtain three different 
PAL values to cover the three types of day in the year. By integrating these for the 
whole year one arrives at an average energy requirement equivalent to 1.69 PAL or 
a total energy need, given her age and weight, of 9.78 MJ (2340 kcal) per day. 18 Reports of the Scientific Committee for Food: 31st series 
Generating an average value for European adult energy 
requirements 
It is useful to determine if possible the average energy requirement of European 
adults taking into account the known or estimated variations in population structure, 
in adult weights and heights and the physical activity patterns within the 
Community. 
First estimates of light, moderate and heavy life styles activity levels were specified 
with or without desirable increments in activity for promoting health and general 
well-being. These life style PAL values, expressed as ratios of the basal metabolic 
rate, are set out in Table 2.3. 
It is more difficult to obtain a suitable estimate of European adult weights. Desirable 
weights for observed heights were calculated taking a BMI of 22. Actual adult 
weights and heights were taken from representative national samples or from 
specific surveys (see data sources in footnote to Table 2.4). These adult body 
weights and heights were weighted for the total number of adults in each age group 
in each country, as obtained from Eurostat
 14, to obtain estimates of the average 
weight and height of European men and women of the various age groups. The 
calculated weights are given in Table 2.4. 
Subsequently in this report when standard weights are required for calculating 
nutrient needs, the value for an adult male is taken as 75 kg, with 62 kg for an adult 
female, as being the mean actual body weights in the age range 30-59 years. 
Energy requirements for each age and sex group were then derived (Table 2.4) by 
making assumptions about the proportion of men and women of different ages who 
are involved in different activity levels. These arbitrary assumptions are set out in 
the footnote to Table 2.4. Table 2.4 also indicates the extent to which the 
requirements are altered if an allowance is made for physically desirable activities. 
Elsewhere in this report, when an average energy intake is required for calculating 
nutrient needs, the daily value for adult men is taken as 11.3 MJ, and for adult 
women, 8.5 MJ, from the mean energy requirement of men and women, without any 
addition being made for desirable physical activity. 
In developing these estimates of energy requirements it should be recognised that 
they are based on extensive data relating to the basal metabolic rate of individuals of 
different ages but on very limited information on the average and range of physical 
activity patterns in European adults of different ages. These estimates of 
requirements may then need to be changed. Social and economic changes will also Nutrition. Chapter 2: Energy 11-12-1992 19 
alter our estimates. Health promotion is already leading some adults to undertake 
more physical exercise in their spare time. But automation at work and in the home 
is tending to reduce the demand for physical activity to an unknown degree. The 
more generalised introduction of central heating and cooling of offices, factories and 
homes may also alter behavioural patterns to an unknown extent. These social 
changes mean that the energy needs of European adults are likely to alter with time. 
The values presented here are estimates of current European patterns of activity at 
work and in leisure time. They should therefore be treated with great caution. 
Children 
Estimating energy requirements from measurements of expenditure is ideal but this 
is particularly difficult in children because so few measurements have been made. 
There are coherent, long standing data on the BMR of infants, young children and 
adolescents but measures of physical activity are few and rarely apply to modern 
European circumstances, where there seems to have been an appreciable decline in 
activity patterns over the last 40 years. There are now a few measurements of total 
energy expenditure by the
 2H2 O method in a selected group of British children but 
they may well not be representative of the usual pattern in Europe. Reliance must 
therefore be placed on measures of food intake as well as expenditure data and 
these need to be related to the European children's growth patterns. 
Growth patterns of children in Europe 
There has been a substantial number of studies of children's weight and height at 
different ages but these are rarely conducted on representative populations and no 
attempt has been made as yet to derive a collated set of data taking into account the 
size of different European groups and the nature of the sampling and measurement 
techniques. The Tanner standards
 15, based on about 2000 London schoolchildren 
and on a smaller sample of pre-school children studied repeatedly over many years, 
were set out in the 1960s. These have been widely used and a British nation-wide 
survey
 1
6 showed that Tanner's graphs were still a reasonable reflection of British 
growth patterns in the 1970s. Primary data sources have been obtained from nine 
European countries, where cross-sectional, mixed longitudinal and longitudinal 
studies have been published in the 1970s and 1980s. Values from each country have 
been weighted by the size of the population in each age and sex group and averaged. 
Plots of the European growth curves are very close to the United States National 
Center for Health Statistics (NCHS) growth curves. Tables A.3 and A.4 (Appendix) 
show the mean values for height and weight from 1 month to 17 years of age; they 
correspond closely with the NCHS values. 20 Reports of the Scientific Committee for Food: 31st series 
Basal metabolic rates of children 
These were collected and calculated by Schofield et al.
 I
7 for use by the 
FAO/WHO/UNU Committee. Equations were derived based on age, sex, weight and 
height to derive the average BMR of boys and girls. These are given in Table A.l 
(Appendix). In practice it is simple to use weight alone, although height does reduce 
the variability of the predicted BMR in children
 17. 
Physical activity and other thermogenic processes 
Unfortunately there are few data on physical activity patterns, energy costs of 
growth or the thermogenic response to meals in European children of different ages. 
If these were available it could be possible to build up estimates of the energy used 
for BMR and these other processes and thereby derive requirement values in the 
same way as in adults. The pre-adolescent data are sparse and information on 
adolescents is confined to an unpublished Italian study. Two alternative approaches 
involve the use of the
 2H2
180 method for measuring the total energy expenditure of 
children or the estimation of requirements from intake data. The
 2H2
180 method has 
recently been introduced into human studies and only lately have some of the 
theoretical and technical problems associated with its use been evaluated '
8. 
Nevertheless the recent British report
 1
9 used the data collected by the Cambridge 
group on 355 healthy infants to illustrate that the energy allowances set out for 
children by FAO/WHO/UNU ' were higher than those estimated by adding the 
estimated energy deposited during growth to the
 2H2
180 estimation of total energy 
expenditure. This new approach used a variety of assumptions which differed from 
those chosen in the initial validation studies on the
 2H2
180 method and it is possible 
that there might be a small systematic bias in these data. 
The FAO/WHO/UNU's ' allowances for children under 3 years were based on 
measurements of energy intakes which themselves are subject to error and include 
assumptions for the digestibility factors for different diets which were derived from 
adult studies and may not be transferable to children. The FAO/WHO/UNU 
allowances also included a 5 % increase for a possible underestimate of intakes of 
energy from breast milk in the first year of life. The same increment was assigned on 
a prescriptive basis for children in the second and third year. In the values given here 
for European children this adjustment is not included. The daily energy needs of 
children decline from 480 kJ/kg at birth to about 360 kJ/kg at 9 months of age because 
of the very marked fall in the energy need for deposition of new tissue. The total 
energy cost of synthesizing and storing new tissue amounts to a little over 20 kJ/g 
weight gain and after the first year of life is always less than 4% of energy needs. Nutrition. Chapter 2: Energy 11-12-1992 21 
Infants 
Breast feeding provides the best nourishment for new born babies and young infants. 
In these children there is no need to develop energy requirement figures; however it 
is sometimes useful to have these values for those who are bottle fed. The older 
data were based on energy-dense milk formulas and energy intakes tended to be 40-
50 kJ/kg higher than those now found with infants feeding on new formulas which 
have a lower solute and energy load. These modern formulas still seem to be 
consumed in excess of the estimated energy intake of wholly or partially breast-fed 
babies. This may reflect the greater induction of thermogenic responses by formula 
feeding or differences in digestibility as well as perhaps the induction of faster 
growth rates in formula than breast-fed children. 
Since estimates of energy requirements are derived in part to help with the artificial 
feeding of children and in the absence of clear information on the optimal growth rate 
for long term health, it is sensible for the present to base infant energy requirements 
on modem formula feeding data. These are set out in Table 2.5. The intake of 400 
kJ/kg/d should be ample for growth since new estimates of intake are now tending to 
be somewhat lower 20. it is better, however, to err on the side of a slight over-
estimate than an underestimate. 
In children aged 1-3 years there seems to be increasing evidence that their 
expenditure is lower than 40 years ago. This may reflect the lower activity or a lower 
thermoregulatory demand in modem children living indoors at higher environmental 
temperatures controlled by central heating, or a reduction in physical exertion 
consequent upon the increasing use of cars. 
Children aged 3-9 years 
The FAO/WHO/UNU report ' had to rely on intake data for this age group because 
physical activity and total energy expenditure data are very limited. Few new 
studies have been reported since then so it remains appropriate to rely on intake 
data. In a European context the principal concern in relation to energy is one of 
overweight and obesity in children rather than of underweight and malnutrition. So 
the additional 5 % allowance prescribed by FAO/WHO/UNU ' was not used in 
deriving the estimates shown in Table 2.6. 
Children and adolescents aged 10-18 years 
These can more readily be assessed in terms of energy expenditure using a system 
similar to that applied to adults. Typical time use and energy costs of activities in 
boys and girls were provided by the FAO/WHO/UNU approach (Table A.5, Reports of the Scientific Committee for Food: 31st series 
Appendix). In different parts of Europe the demand on adolescents will vary 
substantially with many, perhaps especially in rural areas, contributing to the 
physical work of the household. 
Adjustments for these differing activity patterns can readily be made by reference to 
Table A.5 (Appendix) and the approach adopted for adults. Table 2.7 summarises 
the components of energy expenditure and the average energy requirement of 
adolescents who are moderately active with a physical activity level of about 1.65 for 
boys and 1.55 for girls, aged 10-13 years. For older adolescents, spending more time 
in school and related light type activities, calculations are made on the basis of 
physical activity levels of 1.58 for boys and 1.50 for the girls. 
Pregnancy 
There have been several detailed European studies of energy metabolism in 
pregnancy since the FAO/WHO/UNU collation of data in 1981. This has allowed a 
re-evaluation of the estimates of need. Studies on total energy expenditure in whole 
body calorimeters
 2
1 have shown considerable variability in the metabolic changes in 
pregnancy in different women. Analyses of post-prandial thermogenesis have found a 
more efficient processing of nutrients with a lower metabolic response to meals in 
pregnant and lactating women 22. There have also been two major studies in Glas-
gow and Wageningen as part of an international prospective study of the changes in 
food intake, energy expenditure and body composition during pregnancy
 24. These 
European studies are still in progress but sufficient data are available to justify the 
derivation of values which differ from those given by FAO/WHO/UNU ·. 
The original estimates of energy need were based on data collected on the weight 
gain and body compositional changes in careful studies conducted before and after 
the war in Scotland. These data and the approach adopted have been used 
throughout the world for the last 30 years
 25. If a mother gained 12.5 kg and gave 
birth to a 3.3 kg baby then the total cost of the energy deposited in both maternal and 
fetal tissues together with the additional cost of maintaining the extra tissue 
amounted to an extra demand for 80,000 kcal (335 MJ) over the whole of pregnancy 
25. The FAO/WHO/UNU Consultation therefore divided this value by the 250 days 
after the first month of pregnancy to derive an additional need of about 1.3 MJ per 
day i. 
The supposed extra energy requirement is not matched by a corresponding increase 
in measured food intake in the new Glasgow and Wageningen studies. In fact an 
analysis of 10 studies in Australia, Holland and Britain showed increased intakes of 
only about 0.42 MJ/d in lhe third trimester of pregnancy and there was little if any Nutrition. Chapter 2: Energy 11-12-1992 23 
change before that
 19. The UK proposed an increment of 0.8 MJ/day during the last 
trimester in view of the conflicting evidence from intake data and estimates based on 
BMR and tissue compositional changes
 19. 
The discrepancies in the European data between the estimated need for energy 
retention in pregnancy and the actual intake amount to 193 MJ in the Glasgow 
studies and to 264 MJ in Wageningen. This implies an average energy storage of 
0.77-1.06 MJ/day 24. Some of this saving may reflect differences between the pre-
pregnancy values for intake and BMR and those used for calculating data which were 
collected at 10 weeks of pregnancy. 
The decline in physical activity in late pregnancy is also difficult to document and 
may be a mechanism for saving energy. 
Variable needs in pregnancy 
The estimate of need presupposes that all women are of normal weight and sustain 
the appropriate weight gain which, in the five country study, amounted to 11.7 kg in 
Scotland, 10.5 kg in the Netherlands and 7.3-8.9 kg in the other three countries
 24. 
However new detailed analyses from the US show that both pre-pregnancy weight 
and weight gain are important indices of birth weight, and perinatal morbidity and 
mortality. 
Provisional weight gain charts related to pre-pregnancy body mass index are now 
available showing that thin women, e.g. with a BMI below 20, need to gain between 
12.5 and 18 kg by 40 weeks of pregnancy and at a rate of 0.5 kg/week during the 
second and third trimester
5 to reduce the risk to the baby. This compares with a 11.4 
to 16 kg gain for most European women with a BMI of 20 to 26 before pregnancy and 
7-11.5 kg weight gain for overweight women with BMI > 26. The latest US National 
Academy report 26 estimates the lowest neonatal and post neonatal mortality rate is 
achieved when babies are born weighing more than 3.5 kg. Underweight women 
respond to food supplementation during pregnancy by increasing their own body 
weight and the birth weight of their children. This implies that the energy 
requirements of pregnant women should be individually determined and that 
underweight women should be encouraged to eat more to improve the chance of 
having a normal weight child. Table 2.8 provides estimates for the additional energy 
requirements of underweight, normal and overweight European women who may 
either reduce their physical activity or be forced to maintain their activity patterns, 
for example because of the demands made by the family and the continuing need to 
work. Thus thin women require an increase in daily intake of about 1.7 MJ/day from 
the 10th week of pregnancy unless they become remarkably inactive with a PAL of 
1.31 (Table 2.8). Clearly overweight and normal weight women who are usually 24 Reports of lhe Scientific Committee for Food: 31st series 
moderately active can adjust for the extra energy needs by becoming sedentary. 
There is no direct evidence that such a change occurs, but food intake data suggest 
that some adjustment has been made in either physical activity or metabolism by the 
second trimester of pregnancy. On practical grounds therefore, it seems reasonable 
to halve the supposed extra energy demand, which therefore would be 0.75 MJ/d 
from the 10th week of pregnancy for normal weight women. 
Lactation 
The energy requirements for lactation are proportional to the quantity of milk 
produced. The average energy content of human milk is about 280 kJ/100 ml ' . Milk 
output data for Swedish and British women corrected for insensible water losses 
from the infant being test-weighed reveal that the amount of milk produced increases 
steadily in the first 3 months of breast feeding. Thereafter output depends on the 
extent to which weaning foods are introduced. The greater their use the less breast 
milk the baby drinks. Thus mothers who continue almost exclusively breast feeding 
to 6 months of age produce 750 ml/d but this can decline rapidly to 300 ml/d with the 
use of appreciable weaning food. 
In calculating energy costs of milk production an assessment of the conversion 
efficiency of dietary energy to milk energy is needed. This has been traditionally 
taken as 80 % although in the original calculation 27 [his figure was taken as the 
extreme; the actual value was estimated as 97 %. Recently the issue has been 
reassessed in Gambian women in a whole body indirect calorimeter 28. The efficiency 
was calculated from the energy content of the milk produced and the increment in 
BMR due to the lactational process. The mean efficiency of milk production was 94.2 
% with a milk density of 2.9 kJ/g. Therefore it is now proposed to use an efficiency 
value of 95 % rather then 80 %. Recent separate studies in Scotland, Sweden and 
England also found efficiency values of between 97 and 100 %. 
Table 2.9 provides new estimates which make use of these allowances and include 2 
groups of women who wean their children to varying degrees after 6 months of 
breast feeding. An allowance is included for the average weight loss of 0.5 kg/month 
following delivery. From these data it is clear that the energy demands of lactation 
are substantial compared with those of pregnancy. Nutrition. Chapter 2: Energy 11-12-1992 25 
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Table 2.1 Classification of occupations into IEI* categories 
Light 
M 
1.60 
F 
1.60 
Moderate 
M 
2.25 
F 
1.90 
Moderate/Heavy 
M 
3.0 
F 
2.3 
Heavy 
M 
3.8 
F 
2.8 
Housewives 
Clerical and related 
workers 
Administrative and 
managerial 
Professional, technical 
and related workers 
Domestic helpers 
Sales workers 
Service workers 
Agricultural, animal 
husbandry, forestry 
and fishery workers 
Labourers 
Production and 
related transport 
equipment 
operators 
Occupations are a: 
in the moderate/ 
heavy category bu 
conducted under 
poorly mechanised 
conditions 
* These IEIs apply under moderately mechanised work conditions. They may need to 
be shifted towards higher values when dealing with relatively low automation levels. 
The values for IEI reported in this Table only apply to the part of the day involved in 
work. The values take account of pauses and intervals in working but they are not 
weighted to generate an average daily value which includes week-end, summer 
vacations etc. Nutrition. Chapter 2: Energy 11-12-1992 29 
Table 2.2 Energy requirements of a female domestic helper in a Southern 
European country 
1) In bed 
2) Occupational activities 
a) Household work 
b) Domestic labour 
c) Tomato harvesting 
3) Discretionary activities 
a) Household 
maintenance 
b) Socially desirable 
c) Cardiovascular and 
muscular maintenance 
4) Rest of day 
Daily Total PAL (MJ) 
IEI* 
1.0 
2.7 
2.8 
3.0 
2.0 
1.7 
6.0 
1.4 
-
!age 25 years; weight 60 kg; 
Day type 1 
housewife 
hr 
8 
2 
-
-
2 
4 
0.25 
7.75 
1.53 
MJ 
1.93 
1.31 
-
-
1.00 
1.64 
0.36 
2.62 
(8.86) 
Day type 2 
domestic labour 
hr 
8 
1 
8 
-
-
2 
-
5 
1.81 
MJ 
1.93 
0.65 
5.41 
-
-
0.82 
-
1.69 
(10.50) 
BMR 5.8 MJ/day) 
Day type 3 
agrie, labour 
hr 
8 
1 
-
8 
-
2 
-
5 
1.88 
MJ 
1.93 
0.65 
-
5.8 
-
0.82 
-
1.69 
(10.89) 
Integrated PAL (MJ) 1.69 (9.78) 
Day type 1 = 4 days per week for 10 months (48% of the year) 
Day type 2 = 3 days per week for 10 months + 1 day per week for 2 months (38% of the year) 
Day type 3 = 5 days per week for 2 monihs (14% of the year) 
* The IEI values used in ihis Table are higher than the corresponding values in Table 2.1, because 
lhe example describes a poorly mechanised silualion. The value for cardiovascular and muscular 
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Table 2.3 The variety of physical activity levels (in PAL and in M J Id) used in 
estimating energy requirements in European men and women (actual 
body weight, see table 2.4). 
Men 
Women 
Lifestyle Activity Level 
aged 18-59 years (wt. 74.6 kg) 
Light 
Moderate 
Heavy 
aged 60-74 years (wt. 73.5 kg) 
aged> 75 years (wt. 73.5 kg) 
aged 18-59 years (wt. 62.1 kg) 
Light 
Moderate 
Heavy 
aged 60-74 years (wt. 66.1 kg) 
aged> 75 years (wt. 66.1 kg) 
Including desirable 
physical activities 
PAL 
1.55 
1.78 
2.10 
1.51 
1.51 
1.56 
1.64 
1.82 
1.56 
1.56 
MJ/d 
11.5 
13.3 
15.6 
10.0 
9.1 
9.1 
9.5 
10.6 
8.5 
8.3 
Without desirable 
physical activities 
PAL 
1.41 
1.70 
2.01 
1.40 
1.33 
1.42 
1.56 
1.73 
1.44 
1.37 
MJ/d 
10.5 
12.7 
15.0 
9.2 
8.0 
8.3 
9.1 
10.1 
7.8 
7.3 
The physical activity levels are based on the 1985 WHO/FAO/UNU report ' on energy 
requirements for the men and women under 60 years. An adjustment for estimating 
PAL values without desirable physical activity has been specified by James and 
Schofield
 1
3 and data on the elderly depend on new assessments of physical activity in 
these groups as monitored by Ferro-Luzzi '
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Table 2.4 Desirable and actual average body weights (kg) and normative and 
actual energy requirements (in MJ/d and as PAL) for European 
men and women of various ages. 
Age in 
years 
Men 
18-29 
30-59 
60-74 
>75 
Average 
Women 
18-29 
30-59 
60-74 
>75 
Average 
Men 
18-29 
30-59 
60-74 
>75 
Average 
Women 
18-29 
30-59 
60-74 
>75 
Average 
Desirable* body 
weight (kg) 
66.3 
66.3 
63.5 
63.5 
57.3 
57.3 
55.5 
55.5 
Actual**body 
weight 
74.6 
74.6 
73.5 
73.5 
62.1 
62.1 
66.1 
66.1 
With desirable physical 
activity 
MJ/d 
12.5 
11.5 
9.2 
8.5 
11.4 
9.1 
8.9 
7.8 
7.6 
8.7 
MJ/d 
13.4 
12.1 
10.0 
9.1 
12.1 
9.6 
9.2 
8.5 
8.3 
9.2 
PAL 
1.77 
1.66 
1.51 
1.51 
1.67 
1.63 
1.60 
1.56 
1.56 
1.60 
PAL 
1.77 
1.67 
1.51 
1.51 
1.68 
1.63 
1.60 
1.56 
1.56 
1.60 
Without desirable physical 
activity 
MJ/d 
11.9 
10.7 
8.5 
7.5 
10.7 
8.5 
8.3 
7.2 
6.7 
8.1 
MJ/d 
12.7 
11.3 
9.2 
8.0 
113 
9.0 
8.5 
7.8 
7.3 
8.5 
PAL 
1.67 
1.55 
1.40 
1.33 
1.56 
1.52 
1.49 
1.44 
1.37 
1.48 
PAL 
1.67 
1.56 
1.40 
1.33 
1.57 
1.52 
1.49 
1.44 
1.37 
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(continues Table 2.4) 
* Desirable weight for observed height taking the BMI as 22. 
** Weighted median weights of European men and women derived from the studies 
listed below. Data had to be combined for the whole age ranges 18-59 years and 60 
to 75 years because appropriate age groupings were not available. In calculating 
energy requirements, BMR and activity data appropriate to the specified age groups 
were applied. The basal metabolic rate values were obtained from Table A.l 
(Appendix) and a series of assumptions were made for the proportion of each age 
group involved at light, moderate and heavy physical activity levels, the cost of these 
levels being taken as in Table 2.3. It was assumed that for 18-29 year old European 
men 10 % were engaged in heavy activity, 70 % in moderate and 20 % in light activity 
levels. For women of the same age 10 % were also considered to engage in heavy 
activity, 50 % in moderate and 40 % in light activity. For 30-59 years old men and 
women half were considered to be at moderate activity and the remaining half at light 
activity levels. All men and women over 60 years were specified as engaged in light 
activity patterns. 
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Table 2.5 Estimated average requirements of energy for children aged 0-36 
months. 
Age 
(months) 
1 
3 
6 
9 
12 
18 
24 
30 
36 
Average weight (kg) 
Boys 
4.0 
6.0 
8.0 
9.0 
10.0 
11.5 
12.5 
14.0 
15.0 
Girls 
4.0 
5.5 
7.5 
8.5 
9.5 
11.0 
12.0 
13.0 
14.0 
Intake 
(kJ/kg 
body weight) 
480 
420 
400 
400 
400 
400 
400 
400 
400 
Estimated energy 
requirements (kj/d) 
Boys 
1900 
2500 
3200 
3600 
4000 
4600 
5000 
5600 
6000 
Girls 
1900 
2300 
3000 
3400 
3800 
4400 
4800 
5200 
5600 
Taken in part from reference 19. The body weights have been rounded to the nearest 
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Table 2.6 Estimated average requirements of energy for children aged 3-9 
years 
Age 
(years) 
3.5 
4.5 
5.5 
6.5 
7.5 
8.5 
9.5 
Average weight (kg) 
Boys 
15.5 
17.5 
19.5 
22.0 
24.5 
27.0 
30.0 
Girls 
15.0 
17.0 
19.5 
21.5 
24.0 
27.0 
30.5 
Intake* (kJ/kg) 
Boys 
395 
375 
365 
350 
330 
305 
285 
Girls 
375 
365 
350 
330 
305 
275 
245 
Estimated energy 
requirements (kj/d) 
Boys 
6100 
6550 
7100 
7700 
8100 
8250 
8550 
Girls 
5650 
6200 
6800 
7100 
7300 
7400 
7500 
* Intake derived from table 23 of reference 1. The body weights have been rounded to the 
nearest 0.5 kg, and the estimated energy requirements to the nearest 50 KJ/d, with some 
smoothing of the final values. 36 Reporis of lhe Scientific Committee for Food: 31st series 
Table 2.7 Calculation of basal metabo 
expenditure (TEE) and average 
children and adolescents aged 10-
lic rate (BMR), total energy 
requirements of energy of older 
17 years 
Age (years) 
Boys 
Weight (kg) 
BMR (MJ/day) 
TEE (MJ/day) * 
Growth (MJ/day) ** 
Estimated energy 
requirements 
(MJ/day) 
Girls 
Weight (kg) 
BMR (MJ/day) 
TEE (MJ/day) * 
Growth (MJ/day) 
Estimated Energy 
Requirements 
(MJ/day) 
10.5 
33.0 
5.19 
8.56 
0.17 
8.73 
34.0 
4.80 
7.44 
0.20 
7.64 
11.5 
36.5 
5.45 
8.99 
0.20 
9.19 
37.5 
5.00 
7.75 
0.20 
7.95 
12.5 
41.0 
5.78 
9.54 
0.26 
9.80 
43.0 
5.31 
8.23 
0.32 
8.55 
13.5 
47.0 
6.23 
10.28 
0.35 
10.63 
48.0 
5.59 
8.66 
0.29 
8.95 
14.5 
53.0 
6.67 
10.54 
0.35 
10.89 
50.5 
5.73 
8.60 
0.14 
8.74 
*** 
15.5 
58.0 
7.04 
11.12 
0.29 
11.41 
52.5 
5.84 
876 
0.12 
8.88 
16.5 
62.5 
7.38 
11.66 
0.26 
11.92 
54.0 
5.92 
8.88 
0.09 
8.97 
17.5 
64.5 
7.52 
11.88 
0.12 
12.00 
54.5 
5.95 
8.93 
0.03 
8.96 
at a PAL of 1.65 for boys and 1.58 for girls aged 10-13 years, and 1.55 for boys and 
1.50 for girls aged 14-17 years. 
at a cost of 21 kJ per daily weight gain. 
The small decrease in energy requirement at this stage relates mainly to the fall in 
the growth rate. Nutrition. Chapter 2: Energy 11-12-1992 37 
Table 2.8 Assessing pregnancy energy needs in relation to pre-pregnancy weight 
and desirable weight gain. 
Pre-pregnancy BMI 
Ideal weight gain (kg) 
Estimated extra needs (MJ) 
BMR 
Maternal fat store 
Other maternal tissue 
Fetus 
Theoretical total extra need from 10th 
week of pregnancy 
Calculated daily extra demand (MJ) 
from 10th week 
Practical recommendation for extra 
intake from 10th week (MJ/d) 
Pre-pregnancy intake (MJ/d) at 
moderate activity (PAL 1.64) 
Activity PAL to adjust for tissue 
storage and metabolism while 
maintaining pre-pregnancy intake 
18.5-19.9 
12.5-18.0 
175 
150 
20 
35 
360 
1.7 
1.7 
6.78 
1.31 
20.0-25.9 
11.4-16.0 
150 
110 
15 
35 
310 
1.5 
0.75 
10.30 
1.40 
>25.9 
7.0-11.5 
100 
60 
10 
35 
205 
1.0 
0.5 
12.50 
1.51 
Calculations based on National Academy of Science assessment
 2
6 of ranges of pre-pregnancy 
weight and desirable weight gains which on average were assumed to be BMIs of 19, 23 and 
28 with weight gains of 15.5, 13.5 and 9 kg. All women were assumed to be 1.65 m and 
moderately active (PAL 1.64 before pregnancy). Values for storage adapted from Durnin
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Table 2.9 Additional energy requirements for lactation 
Full breast 
feeding 
Months 
0-1 
1-2 
2-3 
3-6 
Milk Volume 
ml/d 
680 
780 
820 
750 
Energy Cost 
MJ/d 
2.00 
2.30 
2.42 
2.21 
Allowance 
weight loss 
MJ/d 
-0.5 
-0.5 
-0.5 
-0.5 
Total extra 
requirements 
MJ/d 
1.5 
1.8 
1.92 
1.71 
Weaning Practice from 6 months 
Minor 
Substantial 
650 
300 
1.92 
0.88 
0 
0 
1.92 
0.88 
Derived from the UK report
1
9 but using new value for the efficiency of milk production. 3. Protein 
Definition 
The physiological requirement for protein of an individual is the lowest level of 
dietary protein intake that will balance the losses of nitrogen from the body in adults 
maintaining energy balance at modest levels of physical activity >. 
Physiology of protein metabolism 
The body protein amounts to about 12 kg in adult man. The proteins are formed by 
chains of the 20 amino acids; the structural integrity of the body and its metabolism 
are wholly dependent on specific proteins. The provision of enough dietary amino 
acids to maintain these proteins is crucial to survival. 
The body's proteins are constantly being synthesized and degraded; in an adult man 
eating 70g of protein daily the total protein turnover of the body amounts to about 
250g protein per day. This in turn means that about 180g protein is being 
resynthesized without the involvement of new dietary sources of amino acids. The 
turnover of proteins is controlled, thereby allowing the mass of specific enzymes or 
structural proteins to be altered. The inflow of amino acids from the cells' cytoplasm 
into the bloodstream enables the body to reroute the amino acid supply from one 
organ to another. 
The body's proteins contain 96% of the total body nitrogen so a study of nitrogen 
metabolism usually reflects protein metabolism. Other nitrogenous compounds, e.g., 
creatine, purine and pyrimidine bases and the porphyrins, are all in part derived from 
amino acids. Not all the 20 amino acids used to provide these nitrogen-containing 
compounds can be synthesized in sufficient quantity to meet the body's needs. Nine 
amino acids are classified as essential because they have to be provided as such in 
the diet (see Table 3.2). Methionine and phenylalanine are required as such and also 
as sources of cysteine and tyrosine. Histidine cannot be made in sufficient quantity 
for children's needs so histidine is also specified as an essential amino acid (and 
may be required for adults). It is suggested that other amino acids, e.g. glycine, may 
be needed in the diet to boost amino acid availability when the body's demand 
exceeds its capacity to synthesize the amino acid. Thus the distinction between 
essential and some non-essential amino acids is becoming blurred
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Protein digestion and amino acid absorption 
Dietary proteins are digested by a complex of enzymes secreted by the stomach and 
pancreas. Amino acids and peptides are released by selective enzymic splitting of 
the protein chains. Peptides are hydrolysed further by intestinal enzymes so amino 
acids and small peptides are transferred across the intestinal wall. 
The intestine itself is rapidly turning over with protein-rich cells continually 
sloughing into the lumen. The pancreatic, biliary, and intestinal secretions of 
proteins, together with sloughed cells, contribute a mass of "endogenous" protein to 
the intestinal pool. This is thought to amount to about 20-80g or more per day
 3·
4. 
Not all this endogenous protein is readily digestible so the residuum, together with 
any undigested dietary protein and the proteins incorporated into the bacterial 
population within the small intestine, will pass into the colon where they are 
fermented by the bacterial flora. Some of the nitrogen released from fermentation is 
reabsorbed as ammonia which can be re-used by the liver to synthesize non-
essential amino acids. Bacterially produced nutrients including amino acids may also 
contribute to the body's needs. Thus the assessment of protein digestibility by 
simply monitoring dietary protein (or N) intake and faecal nitrogen excretion 
neglects a multiplicity of events within the intestine. The differences between intake 
and faecal excretion may bear little relationship to the true amino acid supply if 
considerable amounts of essential amino acids are lost into the colon to be 
reabsorbed as energy sources such as volatile fatty acids and as ammonia. The true 
digestibility of dietary proteins in man is therefore uncertain. 
Nevertheless, proteins from hen's eggs, cow's milk, meal and fish are usually 
considered to be 100% absorbed in adults. Protein-containing foods from plant 
sources are not so readily digested and the true digestibility is more difficult to 
calculate because of non-protein N-containing compounds in the plant food. The fall in 
apparent digestibility reflects both an increase in faecal N output, which stems from 
increased transfer of sloughed cells and protein into the colon, and the additional 
proliferation of colonic bacteria once a greater supply of undigested polysaccharides 
enters the colon to provide energy for bacterial proliferation. 
Large intakes of fibre-rich foods, especially those containing cereal bran, reduce the 
apparent digestibility of protein by about 10%>. Diets based on coarse whole-grain 
cereals and vegetables may be given a digestibility value of 85% and those diets 
based on refined cereals a correction value of 95%. Nutrition. Chapter 3: Protein 11-12-1992 41 
Amino acid metabolism 
Amino acids are transported from the intestine in both the red cells and plasma, and 
are extracted first by the liver and then by the other tissues. Specific transport 
systems under hormonal control determine the distribution of amino acids, which 
themselves not only provide the building blocks for new protein synthesis but may 
also stimulate an "anabolic drive" of hormonal secretion and tissue responses to 
amplify the formation of specific proteins
 5. The "anabolic drive" may explain the 
selective effect of dietary proteins, and particularly those of animal origin rich in 
essential amino acids, in stimulating the longitudinal growth of children. In addition 
to protein synthesis individual amino acids are needed for other metabolic functions, 
including the synthesis of peptide hormones, nucleic acids, neurotransmitters to 
control brain cell communication, and other hormones. 
The use of the amino acids for protein synthesis depends upon the balance of need 
between the fast and slow turnover proteins
 6 and on the controlled changes in 
synthesis and breakdown occurring in response to dietary changes
 7·
8. The amino 
acid composition of each protein is fixed so the controlled synthesis of a particular 
array of proteins determines the amino acids needed. If some amino acids are not 
available in adequate amounts then the synthetic machinery competes for the 
limiting amino acids and cannot synthesize the whole range of proteins in the 
intended quantities. Thus amino acid intake may be too limited for the requirements 
of the growing child or when an adult needs to produce a greater mass of specific 
proteins, e.g. during pregnancy or lactation or when responding to an infection with 
the production of antibodies. 
Each amino acid has its own pathway for oxidation. They are metabolised and 
excreted as carbon dioxide, water and as urea formed by the liver. The enzymatic 
oxidative pathway of each amino acid is controlled in part by the inflow of the amino 
acid so an excess supply leads to its preferential oxidation. The oxidation of one 
amino acid may, however, be affected by the inflow of other dietary amino acids so 
the rate of oxidation of an amino acid may not be solely dependent on its 
accumulation in the cellular pools of the tissues. 
The concept that oxidation reflects an "overflow" of an excess intake has been used 
to assess amino acid requirements by monitoring the oxidative loss of isotopically 
labelled carbon or nitrogen in the amino acid at different levels of amino acid intake. 
The total amount of amino acid catabolized to carbon dioxide and urea is not 
equivalent to the requirement for absorbed amino acid because of other irretrievable 
losses. Proteins are lost as hair, in skin and intestinal cells, in bronchial and other 
secretions and in lactating women as milk protein. New protein formation during 
growth, pregnancy and early lactation also has to be estimated. Amino acids are also 42 Reports of the Scientific Committee for Food: 31 si scries 
being lost from the body, as other metabolic non-reutilizeable products such as 
creatinine and some hormones. It is the total utilisation of each amino acid which 
determines its turnover ; the requirement is that minimum dietary intake needed to 
supplement the body's synthesis of the amino acid and meet minimum synthetic and 
catabolic processes. This approach neglects the potential need for a greater supply 
than the minimum to stimulate the "anabolic drive" or to sustain protein synthesis 
rates at a higher "optimum" level than the minimum. 
Adults in N balance are assumed to be eating enough protein once an allowance is 
made for the irretrievable loss of body proteins. Egg or milk protein is used since 
these proteins are readily digested with a presumed 100 % small intestinal recovery 
and the protein's amino acid composition is well balanced. The amino acid needs of 
children and adults are also usually determined by N balance. Faecal and urinary 
nitrogen output are determined and the net loss of body proteins and amino acids 
estimated as nitrogen. 
If the intake of an essential amino acid falls below the body's needs then the other 
available amino acids cannot be used to sustain body protein metabolism; they are 
therefore present in relative excess and have to be oxidised with further urea 
synthesis and urinary N loss. Thus the N output can be monitored at different 
carefully defined intakes to find the level which induces the lowest urinary N output. 
This gives a value for the minimum dietary requirement and includes provision for 
other losses in skin hair and secretions
 9. 
Responses to a low protein intake 
The body adjusts to a low protein intake by adapting over a period of up to a week 
during which there is a net loss of body protein amounting to about 1.5% of the total 
protein mass
 10. The reduced inflow of amino acids into the body fails to meet the 
body's needs for protein synthesis and amino acids are initially oxidised by the 
highly active catabolic enzymes, which were set at their prevailing level by the 
previous protein intake. Protein breakdown continues despite the fall in protein 
synthesis so there is a net loss of protein. However the amino acid catabolic 
enzymes begin adjusting within hours so the experimental evolution of isotope from 
14C or
 15N labelled amino acids is rapidly reduced. As adaptation occurs there is an 
immediate fall in urinary nitrogen excretion as urea synthesis falls and amino acid 
catabolism declines. Thus amino acids derived from both the diet and from protein 
breakdown are conserved and channelled preferentially into protein synthesis; 
activating enzymes for protein synthesis are stimulated and the enzyme activities 
involved in the urea cycle and in amino acid catabolism decline ". The conservation 
of the essential amino acids, which is a fundamental feature of the metabolism of Nutrition. Chapter 3: Prolein 11-12-1992 43 
animals, including man, is accentuated. The rates of breakdown of body proteins and 
of amino acid exchange across cellular membranes are further reduced so internal 
recycling of amino acids within the body's cells is enhanced. The residual amino acids 
entering the blood are also preferentially channelled into protein synthesis rather 
than oxidation. The factors controlling these events are largely unknown. 
If no dietary protein is given but energy intake is maintained then urinary N falls 
even further as the catabolic amino acid enzymes adjust to the complete absence of 
dietary protein. This obligatory nitrogen loss (ONL) on a protein-free diet reflects 
the progressive loss of body protein in the faeces, as urea in the urine and as 
sloughed and secreted proteins. In a series of 11 studies involving more than 200 
adults aged 22-77 years from many different countries the observed ONL did not 
differ greatly (mean, 53 mg N/kg bodyweight /d; range, 41-69 mg) and corresponded 
to a mean milk protein intake of 0.33 g/kg bodyweight/day
 l. 
Excessive intakes of protein and amino acids 
Excessive protein intake may be associated with health risks, but the level of intake 
at which a risk is induced and the precise role of protein in the pathophysiological 
processes remain uncertain. The principal concerns relate to the maintenance of renal 
function and bone mass. High protein intakes seem to accelerate loss of renal 
function in some kidney diseases, but whether these effects of dietary protein are 
relevant to the general population remains uncertain
 12. Similarly the potential for 
excess dietary protein to mobilise bone calcium and accelerate bone loss needs 
further study
 13. 
Animal studies indicate that an unusually high intake of a single amino acid may 
induce not only a loss of appetite but also secondary metabolic changes in 
metabolism which are disadvantageous. Recent reports of toxic effects associated 
with the ingestion of unusual amounts of tryptophan may relate to toxic 
contaminants but the use of supplements of selected amino acids in individuals on 
European diets is unwise. 
Physiological requirements for protein 
Early attempts to estimate protein requirements in adults depended on determining 
the obligatory nitrogen loss (ONL) of volunteers and then adding each component of 
the N or protein loss or extra factors. It was assumed that 100% of the milk protein 
fed was efficiently utilised. In practice the provision of milk protein in amounts 44 Reports of the Scientific Committee for Food: 31st scries 
corresponding to the ONL is inadequate to induce N balance because the observed 
loss of N increases above the ONL value. This is because the input of dietary amino 
acids necessarily stimulates a modest increase in amino acid oxidation and therefore 
a 25-50 % rise in urinary N output. The minimum requirement for totally digestible 
protein of high amino acid quality is therefore greater than the ONL and it is this 
higher intake to maintain N balance which is taken as the minimum dietary 
requirement under practical everyday conditions ' . Measuring N balance is not easy 
because analytical losses of dietary or urinary nitrogen give the false impression of 
better N accumulation in the body. Repeated studies with short-term balances 
measured over about 2 weeks provide estimated mean protein requirements of 
0.63 g milk or egg protein per kg bodyweight per day. Longer term balance studies 
over 1-3 months on 34 adults fed egg or milk protein suggested an average minimum 
protein requirement of 0.58 g/kg bodyweight/d so the WHO/FAO/UNU Committee ' 
chose an average of 0.6 g protein/kg bodyweight/d as a reasonable minimum figure 
for both adult men and women. 
This figure is considered to be the average minimal value of dietary protein 
compatible with sustained nitrogen balance in health. The intakes needed to achieve 
N balance have a coefficient of variation of 12.5 %. Thus the minimum on which an 
individual may sustain N balance can vary from about 0.45 g/kg/d to 0.75 g/kg/d. This 
upper figure is considered likely to cover the needs of all subjects and has therefore 
been designated a "safe" protein intake for healthy young adults. The various values 
for protein intake are included in Table 3.1. 
Protein quality and essential amino acid requirements 
Table 3.2 provides estimates of the essential amino acid intakes based on the 
classic studies of Rose
 1
4 as adjusted by FAO/WHO
 9. Rose undertook highly 
controlled feeding studies on volunteers fed adequate intakes of all the amino acids 
except the amino acid under test. Therefore the studies were not conducted under 
physiological conditions and little is known of the potential impact of the 
concentration of the other amino acids on the catabolism of the tested amino acid. 
Several authors have suggested that in adults these estimates of essential amino 
acid requirements are too low. In short term balance studies, purified amino acid 
mixtures containing more than the current requirement level have failed to allow 
balance to occur. From a series of recent experiments on the kinetics of essential 
amino acid metabolism in which the minimal physiological requirement might be 
obtained by estimating the obligatory rates of oxidation of essential amino acids, 
Young et al '
5 have suggested new requirement values which are about two or three 
limes higher than current requirement figures. However these high estimates have Nutrition. Chapter 3: Protein 11-12-1992 45 
been challenged
 5-
1
6 on methodological and theoretical grounds. The relatively low 
requirements estimated for adults have been confirmed by a series of nitrogen 
balance studies on normal volunteers fed normal diets rather than purified amino acid 
mixtures
 17. There seems to be an appreciable need for non-essential amino acids or 
N for their synthesis at low protein intakes but detailed studies are still awaited. 
Children 
The assessment of needs made by the FAO/WHO/UNU Consultation ' has not been 
superseded by new information suggesting the need for any changes in the protein 
requirement of children. The values are based on the amount of high quality egg or 
milk protein needed for achieving N balance plus the additional need for growth. 
Table 3.3 shows requirements for children, with a 50% increase being added to the 
average requirement to take account of the day to day variability in growth. The 
efficiency of utilisation was assumed to be 707c with all children receiving adequate 
energy intakes. Breast milk N, although containing appreciable quantities of non-
amino N, is extremely well utilised for reasons which are unclear. It is therefore 
unwise to rely on breast milk data in producing recommendations on protein need for 
bottle-fed babies. Table 3.3 is derived from the FAO/WHO/UNU report
l but taking 
account of European growth patterns. The values all refer to milk protein, which is 
assumed to be completely absorbed. Digestibility of dietary protein will vary from 80 
to 100% of the reference protein depending on the type of diet consumed; cereal diets 
rich in fibre have digestibility values between 80 and 90%. Adjustments for lower 
quality protein will need to be made in the manner suggested by FAO/WHO/UNU ', 
where the total protein intake is increased to ensure that the intake of each essential 
amino acid is equivalent to that which would have been obtained from milk protein. 
The essential amino acid requirement as a proportion of the protein requirement falls 
markedly with age from 54% in infants to 14% in adults. The reason for this is not 
completely explained by the high essential amino acid requirements for growth. 
Examples of the essential amino acid requirements of children aged about two years 
and 10-12 years are shown in Table 3.2. 
Pregnancy 
The extra protein needs in pregnancy are usually based on the FAO/WHO/UNU 
report ', these values having been accepted by the National Academy of Sciences
 18. 
The estimates of protein used are based on the original Hytten and Leitch
 1
9 
estimates of body compositional changes and their likely protein content, a total of 
925 g accumulated protein being accepted by both groups. It is increasingly 
recognised however that pregnancy is associated with changes in protein 
metabolism which may well increase the efficiency of utilisation of amino acids
 20·
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so it may be unwise to consider that the accumulated protein gain has to be 
superimposed on the normal protein requirement of the non-pregnant woman. Given 
these uncertainties the recommendation of the US RDA committee to increase 
protein intakes by 10 g reference protein throughout pregnancy seems appropriate. 
Lactation 
The need for lactation will depend on the amount of breast milk provided but, with 
suitable allowances for individual variation, an extra protein intake of 16 g/d in the 
first 6 months is reasonable, with 12 g being needed for the second six months of 
breast feeding when the child is beginning to derive additional nutrition from foods. 
The elderly 
There are no grounds for reducing the figure for the protein requirements of the 
elderly. Data collated by FAO/WHO/UNU ' suggest that there may be a somewhat 
greater need, but a safe adult level of 0.75 g/kg bodyweight/d will provide a higher 
intake per kg of lean body mass in the elderly because of their having lost lean 
tissue. Nutrition. Chapter 3: Protein 11-12-1992 47 
Table 3.1 Levels of intake of high quality protein f or achieving nitrogen balance 
in adults. 
(g/kg bodyweight/d) 
Average minimum protein 
Requirement 
Population Reference Intake 
Lowest Threshold Intake 
0.6 
0.75 
0.45 
(expressed as g/d) 
Average Requirement 
Population Reference Intake 
Males 
45 
56 
Females 
37 
47 
(increases, g/d) 
Pregnancy 
Lactation  First 6 months 
Second 6 months 
10 
16 
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Table 3.2 Estimates of essential amino acid requirements 
(mg/kg bodyweight/d ) 
Amino acid 
Histidine 
Isoleucine 
Leucine 
Lysine 
Methionine + Cysteine 
Phenylalanine + 
Tyrosine 
Threonine 
Tryptophan 
Valine 
Total without histidine 
Children 
about 2 y 
Mean 
requirement 
Ί 
31 
73 
64 
27 
69 
37 
12.5 
38 
352 
Children 10-
12 y 
Mean 
requirement 
9 
28 
42 
44 
22 
22 
28 
3.3 
25 
214 
Adults 
Mean 
requirement 
[8 - 12]* 
10 
14 
12 
13 
14 
7 
3.5 
10 
84 
Population 
Reference 
Intake 
[16]* 
13 
19 
16 
17 
19 
9 
5 
13 
111 
This figure based on work with children
 2
2 remains uncertain with only limited 
evidence yet available on the essentiality of histidine for adults. Nutrition. Chapter 3: Protein 11-12-1992 49 
Table 3.3 Recommended intakes of protein in children, based on milk protein* 
Age** 
4-6 m 
7-9 m 
10-12 m 
1.0-1.5 y 
1.5-2.0 y 
2-3 y 
3-4 y 
4-5 y 
5-6 y 
6-7 y 
7-8 y 
8-9 y 
9-10 y 
Maies 10 y 
il y 
12 y 
13 y 
14 y 
15y 
16y 
17y 
Females 10 y 
il y 
12y 
13y 
14 y 
15y 
16y 
17 y 
Bodyweight (kg) 
7.5 
9.0 
10.0 
11.0 
12.5 
13.5 
15.5 
17.5 
19.5 
22.0 
24.5 
27.0 
30.0 
33.0 
36.5 
41.0 
47.0 
53.0 
58.0 
62.5 
64.5 
34.0 
37.5 
43.0 
48.0 
50.5 
52.5 
54.0 
54.5 
Safe level (g protein/ 
kg bodyweight/d) 
1.86 
1.65 
1.48 
1.26 
1.17 
1.13 
1.09 
1.06 
1.02 
1.01 
1.01 
1.01 
0.99 
0.99 
0.98 
1.00 
0.97 
0.96 
0.92 
0.90 
0.86 
1.00 
0.98 
0.96 
0.94 
0.90 
0.87 
0.83 
0.80 
Total intake 
(g/d)*** 
14.0 
15.0 
15.0 
14.0 
14.5 
15.5 
17.0 
18.5 
20.0 
22.0 
24.5 
27.5 
29.5 
32.5 
36.0 
41.0 
45.5 
51.0 
53.5 
56.5 
55.5 
34.0 
37.0 
41.5 
45.0 
45.5 
45.5 
45.0 
43.5 
* Calculated as in Tables 33 and 34 in FAO/WHO/UNU report '. 
** The midpoint of each age group was used, except for those below 2 years, 
6 months. 9 months. 12 months. 1.5 years (for 1.0-1..S y) and 2.0 years (for 1 
*** Rounded to nearest 0.5 g. 
where the ages taken were 
.5 to 2.0 y). 50 Reports of Lie Scientific Committee for Food: 31st series 
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Physiology and metabolism 
Dietary fat is a major source of energy and also provides fat soluble vitamins and 
essential fatty acids. The properties of dietary fat are primarily determined by the 
composition of its fatty acids, which may be saturated (no double bonds), 
monounsaturated (one double bond) or polyunsaturated (2 or more double bonds). 
Certain polyunsaturated fatty acids (PUFA) of the n-6 and n-3 series (with the 
terminal double bond 6 or 3 carbon atoms from the methyl end) cannot be 
synthesized by man and must be supplied with the diet to avoid deficiency. The 
major PUFA in vegetable oils, linoleic acid (18:2n-6*), until recently was thought to 
be the only true essential fatty acid. Linoleic acid can be converted into other n-6 
fatty acids, such as dihomo-y-linolenic acid (20:3n-6) and arachidonic acid (20:4n-6), 
by consecutive desaturation and chain elongation. These longer chain n-6 fatty acids 
have an even stronger essential fatty acid activity and specific physiological 
functions '-
2. 
N-6 fatty acids are not interconvertible with n-3 fatty acids, such as a-linolenic 
(18:3n-3) found in some vegetable oils, and eicosapentaenoic (20:5n-3) and 
docosahexaenoic acids (22:6n-3) found in marine fish. N-3 fatty acids must be 
independently supplied in the diet. 
Linoleic acid (18:2n-6) and a-linolenic acid (18:3n-3) compete for binding to the same 
enzyme system, for which a-linolenic acid has a higher affinity. Excessive dietary 
intakes of a-linolenic acid in relation to linoleic acid may reduce tissue levels of 
linoleic acid metabolites. 
PUFA are indispensable lipid components of cellular and subcellular membranes in 
all tissues. The extent to which they are incorporated into membranes consequeni 
upon their availability modulates a variety of membrane functions, including 
membrane fluidity, permeability for metabolite exchange, activity of membrane-bound 
In the short formula describing fatly acids, die first figure represents the number of carbon atoms, 
the second figure after a colon represents the number of double bonds, and finally the position of die 
terminal double bond is indicated (n-x). Nutrition. Chapter 4: Essential fatty acids 11-12-1992 53 
enzymes and receptors, electrical and humoral signal transduction, and hence 
properties of cells and organs '·
2. 
Some highly unsaturated fatty acids (20:3n-6, 20:4n-6, 20:5n-3) are also required as 
precursors for the synthesis of eicosanoids. These biologically active compounds, 
which include prostaglandins, thromboxanes, prostacyclins and leukotrienes, are 
regulators of the cardiovascular system, blood coagulation, renal function, 
inflammation and immune response, and a large variety of other tissue functions. 
The quality and quantity of dietary fat intake is related to several risk factors for the 
occurrence of coronary heart disease. This report however is restricted to the 
requirements for essential fatty acids and is not concerned with recommendations for 
the reduction of risk of coronary heart disease. 
Levels of deficiency and excess 
Clinical signs of linoleic acid (18:2n-6) deficiency, such as growth failure and skin 
changes, may develop in healthy newborn infants fed a diet with less than 1 % of 
energy as linoleic acid for 2-3 months
 2·
3. In human adults, clinical linoleic acid 
deficiency has been described only in individuals with chronic disease states or after 
long-term intravenous feeding. Minimal requirements of linoleic acid for preventing 
clinical signs of deficiency in healthy adults are not well defined. The occurrence of 
human a-linolenic acid (18:3n-3) deficiency has been reported
 4-
5 but the evidence 
has been questioned
 6·
Ί. Deficiency of n-6 and n-3 very long-chain PUFA 
(metabolites of linoleic and a-linolenic acids) may occur during the perinatal period
 8 
but has not been documented in human adults. However, it must be assumed that 
human adults do require a certain amount of n-3 fatty acids to replace physiological 
losses (e. g. oxidation and eicosanoid formation, losses with cellular debris). 
A large number of infants have been fed formulas with very high amounts of linoleic 
acid (60 % of total fat) without the occurrence of any apparent short term adverse 
effects
9. Nonetheless side effects of very high consumptions of PUFA are 
conceivable, including formation of potentially toxic lipid peroxides and alterations of 
immune functions. Diets with a very high ratio of PUFA to saturated fatty acids 
(P/S-ratio) cause an undesirable decrease of high-density lipoprotein (HDL) 
cholesterol, while similar absolute PUFA intakes with higher fat intakes and lower 
P/S-ratios are not associated with this side effect i°."·
12. High intakes of very long-
chain n-3 fatty acids may increase rates of bleeding and apoplectic insults. Therefore, 
it appears prudent to avoid extremely high dietary intakes of PUFA. 54 Reports of the Scientific Committee for Food: 31st scries 
An increased intake of PUFA raises the need for vitamin E to prevent unwanted 
oxidation. Fortunately foods rich in PUFA tend to contain sufficient vitamin E, but 
this is not always the case, and may not necessarily be so in preparations of 
supplements. With high dietary intakes of PUFA it is essential to ensure that the 
intake of vitamin E is adequate. 
Methods of establishing physiological requirements 
Adults 
Minimal requirements for linoleic acid in human adults are not well established. 
There are no long-term studies on the amount of linoleic acid required to maintain a 
stable body pool. In laboratory rats a low dietary intake of linoleic acid leads to an 
increase of a specific trienoic acid (20:3n-9) and the triene-tetraene ratio (ratio 
20:3n-9/20:4n-6). It has been proposed that an increased triene-tetraene ratio may 
also indicate linoleic acid deficiency in human adults, but there are not enough data to 
support this assumption or to establish a reliable threshold level of this ratio above 
which clinical signs of deficiency would appear. Therefore, linoleic acid requirements 
of healthy adults can only be estimated roughly from the results of feeding studies in 
infants. As a lower threshold of habitual intake below which deficiency is probable or 
metabolic integrity is unlikely to be maintained, 0.5 % of dietary energy is suggested. 
Average physiological requirements are estimated to be 1 % of dietary energy. With 
a certain margin of safety, a Population Reference Intake of 2 % of dietary energy is 
proposed. 
In addition to n-6 fatty acids, n-3 PUFA (a-linolenic acid and its metabolites) should 
be supplied to replace physiological losses of endogenous stores. It may be 
concluded from data on current dietary habits in Europe that an intake of 0.2 % of 
energy as n-3 PUFA results in no apparent clinical signs and appears to meet 
average physiological requirements. With a certain margin of safety, a Population 
Reference Intake of 0.5 % of dietary energy is proposed. 
It appears prudent to set upper limits for the dietary intake of PUFA because of 
potential untoward side effects of excessive consumption, such as lipid peroxidation, 
immunosuppression and bleeding. 
Administration of fish oil providing 1.5 % n-3 PUFA (mainly eicosapentaenoic acid)/d 
over several months was associated with bleeding problems in adolescents and 
young adults
 13. Suppression of antiinfective functions of leukocytes occurred in 
human subjects consuming diets containing 6.3 % of energy as a-linolenic acid '
4 or 
receiving fish oil supplements providing approximately 1.5 % of energy as Nutrition. Chapter 4: Essential falty acids 11-12-1992 55 
cicosapentaenoic plus docosahexaenoic acids
 15·
16. Dietary n-3 PUFA usually 
consist mostly of a-linolenic acid, and only a smaller portion is contributed by its 
metabolites. 
It is recommended that habitual intakes of total n-3 PUFA should not exceed 5 % of 
energy and intakes of total PUFA (n-6 + n-3) should not exceed 15 % of energy. 
Other groups 
There is no evidence that essential fatty acid requirements during pregnancy and 
lactation are different, if they are expressed as percentages of energy intake. 
It has been suggested
 9 that the dietary essential fatty acid intakes for formula-fed 
infants should be 4.5 % of energy for n-6 PUFA and approximately 0.5 % of energy for 
n-3 PUFA and these are now put forward as PRIs for infants 6-1 lm. Population 
Reference Intakes for children aged 1-3 years should be 3 % of energy for n-6 PUFA 
and 0.5 % of energy for n-3 PUFA. Population Reference Intakes for children from 
4 years, expressed as percentages of energy intake, should be the same as those for 
adults. 56 Reports of the Scientific Committee for Food: 31st series 
Summary 
Expressed as a percentage of dietary energy 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
Pregnancy 
Lactaiion 
Children 
Age 
6- 11 m 
l-3y 
4-6y 
7- 10 y 
11 -14 y 
15 -17 y 
n-6 polyunsaturated 
fatty acids 
1 
2 
0.5 
n-3 polyunsaturated 
fatty acids 
0.2 
0.5 
0.1 
As for all adults 
As for all adults 
PRI 
n-6 PUFA 
4.5 
3 
2 
2 
2 
2 
n-3 PUFA 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 Nutrition. Chapter 4: Essential fally acids 11-12-1992 57 
These values can be expressed for average energy expenditures in g PUFA/d. 
Adults 
Average requirement 
Population Reference 
Intake 
Pregnancy (from 10th week) 
Lactation 
Males 
n-6 PUFA 
3 
6 
n-3 PUFA 
0.6 
1.5 
Females 
n-6 PUFA 
2.5 
4.5 
5 
5.5 
n-3 PUFA 
0.5 
1 
1 
1 
Population Reference Intakes for younger age groups (g PUFA/d) 
Age group 
6- 11 m 
l-3y 
4-6y 
7- 10 y 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
n-6 PUFA 
4 
4 
4 
4 
5 
6 
4 
5 
n-3 PUFA 
0.5 
0.7 
1.5 
Level above which concern should be expressed about possible development of 
metabolic abnormalities: 
n-3 PUFA 
n-3 PUFA + n-6 PUFA 
59c of dietary energy 
15% of dietary energy 58 Reports of the Scientific Committee for Food: 31st serie 
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Physiology and metabolism 
Vitamin A can be obtained in two ways: as preformed vitamin A (retinol) and as 
carotenoid pigments that can be cleaved in the body to give retinol. Preformed 
vitamin A (usually in the form of retinyl esters) occurs naturally only in animals. It is 
also synthesized for fortification of foodstuffs and inclusion in pharmaceutical 
preparations. Most of the vitamin A in European diets comes as preformed vitamin 
A, but a substantial contribution is made by carotenoids, mainly from plant foods, 
and overwhelmingly as ß-carotene, although some other carotenoids can also act as 
provitamins A. 
The two contributions have to be added to give the total vitamin A activity. The 
widely accepted convention is that as they usually come in the diet 6 μg ß-carotene 
and 12 μg other provitamin A carotenoids can be considered to be nutritionally 
equivalent to 1 μg retinol. The weights of provitamin A carotenoids are converted to 
the equivalents of retinol and added to the weight of preformed retinol, to express 
the total vitamin A in terms of retinol equivalents, e.g. an intake of 1800 μg ß-
carotene plus 600 μg retinol would amount to 300 + 600 = 900 μg retinol 
equivalents '. Retinol equivalents are replacing the older international units (1 
international unit = 0.3 μg retinol) as a measure of vitamin A activity, in part because 
of the problem of adding in the contribution of dietary carotenoids 
Provitamin A carotenoids raise a difficult problem of bioavailability. Carotenoids are 
absorbed better from some foodstuffs and diets than from others and the percentage 
converted to retinol depends to some extent on how much is ingested in a meal. The 
vitamin A potency will therefore vary quite substantially according to 
circumstances '. For practical purposes it is necessary to select some value that can 
be used routinely and the factors mentioned were chosen by an FAO/WHO Expert 
Group '.Taken over a period of time and a variety of foodstuffs, they are a crude but 
serviceable compromise. They have been used for many years and are internationally 
accepted; there seems no reason to propose any change. 
The conversion of carotenoids to retinol takes place mainly in the intestinal mucosa. 
The newly formed retinol, along with any preformed retinol in the diet, is esterified in 
the intestinal mucosa and transported to the liver. The liver is the major organ for 
storage of reserves of esterified vitamin A. Retinyl esters in the liver are hydrolysed 
to free retinol, which is put into the plasma on a carrier protein, retinol-binding Nutrition. Chapter 5: Vitamin A 11-12-1992 61 
protein. The rate of output of retinol from the liver is controlled so as to keep the 
plasma retinol concentration fairly constant. Dietary vitamin A surplus to immediate 
requirements is used to build up liver reserves, which can subsequently be drawn 
upon during any temporary dietary shortage. 
Retinol is delivered by retinol-binding protein to the tissues that utilize it. In the eye 
it serves in its aldehyde form as the light-gathering pan of the visual pigments. In 
other organs it has different functions, being necessary for growth and development 
and for the normal differentiation of cells; in this role, perhaps in the form of retinoic 
acid, it appears to react with nuclear receptors to modify gene expression
 2. 
Levels of deficiency and excess 
The reserves of retinyl esters in the liver can be used to maintain the plasma retinol 
concentration reasonably constant, so normal delivery to target organs can continue. 
Only when the liver reserves are exhausted does the plasma retinol concentration 
fall below 20 μg/dl (0.7 μιτιοΙ/L) and deficiency signs begin to appear. An early 
indication is impaired adaptation to low-intensity light (night blindness). Other signs 
show, and in the later stages dryness of the conjunctiva and cornea (xerophthalmia) 
develops, which can lead to permanent eye damage. 
Intakes of vitamin A in excess of needs are used to build up liver reserves of retinyl 
esters. If however very large amounts of retinol and retinyl esters are ingested, they 
can overwhelm this liver mechanism and cause liver and bone damage, hair loss, 
double vision, vomiting, headaches and other abnormalities. 
Large single doses (e.g. 300 mg in adults) can cause acute toxicity, but 
hypervitaminosis A usually arises from chronic ingestion of retinol or retinyl esters, 
not necessarily in very large amounts (e.g. 15 mg per day) but sufficient over a period 
of time to build up stocks that exceed the liver's ability to store or destroy them
 3. It 
has been suggested that even lower daily doses can cause liver damage if taken for 
long enough
 4. 
Worst of all, retinol and retinyl esters are highly teratogenic
 3, probably as a 
consequence of the excessive formation of retinoic acid, which modulates gene 
expression
 2 and is a natural morphogen
 5. The lowest intake of retinol (free or 
esterified) that has teratogenic potential cannot be estimated reliably from the 
available data. Regular consumption of more than 6,000 μg per day has been 
associated with birth defects, but the risk seems not to be high unless much larger 
amounts are taken; chronic intakes of 30,000 μg per day will almost certainly be Reports of the Scientific Committee for Food: 31st series 
It is recommended that single doses of retinol and retinyl esters should not exceed 
120 mg retinol equivalents, and regular intakes should not exceed 9,000 μg/d for adult 
men, and 7,500 μπ/d for women that are not pregnant or likely to become pregnant
 
6. 
Pregnant women should not take supplementary vitamin A except under medical 
supervision. Proportionately lower amounts are suggested for children
 
f'. 
ß-Carotene does not cause hypervitaminosis A because it cannot be converted 10 
retinol sufficiently quickly. 
Methods of establishing physiological requirements 
As mentioned, vitamin A absorbed in excess of immediate needs is stored in the 
liver in esterified form. The size of the liver reserve is therefore the best objective 
measure of vitamin A status, and is commonly used for post-mortem studies. 
A biochemical measure that can be easily made in living subjects is the plasma 
retinol concentration, but this is an insensitive indicator of vitamin A status, for a 
homoeostatic mechanism maintains the plasma level reasonably constant over quite 
a wide range of liver reserves. The plasma retinol concentration falls to a potentially 
hazardous level only in the later stages of deficiency, when other signs are beginning 
to show. 
Most recommendations for the vitamin A requirements of adults have been based on 
repletion studies with vitamin Α-depleted human volunteers. The best known are the 
so-called Sheffield experiment in UK
 
7 and a later, and more thorough, American 
investigation
 
s·
9. In these studies increasing doses of vitamin A were given to 
depleted volunteers to cure deficiency signs such as impaired dark adaptation, 
abnormal electroretinograms, follicular hyperkeratosis and lowered blood 
haemoglobin and also to restore normal plasma retinol concentrations. 
Another approach suggested by Olson
 
1
0 defines vitamin A status in terms of an 
adequate body pool size, conveniently expressed in terms of the liver vitamin A 
content. Olson proposed as a criterion for vitamin A sufficiency a liver concentration 
of 20 μg retinol (or the equivalent in the esterified form) per g wet weight liver. This 
level for vitamin A reserves meets a number of criteria
 
7. 
1. No clinical signs of deficiency have been noted in subjects with this liver 
concentration. 
2. This liver concentration will maintain a steady-state concentration of retinol in 
the plasma above 20 pg/dl (0.7 μιηοΙ/L). Nutrition. Chapter 5. Vitamin A 11-12-1992 63 
3. This concentration should maintain an adult on a diet containing no vitamin A 
free from deficiency signs for a period of months. 
Translation of physiological requirements into dietary intake 
Olson
 1
0 suggested a method of calculating the mean dietary intake needed to 
maintain a liver retinol concentration of 20 μg/g assuming that the liver reserves 
represent 90% of the total body vitamin A and the efficiency of storage in the liver of 
an ingested dose of vitamin A is 50% (reported values 40-90%). 
Studies with radioactive vitamin A in eight adult male volunteers
 5 gave a mean 
fractional catabolic rate, i.e. the percentage of total body stores lost per day, of 0.5%. 
Calculations based on this and the assumptions mentioned gave a mean dietary 
intake of 6.7 μg retinol per kilogram body weight per day. For a 75 kg man this would 
be 503 μ^ά; for a 62 kg woman, 415 μ g/d. 
The coefficient of variation for the rates of depletion in these experimental subjects 
was about 20%, so the mean ± 2SD daily dietary requirement would be 503 μ° ± 201 
for men and 415 μg + 166 for women. 
Although these calculations rest on a number of assumptions that have to be 
arbitrary and will not hold in all circumstances, the derived requirements appear 
consistent with the effects on deficiency signs observed in depletion-repletion 
studies in human volunteers
 7·
8,9. They also provide some indication of what the 
range of individual requirements might be, even though only eight subjects were 
investigated. Such calculations have been used as the basis of the latest 
FAO/WHO
 u and UK
 1
2 recommendations. 
Other reviewing bodies have preferred to base their recommendations on repletion 
studies. Some indeed specifically reject the body pool approach
 13-
14, in part because 
of some doubts about the assumptions underlying the calculations, but mainly 
because it was thought safer to have reserves in the liver higher than 20 μ^, and to 
aim for a plasma retinol concentration above 30 μ^Ι (1 μπιοΙ/L) rather than 20 μg/dl 
(0.7 μπιοΙ/L). Mild deficiency signs have been reported in some American volunteers 
depleted of vitamin A when plasma concentrations were between 20 and 30 μg/dl 
(0.7-1.0 μπΊθΙ/L)
 13. To maintain plasma retinol concentrations over 30 μg/dl a mean 
daily intake of 900 μg appeared to be needed in adult men; the current US RDA for 
adult men is set at 1000 μg. For adult women it is 800 μg/d '
3. 
Repletion studies however lend to overestimate requirements because deficiency 
signs often take some time to improve when a small curative dose of vitamin A is 64 Reports of the Scientific Committee for Food: 31st scries 
given, and there is understandable reluctance to keep subjects on low intakes for 
prolonged periods. 
Both the body pool calculations and the interpretations of the results of repletion 
experiments are open to criticism not least because both have to be based on a small 
number of subjects. There are also differences of opinion on what criterion of vitamin 
A sufficiency should be adopted, notably in terms of the plasma retinol concentration. 
Although a homoeostatic mechanism maintains the plasma retinol concentration 
reasonably constant in an individual, the levels differ between communities. In 
industrialised countries the values are usually high, e.g. in a recent survey in UK, the 
mean plasma retinol concentrations for adult men and women were 63 μg/dl (2.2 
μπιοΐ/ί) and 54 μg/dl (1.9 μπιοΙ/L) respectively
 15. In other parts of the world mucl 
lower concentrations seem compatible with normal function and health. For example, 
many Thais maintain concentrations below 30 μg/dl (1 μΓηοΙ/L) even when livei 
stores are quite high '
6. 
It is unclear why in prosperous communities high plasma retinol concentrations are 
normal and why some such subjects when given an Α-low diet start to develop 
deficiency signs at plasma concentrations well above those maintaining health and 
normal function in other countries. The possibility should be considered that some 
populations have adapted to a high dietary intake of retinol and their high plasma 
concentrations are a consequence of that adaptation. 
Europeans and North Americans are unlikely to need plasma retinol concentrations 
higher than are adequate for many other nations. The National Research Council '
3 
recommended for USA an allowance of 1000 μg/d in order to maintain a plasma retinol 
concentration of 30 μg/dl (1 μπιοΙ/L) in most adult men. Making reasonable 
assumptions about the coefficient of variation and the consequent range of needs, 
one would predict, if this recommendation is realistic, that large numbers of men in 
the world would receive less than the minimum necessary and vitamin A deficiency 
would be far more widespread than it is. It seems doubtful if it is necessary to 
maintain a plasma retinol concentration above 30 μg/dl (1 μιτιοΙ/L) for the whole 
population. 
There seems no need to encourage high consumption of vitamin A in Europe. Intakes 
appear to be adequate; there is no deficiency. In North America there is some 
concern about excessive intakes of vitamin A
 3. This Committee '
7 has advised 
women who are or might become pregnant to avoid eating liver because of its high 
vitamin A content, and has recommended pregnant women not to lake 
supplementary vitamin A in amounts greater than the RDA (here PRI). Nutrition. Chapter 5: Vitamin A 11-12-1992 65 
In these circumstances it seems better to discourage rather than encourage higher 
vitamin A intakes. It is proposed that recommendations be based on the body pool 
procedure as described, i.e. that used by FAO/WHO
 8 but with body weights 
appropriate for Europeans. The rounded off values for adult men and women, 
expressed in retinol equivalents/d are: 
Population Reference Intakes 700 μg (men), 600 μg (women); 
Average Requirements 500 μg (men), 400 μg (women); 
Lowest Threshold Intakes 300 μg (men), 250 μg (women). 
Children 
Whereas adult needs for vitamin A seem to be determined largely by the destruction 
of body stores, children have a requirement for growth, but no good evidence is 
available for estimating population reference intakes for children. 
Most recommendations for formula-fed infants are based on the amounts in breast 
milk, e.g. the most recent FAO/WHO value of 350 μg retinol equivalents/d
 u. This is 
likely to be an overestimate as no breast-fed infants ever show signs of A-
deficiency, even on intakes of 100-200 μg/d
 1819. The value of 350 μg retinol 
equivalents/d is however proposed as the PRI for infants 6-11m. 
PRIs for older children are put forward to make a smooth transition from the infant to 
adult values as shown in the summary. There is little direct evidence to support 
these values, but they appear unlikely to be underestimates; Reddy
 2
0 has reported 
that a daily intake of about 300 μg will meet the requirements of pre-school children. 
Pregnancy 
In pregnancy extra vitamin A is required for the growth of the fetus, for its 
maintenance, for providing some small reserves for the fetus, and for maternal tissue 
growth. Much of the requirement for newborn infants seems to be for growth. The 
fetus grows rapidly during the third trimester, and presumably has needs rising 
towards those of the newborn. 
Recommendations for adult females are intended to maintain a liver concentration of 
20 μg retinol equivalents per gram wet weight. Women with such a liver retinol 
concentration would need an extra supply of retinol to cover the demands of 
pregnancy. An increment of 100 μg daily throughout pregnancy would enhance 66 Reports of the Scientific Committee for Food: 31st scries 
maternal storage to provide adequate vitamin A for the growing fetus in late 
pregnancy. A PRI of 700 μg retinol equivalents per day is proposed. 
Many European women will have intakes of vitamin A higher than that when not 
pregnant, so their habitual diet will be ample for pregnancy. As mentioned, vitamin A 
is highly teratogenic, and consumption by pregnant women of more than 6,000 μg per 
day has been associated with birth defects
 3. Pregnant women on a good diet should 
not take supplementary vitamin A except under medical advice. 
Lactation 
If it is assumed that 350 μg retinol is supplied in the milk, the mother needs to have 
this replaced. The increment proposed throughout lactation is 350 μg retinol 
equivalents/d. Nutrition. Chapter 5: Vitamin A 11-12-1992 67 
Summary 
(all as μg retinol equivalents/d) 
Adults 
Average Requirements 
Population Reference Intake 
Lowest Threshold Intake 
Males 
500 
700 
300 
Females 
400 
600 
250 
Population Reference Intakes for other groups 
Children:  Age Group 
6- 11 m 
l-3y 
4-6y 
7- lOy 
Males  11 - 14 y 
15 - 17 y 
Females  11 - 14 y 
15- 17 y 
Lactation 
Pregnancy 
PRI (ßg retinol equivalents/d) 
350 
400 
400 
500 
600 
700 
600 
600 
950 
700 (total intake) 
(Supplements to be taken 
only under medical advice) 68 Reports of the Scientific Committee for Food: 31st scries 
Potentially harmful intakes of retinol (free and esterified) 
Single doses should not exceed 120 mg. 
Regular intakes should not be greater than the following
 15: 
Adults 
Men 
Women that are not pre 
pregnant* 
enant or likely to become 
9000 μζ/d 
7500 μg/d 
Infants 
Children 
6-11 m 
l-3y 
4-6y 
7 -10 y 
11-17 y 
9(X^g/d 
18(X^g/d 
3000 μ^ 
4500 μ^ 
6000 μg/d 
Therapeutic doses may exceed these limits, but only under medical supervision. 
* Pregnant women should not take supplementary vitamin A except under medical 
supervision. Nutrition. Chapter 5: Vitamin Λ 11-12-1992 69 
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(suppl): 34-37. 6. ß-Carotene (and other carotenoids) 
ß-Carotene is the most abundant member of the carotenoids, a group of pigments of 
which more than 500 are known. They are widely distributed, particularly in the plant 
kingdom. In terms of human nutrition, interest in the past concentrated on the 
function of ß-carotene as a precursor of vitamin A. It can be cleaved enzymically to 
give retinol, mostly in the intestinal mucosa. Some other carotenoids can similarly 
give rise to retinol, but not so effectively as ß-carotene. Most carotenoids have no 
provitamin A activity and in the past have not usually been considered in human 
nutrition. 
Recently however much interest has been shown in possible functions of ß-carotene 
other than as a provitamin A. It can act as an antioxidant, inactivating certain 
reactive oxygen species such as singlet oxygen. It can be a chain-breaking 
antioxidant in a lipid environment, differing from the major fat-soluble antioxidant, 
vitamin E, in being most effective at the low partial pressures of oxygen found in 
mammalian tissues '. 
Some of the dietary ß-carotene is converted to vitamin A, but some is absorbed 
intact, and increased dietary intakes are associated with increased plasma 
concentrations
 
2. 
Carotenoids that are not provitamins A but have a chain of nine or more double 
bonds would be expected to have essentially the same antioxidant properties. In 
considering the biological activities of ß-carotene other than as a precursor of vitamin 
A, one should also consider other dietary carotenoids. A number of carotenoids are 
found in human plasma and tissues, including ß-carotene, α-carotene, lycopene, 
cryptoxanthin and lutein. They may differ in metabolism and rate of uptake by 
tissues, and thus in biological action
 
3. ß-carotene (and other carotenoids) can 
therefore be considered as among the array of antioxidants, including vitamins E and 
C, which have been implicated in the protection of tissues from disease processes 
involving free radicals. 
Much work with cultured cells, tissue preparations and experimental animals has 
indicated that ß-carotene and other carotenoids may protect against mutagens, 
decrease malignant iransformations, prevent the appearance of tumours and enhance 
immune responses, among other things
 
4. The findings are usually based on either in 
vitro systems or the employment of much larger amounts of carotenoids than in a 72 Reports of the Scientific Committee for Food: 31 si scries 
normal diet, so their relevance to physiological nutritional requirements in humans is 
uncertain. 
The most persuasive nutritional claim put forward is that a high dietary intake of ß-
carotene, or carotenoids, confers some protection against cancer. Dietary 
epidemiological studies have shown fairly consistently that people with a relatively 
low intake of ß-carotene or total carotenoids have a higher risk of cancer, especially 
lung cancer
 5. There is an inverse correlation between serum ß-carotene 
concentration and risk of cancer
 6-
7. While there appears to be an inverse relationship 
between the consumption of carotenoid-containing fruits and vegetables and the 
incidence of cancer, there is no proof that ß-carotene or carotenoids are the protective 
factor. Prospective trials of the possible health benefits of ß-carotene other than as a 
provitamin A are in progress. Until the results of these are known, it seems 
unwarranted to make any recommendation other than to encourage the consumption 
of vegetables and fruit. 
Very high doses of ß-carotene may turn the skin yellow, but are not toxic
 8. 
Summary of proposals 
There is as yet insufficient evidence to recommend the consumption of any specific 
amount of ß-carotene, or carotenoids in general, beyond what is needed to supply 
vitamin A. Nutrition. Chapter fi: |ì-Carotcne 11-12-1992 73 
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Physiology and metabolism 
The principal metabolic function of thiamin (vitamin B,) is as the precursor for 
thiamin diphosphate (thiamin pyrophosphate), which is the coenzyme for a number of 
reactions involved in carbohydrate and branched-chain amino acid metabolism and 
central energy-yielding metabolic pathways. In addition thiamin triphosphate has a 
role in the propagation of nerve impulses in the nervous system '. Most thiamin in 
foods is present as phosphates, mainly thiamin diphosphate. These phosphates are 
hydrolysed by phosphatases in the intestinal lumen; free thiamin is absorbed in the 
upper small intestine. The absorption of thiamin is impaired by alcohol. While 
intestinal mucosal cells take up thiamin normally in the presence of alcohol, there is 
impaired transport from the cells into the circulation
 2. Some thiamin is 
phosphorylated to thiamin monophosphate during absorption, or on passage through 
the liver. 
Both free thiamin and thiamin monophosphate circulate at low concentrations in 
plasma, bound to albumin; they are taken up by tissues, and converted to thiamin 
diphosphate (and thiamin triphosphate in nerve tissue). At high intakes, when the 
albumin binding capacity is saturated, the excess (unbound) vitamin is rapidly 
excreted in the urine. A small amount of thiamin is excreted in the urine unchanged 
(normally about 3% of a test dose). The major excretory metabolite is thiochrome, 
although some 20 additional metabolites are excreted in small amounts. There is 
little storage of thiamin in the body, and metabolic abnormalities develop within a 
few days of initiating a thiamin-deficient diet. 
Deficiency and excess 
Thiamin deficiency can result in three distinct syndromes. 
(i) Beriberi, a chronic peripheral neuritis, which may or may not be associated 
with heart failure and oedema. 
(ii) Acute pernicious (fulminating) beriberi, in which heart failure and life-
threatening metabolic acidosis predominate, with little or no evidence of 
peripheral neuritis. Nutrition. Chapter 7: Thiamin 11-12-1992 75 
(iii) Central nervous system disturbances, Wernicke's encephalopathy with 
Korsakoffs psychosis. This is most commonly associated with alcoholism and 
narcotic abuse. 
In general, an acute deficiency is involved in the central nervous system lesions of 
the Wernicke-Korsakoff syndrome, and a relatively high energy intake is a 
predisposing factor. Beriberi is more commonly associated with a more prolonged, 
less severe, deficiency, together with a generally low food intake. A higher intake of 
carbohydrate and physical activity predispose to the development of heart failure and 
oedema. 
The intestinal absorption of thiamin is readily saturated, and no more than about 2.5 
mg can be absorbed in a single dose. Thiamin in the bloodstream which is not bound 
to plasma proteins is rapidly excreted in the urine
 8. There is no evidence of toxicity 
of thiamin taken by mouth, at intakes of up to 500 mg/day (for 1 month). 
Requirements 
Adults 
Because the principal metabolic role of thiamin is in energy-yielding metabolism, and 
especially in carbohydrate metabolism, the requirement is related to energy intake. 
Saturation of the red cell enzyme transketolase with its coenzyme, thiamin 
diphosphate, provides a convenient means of assessing the adequacy of body 
reserves of thiamin. This is generally expressed as the transketolase activation 
coefficient - the ratio of enzyme activity with added thiamin diphosphate/ that 
without added coenzyme. 
Clinical signs of deficiency are seen in subjects receiving less than 30 μg/MJ, so this 
is obviously an inadequate intake. In a long-term feeding study, an intake of 45 
μg/MJ led to a progressive decline in urinary excretion, falling to 15 μg/24h after 20 
months. There were no clinical signs of deficiency, but after 30 months there was an 
impairment in the metabolism of a test dose of glucose
 3·
4. This intake is therefore 
marginally inadequate. 
In depletion / repletion studies, intakes of about 50 μg/MJ are adequate to maintain 
urinary excretion above 15 μg/day. The average requirement for the maintenance of a 
normal erythrocyte transketolase activation coefficient is 72 μg/MJ
 5·
6. Allowing for 
individual variation, this gives a PRI of 100 μg/MJ. For people on energy intakes of 
less than 8 MJ/d, thiamin requirements may not be related directly to energy intake. 
For them a PRI of 0.8 mg/d is suggested. 76 Reports of the Scientific Committee for Food: 31st scries 
Maximum activity of erythrocyte transketolase and complete saturation of the 
enzyme with its coenzyme require an intake of 140-190 μg/MJ
 7. There is no evidence 
that this confers any benefit, or is a desirable aim. 
Other age groups 
There is no evidence that thiamin requirements of women differ from those of men, 
other than as affected by energy expenditure, or that children, adolescents or the 
elderly have different requirements /MJ energy intake. 
Pregnancy and lactation 
In pregnancy and during lactation thiamin requirements/MJ energy intake are 
unchanged. The thiamin produced in the milk should be covered by the extra amount 
accompanying the increased energy intake. Nutrition. Chapter 7: Thiamin 11-12-1992 77 
Summary 
The requirement for thiamin depends on the utilisation of energy-yielding substrates. 
It therefore increases with the energy expenditure. 
Average requirement 
Population Reference Intake 
Lowest Threshold Intake 
72μ§/Μ1 
100 Hg/MJ 
50 μg/MJ 
These can be expressed for average energy expenditure in mg thiamin/d. 
Adults 
Average requirement 
Population Reference Intake 
Lowest Threshold Intake 
Pregnancy 
Lactation 
Males 
0.8 
1.1 
0.6 
Females 
0.6 
0.9 
0.4 
1.0* 
1.1 
* From 10th week of pregnancy 78 Reports of the Scientific Committee for Food: 31st scries 
Population Reference Intakes for younger age groups 
Age Group 
6- 11 m 
l-3y 
4-6y 
7- lOy 
Males 11 - 14 y 
15- 17 y 
Females 11 - 14 y 
15- 17 y 
PRI (mg/d) 
0.3 
0.5 
0.7 
0.8 
1.0 
1.2 
0.9 
0.9 Nutrition. Chapter 7: Thiamin 11-12-1992 79 
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Physiology and metabolism 
Riboflavin is the precursor for the synthesis of two coenzymes, riboflavin phosphate 
(flavin mononucleotide, FMN) and flavin adenine dinucleotide (FAD), and 
covalently bound flavin prosthetic groups in enzymes. These function in a variety of 
enzymes catalysing oxidation and reduction reactions and electron transport; 
riboflavin is thus involved in a wide variety of metabolic pathways, including the 
biosynthesis and catabolism of amino acids, fatty acids and carbohydrates. 
Apart from milk and eggs, which contain a relatively large amount of riboflavin bound 
to specific binding proteins, most of the riboflavin in foods is as riboflavin phosphate 
and FAD bound to enzymes. After release by digestion of the enzyme proteins, the 
coenzymes are hydrolysed in the intestinal lumen by phosphatases. The resultant 
free riboflavin is absorbed in the upper small intestine by an active process. 
Riboflavin is transported in plasma both as the free vitamin and as coenzymes, 
largely bound to plasma proteins. There is rapid excretion from tissues of any 
riboflavin which is not bound to enzymes, and hence functionally active. Riboflavin 
and riboflavin phosphate which are not bound to plasma proteins are rapidly excreted 
by the kidneys, both by simple filtration and by active secretion into the urine. Active 
resorption of riboflavin from the urine is saturated at normal plasma concentrations of 
the vitamin, and so is mainly important in deficiency, acting to conserve the vitamin. 
About 25% of the urinary excretion of riboflavin is as the unchanged vitamin; the 
remainder is excreted as a variety of metabolites. There is little or no storage of 
riboflavin in the body; any surplus intake is rapidly excreted. Once intake is adequate 
to meet requirements, the urinary excretion of the vitamin reflects intake until the 
capacity for intestinal absorption is exceeded. There is very efficient conservation of 
tissue riboflavin in deficiency; as the vitamin is released by protein breakdown, it is 
re-used in the synthesis of new enzymes. Only that relatively small proportion which 
is covalently bound to enzyme proteins cannot be re-utilised '. 
Deficiency and excess 
Riboflavin deficiency is characterised by lesions of the margin of the lips (cheilosis) 
and corners of the mouth (angular stomatitis), a painful desquamaiion of the tongue. Nutrition. Chapter 8: Riboflavin 11-12-1992 81 
so that it is red, dry and atrophic, and a seborrhoeic dermatitis, with filiform 
excrescences. There may also be conjunctivitis, with vascularisation of the cornea 
and opacity of the lens, leading to the development of cataract. On a global scale, 
riboflavin deficiency is common, yet never seems to be fatal, since there is very 
efficient conservation and reutilization of riboflavin in tissues when the dietary intake 
is inadequate. 
Riboflavin deficiency can also result in secondary deficiency of iron, leading to 
anaemia; iron absorption is impaired in deficiency, and the utilisation of iron reserves 
also requires riboflavin. Similarly, riboflavin deficiency can result in impaired 
formation of the active metabolite of vitamin B6, and can thus lead to secondary 
vitamin B6 deficiency, and can also impair the metabolism of tryptophan, so leading 
to development of the tryptophan-niacin deficiency disease pellagra
 2. 
Inadequate riboflavin intake can be demonstrated biochemically by measuring the 
erythrocyte glutathione reductase (EGR) activation coefficient. EGR is an enzyme 
which has FAD as a coenzyme; addition of FAD in vitro increases its activity. The 
size of the activation coefficient is inversely related to riboflavin status. 
Riboflavin has a low solubility in water, and there is only a limited capacity for 
absorption. There is also rapid excretion of any riboflavin not bound to enzymes. This 
means that there is little or no accumulation or storage of the vitamin in the body, 
and there is no evidence of any toxicity of riboflavin taken by mouth. There is some 
concern about the safety of high doses of riboflavin given to infants undergoing 
phototherapy for neonatal hyperbilirubinaemia. 
Requirements 
Adult males 
A number of studies of subjects maintained on controlled intakes of riboflavin over 
several months, conducted in the 1940s and 1950s, defined the requirements of male 
adults. 
Long-term studies of subjects maintained on controlled intakes of riboflavin show 
that 0.55 mg/d is inadequate to prevent signs of deficiency. Intakes of 0.7 mg/d do not 
result in deficiency signs over 41 weeks, while in 22 subjects maintained on 0.75-
0.85 mg/d, deficiency signs were seen in only one. Epidemiological studies show that 
clinical signs of deficiency are apparent in subjects whose habitual intake is between 
0.5-0.8 mc/d, but not at hichcr intakes
 3-
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It is thus apparent that a riboflavin intake of 0.55 mg/d is inadequate, and intakes 
between 0.55-0.8 mg/d are marginally adequate. In subjects maintained on graded 
intakes of riboflavin from 0.55-3.55 mg/d, there is a clear inflection in the relationship 
between intake and excretion, with a considerable increase in the excretion of the 
vitamin as intake is increased from 1.1 to 1.6 mg/d. At intakes of 1.1 mg/d and below, 
only 2-7 % of a test dose is excreted over 4h, and basal excretion is below 
100 μ^241ι. At intakes above 1.6 mg/d, 23-37 % of the test dose is recovered in the 
urine over 4h, and basal excretion begins to increase with intake
 4. 
There is no information on the excretion of riboflavin at intakes between 1.1 and 
1.6 mg/d. Nevertheless, it is clear that intakes below 1.1 mg/d may be adequate to 
prevent the development of deficiency signs, but do not fill tissue reserves, while 
intakes above 1.6 mg/d are more than is required, so the excess is excreted. By 
interpolation, the 'critical intake' at which excretion increases sharply is 1.3 mg/d, 
and this is taken as the average requirement for adult males
 5. 
There have been no detailed studies of riboflavin requirements of adults in which the 
EGR activation coefficient has been used as an index of status. In one report an 
intake of 0.53 mg/d resulted in a significant elevation of the activation coefficient in 6 
weeks, showing that this level of intake is inadequate to prevent the depletion of 
body reserves and the development of biochemical deficiency
 5. 
Because of its central role in energy metabolism, it has been conventional to express 
riboflavin requirements on the basis of energy intake. However, flavoproteins are 
also involved in a large number of other reactions, so riboflavin requirements are not 
related only to energy expenditure. The recommendations here are therefore not 
being given in terms of energy. 
The average requirement of adult males is being taken as 1.3 mg/d, as mentioned 
above. In the urinary excretion studies 1.6 mg/d appeared to be adequate for all adult 
males, and this is given as the PRI. 
Deficiency is highly probable on intakes of less than 0.6 mg/d, and this is taken as 
the Lowest Threshold Intake. 
Adult females 
Although not conclusive, there is a fair amount of indirect evidence that the daily 
amounts of riboflavin required by women are lower than for men. One would expect 
this a priori, and other reviewing bodies have reached this conclusion. The 
recommendations for adult women are therefore reduced in amounts per day below 
those of men. roughly in line with body weight. The Average Requirement for women 
is therefore given as 1.1 mg/d, with a Population Reference Intake of 1.3 mg/d. The Nutrition. Chapter 8: Riboflavin 11-12-1992 83 
Lowest Threshold Intake is not reduced below 0.6 mg/d, in the absence of any 
information that it would be safe to do so in women. 
Children 
These are no good data on the riboflavin requirements of children. The PRIs given 
are derived from those of young adults on the basis of energy expenditure. 
The PRI for infants 6-11 m is based on the finding that Gambian infants in their first 
12 months receive 0.2 mg/d, and have a raised EGR activation coefficient. Increasing 
their intake to 0.4 mg/d restored the EGR activation coefficient satisfactorily
 6. 
Pregnancy and lactation 
Pregnancy is associated with an increased EGR activation coefficient, and in 
populations where riboflavin intake is marginal clinical signs of deficiency are seen in 
pregnant women as parturition approaches. Post partum the deficiency resolves, 
despite continued low intake of the vitamin, and secretion of considerable amounts 
into the milk. While modest supplements during pregnancy prevent the development 
of deficiency signs, relatively large amounts (about 2.5 mg /d) are required to 
maintain the EGR activation coefficient within the range seen in non-pregnant 
women
 2. EGR activation coefficient data are therefore not being used in making a 
recommendation for pregnancy. 
The demand for increased tissue synthesis by the fetus and the mother is estimated 
as 0.3 mg/d, making the PRI for pregnancy 1.6 mg/d. 
The riboflavin content of breast milk varies considerably, being strongly influenced by 
the mother's recent intake. An increment of 0.4 mg/d is proposed during lactation, to 
meet the increased metabolic burden and provide an adequate amount in the milk, 
giving a PRI of 1.7 mg/d. 
The elderly 
There is no evidence that the riboflavin requirements of the elderly are greater than 
for younger people. 84 Reports of the Scientific Committee for Food: 31st : 
Summary 
Population Reference Intakes for other groups 
(amounts as mg/d) 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
Males 
1.3 
1.6 
0.6 
Females 
1.1 
1.3 
0.6 
Age Group 
6- 11 m 
l-3y 
4-6y 
7- lOy 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
Pregnancy 
Lactation 
PRI (mg/d) 
0.4 
0.8 
1.0 
1.2 
1.4 
1.6 
1.2 
1.3 
1.6 
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Physiology and metabolism 
Two related compounds, nicotinic acid and nicotinamide, have the biological activity 
of niacin. Niacin is not strictly a vitamin, and there is no absolute requirement for a 
source of preformed nicotinic acid or nicotinamide in the diet; nicotinamide can be 
synthesised from the essential amino acid tryptophan. Requirements for tryptophan 
and niacin must therefore be considered together, and are generally expressed as 
'niacin equivalents' - the sum of preformed niacin plus that provided by endogenous 
synthesis from tryptophan. 
The metabolic function of niacin is as the precursor of the nicotinamide nucleotide 
coenzymes, NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide 
adenine dinucleotide phosphate), which are involved in a wide variety of oxidation 
and reduction reactions. 
In addition to its role in such reactions, NAD is the source of ADP-ribose for the 
DNA repair mechanism which is activated by a variety of DNA-breaking mutagens 
and other toxins. Much of the nicotinamide released by this poly-(ADP)-ribosyl 
transfer reaction is metabolised further and excreted, so it is likely that heavy 
exposure to such toxins will increase niacin requirements. There is little evidence 
that this is nutritionally significant, although toxins have been implicated in the 
aetiology of pellagra in people whose intake of tryptophan and niacin is marginal. 
Most of the dietary preformed niacin is present in foods as the nicotinamide 
nucleotide coenzymes. These are hydrolysed by intestinal enzymes, and the 
resultant nicotinamide is absorbed either unchanged or as nicotinic acid after 
deamidation. The niacin in cereals is largely present as a glycoside of nicotinic acid, 
niacytin. A small proportion of this is hydrolysed by gastric acid, and more free niacin 
may be liberated in cooking, but 90% of the apparent niacin content of cereals cannot 
be utilised, and hence is biologically unavailable. The preformed niacin of cereals is 
usually ignored in calculating intakes. 
Tissues can take up either nicotinic acid or nicotinamide from the circulation, and 
utilise them for the synthesis of the nicotinamide nucleotide coenzymes. The liver 
has only a very limited capacity for niacin uptake, and functions mainly to release 
nicotinamide and nicotinic acid synthesised from tryptophan, into lhe circulation for 
use by other tissues. Nutrition. Chapter 9: Niacin 11-12-1992 87 
Tryptophan which is not required for net new protein synthesis or the synthesis of 
specialised metabolites (i.e. both 'surplus' tryptophan derived from the diet and that 
released by the turnover of tissue proteins) is oxidised in the liver. This is the fate of 
about 99% of the total dietary intake of tryptophan of an adult in nitrogen balance '. 
The oxidative pathway of tryptophan metabolism leads either to complete oxidation 
or to the synthesis of the nicotinamide ring of the coenzymes. Therefore, the amount 
of nicotinamide coenzymes formed from tryptophan changes with the amount of 
tryptophan available. At normal intakes of tryptophan, about 60 mg dietary 
tryptophan is equivalent to 1 mg preformed niacin, although there is considerable 
variation around this figure. The ratio of 60 mg tryptophan equivalent to 1 mg 
preformed niacin is an over-estimate of the mean requirement, including a 'safety 
margin' to cover individual variation
 2·
3. By convention, the total niacin equivalence of 
a diet is taken to be the sum of preformed niacin (neglecting that in cereals) plus 
1/60 of the tryptophan content. 
Nicotinamide arising from the breakdown of the coenzymes which is not required for 
the synthesis of new coenzyme, and surplus nicotinamide from the diet, are mainly 
converted to N
1 -methyl nicotinamide in the liver. N'-Methyl nicotinamide may be 
either excreted unchanged or may undergo further metabolism to methyl pyridone 
carboxamide before excretion. 
Deficiency and excess 
An inadequate intake of both tryptophan and preformed niacin leads to the 
development of the deficiency disease pellagra. Diseases involving impairment of the 
oxidative metabolism of tryptophan, drugs which inhibit enzymes in the pathway or 
deficiency of riboflavin and vitamin B6, both of which are required for the synthesis of 
nicotinamide nucleotides from tryptophan, can also result in the development of 
pellagra. 
Pellagra is characterised by a photosensitive dermatitis resembling severe sunburn, 
normally restricted to areas of the skin directly exposed to the sun, although physical 
pressure on the knees and elbows, and abrasion by clothes around the wrists and 
ankles, can lead to similar skin lesions in deficient subjects. Advanced pellagra also 
involves a characteristic depressive psychosis or dementia. The psychosis may also 
develop in the absence of skin lesions in subjects not exposed to sunlight. Untreated 
pellagra is fatal because of the severe impairment of nicotinamide nucleotide-
requiring reactions in energy metabolism. Reports of the Scientific Committee for Food: 31st series 
Nicotinic acid in modest doses causes a marked vasodilatation, with Hushing, 
burning and itching of the skin. Very large single doses of nicotinic acid may cause 
sufficient vasodilatation to lead to hypotension; after the administration of 3-6 g of 
nicotinic acid daily for several days the effect wears off. Nicotinamide does not have 
this effect. 
Doses of nicotinic acid, but not nicotinamide, of 3-6 g/day have a modest, but 
potentially useful, hypocholesierolaemic and hypolipidaemic effect. At this level of 
intake there is evidence of liver damage and even clinical liver dysfunction. Use of 
sustained release preparations of nicotinic acid providing more modest intakes of the 
vitamin (500 mg/day) may also result in liver damage as a result of prolonged high 
concentrations in blood and tissues
 4. 
Requirements 
Adults 
The only data available on which to base estimates of niacin requirements are the 
results of depletion-repletion studies in which the amount of preformed niacin or 
tryptophan required to restore 'normal' excretion of N
1-methyl nicotinamide and 
methyl pyridone carboxamide was determined
 2·
3. 
In subjects receiving 1 mg niacin equivalents /MJ, the urinary excretion of N
1-methyl 
nicotinamide fell to the upper limit of that seen in pellagrins, although none of the 
subjects showed clinical signs of deficiency. Adequate excretion of N
1-methyl 
nicotinamide is seen in subjects receiving 1.3 mg niacin equivalents /MJ. Allowing for 
individual variation, the Population Reference Intake is based on 1.6 mg niacin 
equivalents /MJ energy expenditure. 
For people on low energy diets, niacin will be required for the metabolism of tissue 
reserves of metabolic fuels. It is possible that the requirement for those habitually on 
intakes below 8 MJ/d also may not be covered by 1.6 mg niacin equivalents /MJ. For 
such groups a PRI of 13 mg niacin equivalents /d is suggested. 
It is likely that there is no requirement for any preformed niacin in the diet under 
normal conditions, and that endogenous synthesis from tryptophan will meet 
requirements. Average protein intakes in the EC are about 15% of energy intake. On 
the assumption that dietary protein provides 14 mg tryptophan /g (a conservative 
estimate), this represents 2 mg niacin equivalents /MJ energy intake from dietary 
tryptophan, greater than the Population Reference Intake without any preformed 
dietary niacin. Nutrition. Chapter 9: Niacin 11-12-1992 
Other age groups 
There is no evidence that any other group of the population has a requirement for 
niacin different from that for adult men, other than on the basis of energy expenditure. 
Pregnancy and lactation 
The hormonal changes associated with pregnancy increase the efficiency of the 
synthesis of nicotinamide nucleotides from tryptophan. There is thus no increased 
requirement for niacin in pregnancy. In lactation the Population Reference Intake is 
for 2 mg niacin equivalents la above that calculated on the basis of energy intake to 
allow for the vitamin secreted in milk. 90 Reports of lhe Scientific Committee for Food: 31st series 
Summary 
There is no absolute requirement for preformed niacin in the diet, since endogenous 
synthesis from normal intakes of tryptophan is more than adequate to meet 
requirements. There is a requirement for an adequate intake of tryptophan plus 
niacin, apart from the requirement for tryptophan as an essential amino acid for the 
maintenance of nitrogen balance. Population Reference Intakes are based on the 
ratio of 60 mg dietary tryptophan equivalent to 1 mg preformed niacin (i.e. total niacin 
equivalents = preformed niacin + 1/60 χ tryptophan), and assume that intakes of 
riboflavin and vitamin B6 are adequate. 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
1.3 mg niacin equivalents /MJ 
1.6 mg niacin equivalents /MJ 
1.0 mg niacin equivalents /MJ 
These can be expressed for average energy expenditures as mg niacin equivalents/d. 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
Pregnancy 
Lactation 
Harmful effects 
Males 
15 
18 
11 
Females 
11 
14 
9 
14 
16 
>500 mg/day as preformed nicotinic acid Nutrition. Chapter 9: Niacin 11-12-1992 91 
Population Reference Intakes for younger age groups 
Age Group 
6- 11 m 
l-3y 
4-6y 
7-10 y 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
PRI (mg niacin equivalents /d) 
5 
9 
11 
13 
15 
18 
14 
14 92 Reports of the Scientific Committee for Food: 31st series 
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Physiology and metabolism 
Six different chemical forms of vitamin B6 occur in foods: pyridoxine, pyridoxal, 
pyridoxamine and their phosphates. They are readily interconvertible in the body, 
giving rise to the metabolically active coenzyme pyridoxal phosphate. 
The principal metabolic function of pyridoxal phosphate is as the coenzyme in 
reactions of amino acids. It is also required for the enzyme glycogen Phosphorylase 
in muscle and liver, and in the metabolism of polyunsaturated fatty acids and 
phospholipids, and has a role in the function of steroid hormones, acting to release 
hormone-receptor complexes from tight nuclear binding, and so terminate the actions 
of the hormone
 l·
2. 
The phosphate forms of vitamin B6 are dephosphorylated in the intestinal lumen; 
pyridoxine, pyridoxal and pyridoxamine are all taken up from the small intestine by 
an energy-dependent process. The various vitamers are readily converted to 
pyridoxal phosphate in tissues. Pyridoxal phosphate which is not bound to enzymes 
in tissues is oxidised to 4-pyridoxic acid, the major metabolite of the vitamin 
excreted in the urine. 
A proportion of the vitamin B6 in plant foods is biologically unavailable, because it is 
present as pyridoxine glycosides which are not hydrolysed by intestinal enzymes. 
While the glycosides may be absorbed, they are not used in the body, but are 
excreted unchanged in the urine. 
Some 80% of the body's vitamin B6 is associated with the enzyme glycogen 
Phosphorylase in muscle. As glycogen reserves are depleted in prolonged fasting, so 
the vitamin is released from muscle, and made available for the synthesis of glucose 
from amino acids in the liver. However, muscle pyridoxal phosphate is not released 
in vitamin B6 deficiency, so the muscle reserves cannot be regarded as storage of the 
vitamin. 94 Reports of the Scientific Committee for Food: 31st scries 
Deficiency and excess 
Gross clinical deficiency of vitamin B6 is extremely rare; the vitamin is widely 
distributed in foods, and intestinal flora synthesise relatively large amounts, some of 
which may be available. 
Much of our knowledge of human deficiency comes from an 'outbreak' in the early 
1950s, resulting from an infant milk preparation which had undergone severe heating 
in manufacture, leading to the formation of a biologically inactive complex between 
pyridoxal (and pyridoxal phosphate) and lysine in proteins. In addition to 
abnormalities of the metabolism of tryptophan, methionine and other amino acids, the 
affected infants convulsed. They responded to supplements of vitamin B6
 3. 
Intakes of vitamin B6 in excess of 500 mg/day are associated with the development 
of peripheral sensory neuropathy, which is only partially reversible on return to more 
appropriate intakes
 4. Similar symptoms have been reported in subjects taking doses 
of 50-500 mg /day. Intakes of more than 50 mg /day must therefore be regarded as 
potentially harmful
 5. 
Requirements 
Adults 
Although 80% of the body's vitamin B6 is in muscle, this pool turns over relatively 
slowly, and requirements are closely related to protein intake. Attempts to estimate 
requirements by measurement of the turnover of body pools have not yielded useful 
results, and current estimates are based on changes in tryptophan and methionine 
metabolism, and the decline in blood concentrations of vitamin B6 during 
experimental depletion / repletion studies. 
Biochemical indices of vitamin B6 status decline more rapidly in subjects receiving 
high protein intakes (80-160g /day) than in those receiving low intakes of protein 
(30-50g /day). Similarly, restoration of indices of vitamin B6 nutritional status during 
repletion occurs faster in subjects receiving lower intakes of protein
 6·
7·8.9 Such 
studies suggest that the average vitamin B6 requirement is 13 μg/g dietary protein. 
Allowing for individual variation gives a Population Reference Intake of 15 μg vitamin 
B6/g dietary protein, and suggests a Lower Threshold Intake of 11 μg/g protein, 
although there is no experimental evidence to support this lower figure. Nutrition. Chapter 10: Vilamin Β 6 11-12-1992 95 
The relationship with protein intake may not be valid at low intakes of protein, or 
under conditions of restricted food intake, when amino acids will be catabolised for 
energy-yielding metabolism. 
High-oestrogen oral contraceptives cause changes in tryptophan metabolism which 
have been widely interpreted as indicating vitamin B6 depletion. However, relatively 
large intakes of the vitamin are required to normalise tryptophan metabolism in 
women taking oral contraceptives, and other indices of vitamin B6 nutritional status 
are generally unaffected by contraceptives. It seems most likely that the 
derangement of tryptophan metabolism is due to direct effects of oestrogens or their 
metabolites on tryptophan metabolism. There is no evidence for an increased 
requirement for vitamin B6 in women using oral contraceptives
 2. 
Children 
There is no evidence that children have a requirement for vitamin B6 different from 
that for adults, i.e. a Population Reference Intake of 15 μ^ dietary protein. It is 
reasonable to assume that children in the EC have a diet similar to that of adults, 
providing some 15% of energy from protein. 
Pregnancy 
Plasma concentrations of pyridoxal phosphate fall markedly and progressively 
through pregnancy, although erythrocyte transaminase activation coefficients and 
excretion of 4-pyridoxic acid are normal. The drop of plasma pyridoxal phosphate 
appears to be a consequence of the preferential uptake of the vitamin by the fetus, 
and a normal feature of pregnancy. Supplements of 2.5-4 mg/day are required to 
maintain the plasma concentration of pyridoxal phosphate at the pre-pregnancy 
level
 10. This is considered neither necessary or desirable, and the same PRI is 
proposed for pregnancy as in non-pregnant women - 15 μ^ dietary protein. On the 
extra protein intake recommended during pregnancy, this will result in an increase in 
the amount of dietary vitamin B6. 
Lactation 
There is no evidence that vitamin B6 metabolism is changed by lactation, and there 
appears to be no reason for changing the recommendation from that for non-lactating 
women - 15 μg /g dietary protein. This will provide vitamin B6 at a higher level than 
is secreted in milk, and lhe extra protein intake recommended during lactation will 
result in an increase in the amount of dietary vitamin B6. 96 Reports of the Scientific Committee for Food: 31st scries 
The elderly 
There is a fall in the plasma concentration of pyridoxal phosphate with increasing 
age, but erythrocyte transaminase activation coefficients do not show a similar 
change. There is some evidence of age-related changes in the metabolism of the 
vitamin
 8, but there are no good grounds for believing that ageing increases the 
vitamin Bg requirement beyond that for younger adults. 
Summary 
Vitamin B6 requirements (expressed in weight of pyridoxine) vary with protein 
intake in all groups. 
Average Requirement 
Population Reference Intake 
13 μg /g protein intake 
15 μg /g protein intake 
Average protein intakes in the EC are 15% of energy intake. On this basis, and using 
average energy requirements, vitamin B5 requirements of adults can be expressed in 
mg/d. 
Adults 
Average Requirement 
Population Reference Intake 
Males 
1.3 
1.5 
Females 
1.0 
1.1 Nutrition. Chapter 10: Vitamin Β6 11-12-1992 97 
Population Reference Intakes for other groups 
Age Group 
6- 11 m 
l-3y 
4-6y 
7- 10 y 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
Pregnancy 
Lactation 
PRI (mg/d) 
0.4 
0.7 
0.9 
1.1 
1.3 
1.5 
1.1 
1.1 
1.3* 
1.4* 
Based on protein increments in pregnancy and lactation. 
High intakes 
Intakes greater than 500 mg/d are associated with neurological damage and intakes 
of more than 50 mg/d are potentially harmful in adults. 98 Repons of the Scientific Committee for Food: 31st series 
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Physiology and metabolism 
Metabolic functions 
Folate is the general name given to compounds with nutritional properties similar to 
those of folic acid (pteroylglutamic acid). Besides folic acid itself, with one glutamate 
residue, there are other forms with a varying number of extra glutamates attached. 
Reduced derivatives of these participate in enzymic reactions providing single carbon 
units for DNA and RNA biosynthesis and methylation reactions '. 
Absorption and metabolism 
The enzymatic interconversions in which the folate cofactors participate involve eight 
forms of the vitamin. Many of these are easily oxidised, some to forms that can 
subsequently be reduced and which are thus nutritionally active, others to 
catabolized products which are inactive
 2. The extent to which these oxidations occur 
will have a profound effect upon the folate ultimately available from the diet. This in 
tum will depend upon not only the forms of the cofactor predominating in a particular 
food but also the length and conditions of storage, the presence or absence of natural 
or added antioxidants etc. All natural folates exist as polyglutamyl conjugates. 
These extra glutamates may get removed either during storage and processing of 
food or by conjugases that are present in the human intestine. At physiological 
concentrations only folates containing a single glutamyl residue are absorbed into 
the circulation, usually after conversion to the 5-methyltetrahydro form. Human cells 
depend principally upon the uptake of this circulating 5-methyltetrahydrofolate for 
their supply of the vitamin. 
The folate content of the diet is usually estimated by microbiological methods which 
may underestimate the true content of folate in food by as much as 20%-30%. Some 
foods but not others contain factors that inhibit the intestinal folate deconjugation 
enzymes thus decreasing absorption
 3. The degree of inhibition varies considerably 
from food to food, with some foods, for example beans, giving 20% inhibition while 
values as great as 80% are found for orange juice. There is also a solid body of 
evidence that polyglutamyl forms of folate are less well absorbed than 
monoglutamates even in the absence of such inhibitors. Straight comparisons of folic 
acid containing one glutamyl residue with the corresponding heptaglutamyl form have 100 Reports of lhe Scientific Committee for Food: 31st scries 
indicated the latter to be some 58-79% as available as the former. However, an 
important new approach has recently been introduced, namely the comparison of 
various folate forms labelled differently with deuterium, which found that folate 
hexaglutamate was only 50% as available as the monoglutamate when given in pure 
forms at physiological concentrations
 4. This value indicates an even lower 
availability of polyglutamyl forms than previously expected. Thus there are three 
areas where calculations based on mean requirement must be adjusted to get mean 
dietary requirement. There is probably an underestimation of the amount of folate in 
food. Inhibition of intestinal conjugase would decrease the availability of folate 
polyglutamates. Finally even in the absence of such inhibitors folate polyglutamates 
are probably only 50% as available as the corresponding monoglutamates, upon 
which some of the mean requirement calculations are based. Factors one and two 
work in the opposite directions and may cancel each other out, leaving a 50% overall 
adjustment as being an acceptable correction factor. 
Deficiency and excess 
Folate deficiency decreases DNA and RNA biosynthesis, and manifests itself most 
obviously in cell types that turn over rapidly, such as in the bone marrow, thus 
causing anaemia. 
5-Methyltetrahydrofolate is involved in providing, via methionine, methyl groups for 
many methylation reactions; these systems will fail however only in severe 
prolonged folate deficiency. 
A "pseudo folate-deficient" state is seen in B12 deficiency, because cells fail to 
handle folate normally, resulting in the signs of folate deficiency. There is however no 
dietary deficiency of folate; the condition is cured by vitamin B12. The haematological 
picture can however be improved by high intakes of folic acid itself, which is 
particularly effective in this role. Large doses of folic acid, which is the synthetic form 
in supplements, can therefore prevent the timely diagnosis of vitamin B12 deficiency, 
allowing the neuropathy which also occurs to proceed undiagnosed, only to emerge 
at a much more advanced stage when its effects are largely irreversible. 
High levels of folic acid around 5.0 mg per day have been used in pregnancy for 
periods of several months without any apparent ill effects. Thus in normal subjects 
levels of up to 5.0 mg per day would seem to be well tolerated '. There is evidence 
that high levels of folic acid increase fit frequency in epileptics
 5. There is also the 
certainty that such high levels taken on a daily basis would mask the emergence of 
vitamin B12 deficiency. At lower levels of 100-200 μg of folic acid per day this 
masking would be less likely. Since a part of the neurological damage in B,2 Nutrition. Chapter 11: Folate 11-12-1992 101 
deficiency is largely irreversible, it is serious if allowed to go undiagnosed and 
untreated. Vegans and the elderly, being at increased risk of vitamin B12 deficiency, 
should avoid large daily intakes of folic acid supplements. However folic acid 
supplements of around 400 μg per day are in widespread use, particularly in the 
United States, and it is claimed that there is no evidence of their masking pernicious 
anaemia at that level
 6. 
Physiological and dietary requirements 
Adults 
Folate status can be measured from the concentration of folate in serum, but the 
level of folate in the red blood cells gives a much closer estimate of tissue stores '. 
Red cell folate values above 150μg/L are an indication of sufficiency '. However 
there is no clear borderline separating the normal population from those with clinical 
signs of deficiency '. Approaches using depletion of folate
 8·
9 and considerations of 
folate catabolism
 1
0 suggest daily requirements of 50-100 μg. 
The level of oral folic acid required to treat folate deficiency in an adult man has been 
reported as 50 μg/d. A study of a group of normal volunteers found higher amounts 
were needed - 75 μg/d
 12. A limited study on three normal women showed that on a 
daily intake of 50 μg folic acid their red cell folate remained in the normal range but 
respectively fell or rose at levels of 25 or 100μg/d
 13. A different study on four 
women indicated that their plasma levels were stabilized by 80 μg pure folic acid and 
20 μg dietary folate daily
 14. 
From these studies with folic acid, the mean requirement for an adult is taken to be 
70 μ§/ά. As discussed above, one would expect this to be twice as available as food 
folate. The mean dietary requirement of folate would therefore be 140 μg/d. 
Dietary recommendations for folate have often been supported by values for the 
intakes of folate observed in individuals and groups that clearly receive adequate 
amounts of the vitamin. It is probably unwise to rely on this approach as the values 
obtained for food folates may be substantial underestimates because of the 
uncertainties of the analytical procedures. 102 Reports of the Scientific Committee for Food: 31 si scries 
Children 
In a study of infants between 2 and 11 months 3.6 μg folic acid per kg body weight 
per day appeared to maintain plasma levels
 15. Infants between 6 and 11 months of 
age are likely to receive a mixture of folic acid and food folate, so a Population 
Reference Intake of 50 μg/d is proposed. 
In the absence of specific information, values for children have been derived from 
those for adults on the basis of energy expenditure. 
Pregnancy 
Folate deficiency in the later stages of pregnancy in women not ingesting extra folate 
is extremely common. Various studies have shown one quarter to one half would 
have clear signs of deficiency '. Red cell folate drops during pregnancy and while part 
of this drop may be due to haemodilution some of it is certainly due to the mother's 
being unable to meet the extra demand for folate made by the fetus from her stores 
by normal dietary intake. Studies have shown this drop in RBC (red blood cell) folate 
could be prevented by a supplement of 100 μg folic acid daily
 16·
17. Since these 
studies were carried out on women on good diets this level is really a minimum. To 
allow for the problems of bioavailability discussed above, a dietary increment of 
200 μg of folate per day should be sought. Recent work on the increase of folate 
catabolism in pregnancy indicates that this amount is not generous
 10. 
Neural tube defects 
There is now good evidence that daily periconceptual folic acid supplementation may 
have a protective effect on the occurrence of the congenital abnormalities, spina 
bifida and anencephalus, collectively called neural tube defects (NTDs)
 18. While 
some of these studies
 1
9 involved the use of very high levels of folic acid, it seems 
probable that amounts around 400 μg per day confer equal protection with a lesser 
risk of side effects
 20. Even at this lower level one cannot completely exclude the risk 
involved in taking a greater than normal amount of a vitamin in early pregnancy. 
However as far as toxicity to the mother is concerned there are only two established 
causes for concern, which have been mentioned already. Women taking antiepileptic 
drugs should be aware that it has been suggested that taking folic acid supplements 
of much above 400 μg may cause loss of control of their epilepsy. Taking extra folic 
acid, if one is also vitamin B12 deficient, results in the masking or exacerbation of 
neurological disease associated with such deficiency. However vitamin B12 
deficiency is extremely rare in women of less than 40 to 50. Should women, 
particularly when nearing the end of their child-bearing years, plan to take folic acid Nutrition. Chapter 11: Folate 11-12-1992 103 
supplements for periods of months, they should have possible vitamin B12 deficiency 
excluded by a simple blood test. 
While it is possible that improved dietary intake of folate may confer protection from 
NTDs it is difficult to achieve intakes of 400 μg per day because of the low density of 
folate in food and the lower availability of the natural forms of the vitamin than of the 
folic acid used in supplements. Fortified foods containing folic acid in the more 
available form may provide an alternative for women who do not wish to take 
tablets. 
It should be emphasised that the neural tube is formed between three and four 
weeks after conception, at which point many women who are pregnant are not aware 
of the fact. It is thus recommended that women wishing to attempt to achieve 
protection using folic acid should ensure that its intake is commenced before 
conception, so as to ensure adequate levels at the critical time. While there is no 
direct evidence on the issue, the ingestion of folic acid post conception may be of 
benefit up to the time of closure of the neural tube, i.e. four weeks. Thus women who 
suspect that they may be at an early stage of an unplanned pregnancy, e.g. by 
observing a missed period, may wish also to take folic acid even at this later and far 
less certain stage. 
Lactation 
Earlier studies suggested that milk contains about 50 μg per litre
 21. It now seems 
more likely that with better methods of estimation this value should be doubled
 22. 
Assuming a daily output of 750 ml, loss could thus be between 37 and 75 μg per day. 
To allow for bioavailability and taking the higher value one arrives at an increment of 
150 μg per day to compensate for normal lactation. 
The elderly 
A significant body of evidence
 2
3 indicates that the elderly have no increased 
requirement for folate. As mentioned previously, they should avoid large intakes of 
folate supplements. 104 Reports of the Scientific Committee for Food: 31st series 
Summary 
Values expressed in terms of mixed dietary folates (calculated for a relative molecular 
mass of 441), assuming a bioavailability about half that of pure folic acid (monogluiamate 
form), per day. 
Adults 
Average Dietary Requirement 
Population Reference Intake (mean requirement + 2 SD, 
assuming a coefficient of variation of 20%) 
Lowest Threshold Intake (mean requirement - 2 SD ) 
Pregnancy 
Lactation 
140 μδ 
200 μg* 
85 μδ 
400 μβ* 
350 μδ 
Population Reference Intakes for other groups 
Age Group 
6- 11m 
l-3y 
4-6y 
7- lOy 
ll-14y 
15-17y 
PRI 
50 μδ 
100 μg 
130 μδ 
150 μζ 
180μδ 
200 μg 
Neural tube defects have been shown to be prevented in offspring by periconceptual 
ingestion of 400 μg folic acid per day in the form of supplements. Nutrition. Chapter 11: Folate 11-12-1992 105 
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Physiology and metabolism 
Metabolic functions 
The term vitamin B]2 covers the two forms active in the body - 5'-deoxyadenosyl-
cobalamin and methylcobalamin - and a number of other cobalt-containing 
corrinoids which by being converted to the active forms have the same nutritional 
effect. 
Two enzymes in man have a requirement for vitamin B12'. Methionine synthase 
uses methylcobalamin and is involved in the channelling of carbon units from 
amino acids such as serine to remethylate homocysteine to methionine. This 
remethylation is necessary because all tissues use methionine as a source of 
methyl groups and as a consequence generate significant amounts of 
homocysteine which needs to be remethylated. Methylmalonyl CoA mutase, 
which uses 5'-deoxyadenosyl-cobalamin, is necessary in the metabolism of 
propionyl CoA, which arises either from the catabolism of certain amino acids or 
the oxidation of odd-chain fatty acids. 
Absorption 
Dietary vitamin B12 is bound by a glycoprotein called "intrinsic factor" secreted 
by the parietal cells of the stomach. The resultant intrinsic factor - vitamin B12 
complexes pass to the ileum where they are absorbed. About three quarters of an 
oral dose of 0.5 μg is absorbed while the amount absorbed from 1.0 μg is half '. 
Intrinsic factor-mediated absorption seems to have an upper limit of about 1.5 μg 
per meal irrespective of how much vitamin B12 is presented to it. 
Excretion 
It has been calculated that the biliary secretion of vitamin B12 is around 0.5 μg per 
day '. Perhaps less than 20 % or 0.1 μg of this is lost through non-reabsorption
 2. 
Vitamin B12 is very well stored. Its half-life in humans has been measured in a 
number of studies as being of more than one year to almost four years
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Deficiency 
Vitamin B12 levels in most diets appear to be adequate, the exception being strict 
vegetarian or vegan diets. As will be discussed later, individuals or communities 
on such diets have well documented lower than normal blood levels of vitamin B12 
and some studies show biochemical evidence of deficiency. This is easily 
understood since plant food does not contain any vitamin B12 unless contaminated 
with microorganisms '. Individuals among the elderly and the poor may also have 
an increased risk of deficiency where their diet is low in animal produce. 
By far the biggest cause of vitamin B12 deficiency is impairment of absorption
 4. 
This arises most often from destruction of the parietal cells of the stomach by 
autoantibodies, resulting in diminution or absence of secretion of intrinsic factor. 
Autoantibodies are also frequently produced against intrinsic factor itself, some of 
which render it incapable of binding vitamin B12, with more rarely other antibodies 
permitting binding of vitamin B12 but preventing uptake of the complex by the 
ileum '. These three autoimmune conditions are called pernicious anaemia (PA). 
Deficiency, when it occurs, has two general consequences: arrest of cell 
replication and neurological damage '. The former manifests itself clinically in the 
more rapidly dividing cells such as those of the marrow, the immune system, the 
skin and the gastrointestinal tract. Anaemia is the most obvious clinical sign. 
Appropriate treatment with the vitamin completely reverses all the effects on cell 
replication. The neurological lesion presents first as paraesthesia with a tingling 
sensation in the fingers and/or toes with or without numbness. Untreated, this will 
progress to a peripheral neuropathy and ataxia and an overt demyelination of the 
spinal cord called sub-acute combined degeneration. Psychiatric manifestations 
such as confusion, depression, agitation and delusions may also be present. 
Treatment with vitamin B12 appears to completely redress the latter 
manifestations. The peripheral neuropathy will also improve but the demyelination 
of spinal cord is essentially irreversible. 
It is now widely accepted that, as described originally in the 5-methyl-
tetrahydrofolate trap hypothesis
5, the arrest of cell division seen in vitamin B12 
deficiency results from an impairment in the proper utilisation of the folate 
cofactors involved in the synthesis of DNA and RNA in replicating cells. One of 
these cofactors, 5-methyltetrahydrofolate, requires to be demethylated by vitamin 
Β 12-dependent methionine synthase for its further metabolism. In the absence of 
vitamin B12 the other cellular folates needed to synthesise DNA and RNA 
become metabolically trapped in this form resulting in a 'pseudo' folate deficiency Nutrition. Chapter 12: Vitamin B i2 11-12-1992 109 
in such cells, which causes an anaemia identical to that seen in simple folate 
deficiency. 
The neurological lesion is thought to be due to the inability to utilize 5-
methyltetrahydrofolate to remethylate homocysteine to methionine
 6·
7. The latter 
supplies methyl groups for the synthesis of proteins and lipids in myelin and other 
nerve structures. 
Higher and undesirable intakes 
Daily ingestion of high amounts of vitamin B12, of even one or two orders of 
magnitude above normal dietary levels, does not cause any obvious side effects 
even over a prolonged period. However, nutritionally inactive vitamin B12 
analogues can be found in some vitamin preparations and increasing their intake 
may not be without risk. A daily intake greater than 200 μg should be discouraged. 
Requirements 
Criteria of vitamin Bu nutritional adequacy 
A number of methods have been used to assess vitamin B12 status or to detect its 
deficiency. 
The serum concentration of the vitamin can be determined; the results vary 
somewhat according to the procedure used, but most laboratories would regard 
concentrations of less than 100 ng/L as indicating deficiency, 100-150 ng/L as 
possibly deficient, with values above 150 ng/L being taken as normal '·
8. These 
ranges cannot however be regarded as wholly reliable as there is some 
overlapping. 
In B12 deficiency, the methylmalonic acid concentrations in urine and plasma might 
be expected to increase. The recent availability of methods sensitive enough to 
estimate methylmalonate in plasma has revealed a very good correlation between 
raised methylmalonate concentration and the presence of clinical disease, but 
there can be some overlap with the reference range
 9. 
Traditionally the presence of a macrocytic anaemia has been considered to be the 
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deficient subjects can sometimes have normal concentrations of haemoglobin and 
no increase in mean corpuscular volume
 10. 
While they are difficult to perform, neurological assessments, preferably using 
newer methods such as evoked response studies, are really the only way of 
determining the presence or absence of neurological damage due to vitamin B12 
deficiency. 
Individually these tests may not be wholly reliable but the use of two or more 
gives useful information in the B,2 status of individuals and groups that can be 
used to make recommendations on B12 intake. 
Adults 
A number of approaches have been used to calculate requirements. 
Studies have been made on the response of patients with pernicious anaemia, 
who have no contribution from dietary vitamin B12, to daily parenteral doses. They 
indicate that 0.3 μg/d is not quite adequate " but 0.5 μg/d is
 12·
13. These patients 
however will secrete some B12in the bile which will not be reabsorbed and so will 
be lost from the enterohepatic circulation. Dietary values for normal subjects 
would therefore need to be adjusted downwards for that reason, but also upwards 
to allow for incomplete absorption from the diet. If it could be said that these 
would balance out, one might expect a daily intake of 0.3 μg vitamin B12 to be too 
little and 0.5 μg to be adequate on the evidence of these studies using mainly 
haematological criteria. 
The amount of B12 in the diet of strict vegetarians has been investigated. Studies 
on sizeable populations indicated that while a mean intake of 0.26 μg/d might 
provide inadequate stores, no deficiency was detected
 I4. Similar studies indicated 
that smaller groups got by on intakes ranging from 0.3 to 0.5 μg/d
 15·
16. This work 
depended mainly on abnormal haematological findings to detect abnormal states. 
While some studies assessed neurological function, this is not easy to do and 
perhaps subtle changes that were present might not have emerged. While earlier 
studies that related intake to well being did not look for biochemical evidence of 
deficiency, from subsequent studies on similar strict vegetarian groups it seems 
very likely that biochemical deficiency, as detected by elevated urine 
methylmalonic acid levels, exists on diets containing these low levels of vitamin 
B12
 17·
18. It appears that biochemical deficiency would exist with a risk of eventual 
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Two studies have been based on vitamin turnover. They made a number of 
assumptions about various factors and came up with mean daily requirements of 
between 0.25 and 1.0 μg/d
 1
9 and of 1.3 μg/d
 20. 
At levels of 0.5 μg/d that are likely to be consumed by subjects on strict 
vegetarian diets, there is no evidence of haematological or neurological 
dysfunction, but there is biochemical abnormality. Interpretation of many of the 
studies of the type cited above depends very heavily either on the absence of 
apparent clinical problems in populations or upon the apparent adequacy of the 
treatment. These studies regarded the absence of haematological abnormalities 
as being an assurance of general health, and it is difficult to rule out neurological 
damage because it is so much more difficult to assess
 21. Examination of the early 
literature makes it clear that many people with apparently normal haematology 
were developing irreversible neurological damage. More recent studies suggest 
that this circumstance is much more common than is usually appreciated. 
It therefore seems prudent to put forward a mean requirement towards the high 
end of the scale: 1.0 μ g/d. 
Pregnancy 
There seems to be no risk of signs of clinical deficiency developing in a pregnant 
woman, even on a diet low in vitamin B12. The major cause for concern is the effect 
of such low intakes on the developing embryo and on progeny that are 
subsequently breast-fed. It is clear that children of strict vegetarian mothers who 
were subsequently breast-fed, and then went on to vegetarian diets themselves, 
are at serious risk not just of biochemical evidence of deficiency as indicated by 
elevated methylmalonic acid but also of decreased growth rates
 18. Such low 
status has been shown to lead to overt signs of neurological damage, which in 
time would become irreversible
 22. There thus seems no doubt that women on 
strict vegetarian diets should be encouraged to increase their intake of vitamin B12 
during pregnancy and that this advice should, as a precaution, be extended to all 
women. Unlike folate, there is no evidence for a high rate of turnover of vitamin 
B12 in pregnancy. However to allow for transfer of some of the vitamin to the fetus, 
an additional 0.2 μg/d is recommended. 
Lactation 
During lactation, loss of the vitamin in milk depends to a large extent upon the 
mother's vitamin B12 status
 23. It is difficult to assess how much if any of this loss 
needs to be reinstated in women who have normal stores. However if the values 
in milk fall below about 0.37 μg per day, evidence of biochemical deficiency begins 112 Reports of the Scientific Committee for Food: 31st series 
to be seen in breast-fed infants
 1
7 (who probably had very inadequate stores of 
vitamin B12 to begin with). It would thus seem prudent to try to replace at least 
0.37 μg per day. If one estimates that about three quarters of a dose is absorbed 
at this level, this requires an increment of 0.5 μg/d during lactation. 
Children 
Infants bom to women with a diet very low in B)2, and thus with very poor stores 
of the vitamin, needed 0.37 μ^ to cure biochemical deficiency as evidenced by 
methylmalonic acid excretion
 17. A PRI for infants 6-11 months is set at 0.5 μg/d. 
In the absence of specific studies, values for children have been calculated from 
those for adults on the basis of energy expenditure. 
The elderly 
There appears to be no increased requirement for vitamin B,2 with age
 24. While a 
decrease in vitamin B12 status as measured by serum levels has been reported in 
some studies as age advanced, it is almost certainly due to an increased 
prevalence of malabsorption due either to the autoimmune disease pernicious 
anaemia or to atropic gastritis
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Summary 
(amounts in ßg/d, based on a relative molecular mass of 1355) 
Adults 
Pregnancy 
Lactation 
Average Dietary Requirement 
Population Reference Intake 
(Mean requirement + 2SD, 
assuming a coefficient of 
variation in this case of 20%) 
Lowest Threshold Intake 
(Mean requirement - 2SD) 
Plus 
Plus 
1.0 
1.4 
0.6 
0.2 
0.5 
Population Reference Intakes for other age groups 
(amounts in ¡J-g/d, based on a relative molecular mass of 1355) 
6- 11 m 
l-3y 
4-6y 
7- lOy 
11 - 14 y 
15 - 17 y 
0.5 
0.7 
0.9 
1.0 
1.3 
1.4 1 14 Reports of lhe Scientific Committee for Food: 31st series 
References 
1. Chanarin I. (1979). The Megaloblastic Anaemias. 2nd ed. Oxford: Blackwell 
Scientific Publications. 
2. Reizenstein Ρ, Ek G, Matthews CME. (1966). Vitamin B,2 kinetics in man. 
Implications on total-body-B,determinations, human requirements and normal 
and pathological cellular B12 uptake. Phys Med Biol, 11: 295-306. 
3. Hall CA. (1964). Long-term excretion of Co
57-vitamin B,2and turnover within the 
plasma. Am J Clin Nutr, 14: 156-162. 
4. Kolhouse JF, Allen RH. (1977). Absorption, plasma transport and cellular 
retention of cobalamin analogues in the rabbit. Evidence for the existence of 
multiple mechanisms that prevent the absorption and tissue dissemination of 
naturally occurring cobalamin analogues. J Clin Invest, 60: 1381-1392. 
5. Herbert V, Zalusky R. (1962). Interrelationship of vitamin B12 and folic acid 
metabolism: folic acid clearance studies. J Clin Invest, 41: 1263-1276. 
6. Scott JM, Dinn JJ, Wilson P, Weir DG. (1981). Pathogenesis of subacute 
combined degeneration: a result of methyl group deficiency. Lancet, ii: 334-337. 
7. Weir DG, Keating S, Molloy A, McPartlin J, Kennedy S, Blanchflower J, Kennedy 
DG, Rice D, Scott JM. (1988). Methylation deficiency causes vitamin B12-
associated neuropathy in the pig. J Neurochem, 51: 1949-1952. 
8. Lindenbaum J, Savage DG, Stabler SP, Allen RH. (1990). Diagnosis of cobalamin 
deficiency. II. Relative sensitivities of serum cobalamin, methylmalonic acid and 
total homocysteine concentrations. Am J Hematol, 34: 99-107. 
9. Stabler SP, Marceli PD, Podell ER, Allen RH, Lindenbaum J. (1986). Assay of 
methylmalonic acid in the serum of patients with cobalamin deficiency using 
capillary gas chromatography - mass spectrometry. J Clin Invest, 77: 1606-1612. 
10. Lindenbaum J, Healton EB, Savage DG, Brust JCM, Garrett TJ, Podell ER et al. 
(1988). Neuropsychiatrie disorders caused by cobalamin deficiency in the absence 
of anemia or macrocytosis. N Eng J Med, 318: 1720-1728. Nutrition. Chapter 12: Vitamin B i2 11-12-1992 115 
11. Baker SJ, Mathan VI. (1981). Evidence regarding the minimal daily requirement of 
dietary vitamin B12. Am J Clin Nutr, 34: 2423-2433. 
12. Darby WJ, Bridgfort EB, Le Brocquy J. (1958). Vitamin BI2 requirements of adult 
man. Am J Med, 25: 726-732. 
13. Adams JF, Hume R, Kennedy EH, Pirrie TG, Whitelaw TW, White AM. (1968). 
Metabolic responses to low doses of cyanocobalamin in patients with 
megaloblastic anaemia. Br J Nutr, 22: 575-582. 
14. Armstrong BK, Davis RE, Nicol DJ, van Merwyk AJ, Larwood CJ. (1974). 
Hematological, vitamin B12 and folate studies on Seventh-day Adventist 
vegetarians. Am J Clin Nutr, 27: 712-718. 
15. Jathar VS, Inamdar-Deshmukh AB, Rege DV, Satoskar RS. (1975). Vitamin B12 
and vegetarianism in India. Acta Haematol, 53: 90-97. 
16. Abdulla M, Andersson I, Asp NG, Berthelsen K, Birkhed D, Dencker I et al. 
(1981). Nutrient intake and health status of vegans. Chemical analyses of diets 
using the duplicate portion sampling technique. Am J Clin Nutr, 34: 2464-2477. 
17. Specker BL, Black A, Allen L, Morrow F. (1990). Vitamin B12: low milk 
concentrations are related to low serum concentrations in vegetarian women and 
to methylmalonic aciduria in their infants. Am J Clin Nutr, 52: 1073-1076. 
18. Miller DR, Specker BL, Ho ML, Norman EJ. (1991). Vitamin B12 status in a 
macrobiotic community. Am J Clin Nutr, 53: 524-529. 
19. Anderson BB. (1965). Investigations into the Euglena method of assay of vitamin 
B12: the results obtained in human serum and liver using an improved method of 
assay. Ph.D. Thesis, University of London. 
20. Herbert V. (1987). Recommended dietary intakes (RDI), of vitamin B12 in 
humans. Am J Clin Nutr, 45: 671-678. 
21. Kamaze DS, Carmel R. (1990). Neurologic and evoked potential abnormalities in 
subtle cobalamin deficiency states, including deficiency without anaemia and with 
normal absorption of free cobalamin. Arch Neurol, 47: 1008-1012. 
22. Kühne Τ, Bubi R, Baumgarmer R. (1991). Matemal vegan diet causing a serious 
infantile neurological disorder due to vitamin B12 deficiency. Eur J Pediatr, 150: 
205-208. 116 Reports of the Scientific Committee for Food: 3 1st series 
23. Bates CJ, Prentice A. (1988). Vitamins, minerals and essential elements. In: 
Bennett PN ed. Drugs and Human Lactation. Amsterdam: Elsevier: 433-493. 
24. Suter PM, Russell RM. (1987). Vitamin requirements of the elderly. Am J Clin 
Nutr, 45: 501-512. 
25. Siurala M, Isokoski M, Varis K, Kekki M. (1968). Prevalence of gastritis in a rural 
population. Scand J Gastroenterol, 3: 211-223. 13. Pantothenic acid 
Physiology and metabolism 
Pantothenic acid is required for the synthesis of coenzyme A (CoA), which is 
required in the metabolism of carbohydrates, amino acids and fatty acids and the 
synthesis of steroids and other metabolites, and for the synthesis of the prosthetic 
group of acyl carrier protein required for fatty acid synthesis. It thus has a central 
role in a wide variety of metabolic pathways '. 
About 857c of dietary pantothenic acid is as CoA or phosphopantotheine. In the 
intestine these undergo hydrolysis to pantothenic acid, which is absorbed by 
diffusion throughout the small intestine. 
All tissues are capable of forming CoA and the prosthetic group of acyl carrier 
protein from pantothenic acid. This synthesis requires the amino acid cysteine, and 
deficiency of the sulphur amino acids, methionine and cysteine, can result in impaired 
synthesis and hence secondary functional pantothenic acid deficiency. 
Phosphopantotheine, arising from the catabolism of CoA and acyl carrier protein, can 
be reused for CoA synthesis and new synthesis of acyl carrier protein. 
Phosphopantotheine which is not re-utilised is dephosphorylated, and the resultant 
pantotheine is cleaved to pantothenic acid and cysteamine. 
Pantothenic acid is well conserved in the body; over a week after administration of 
tracer doses of [
14C] pantothenic acid only some 38% of the dose is recovered in the 
urine, all as the free vitamin. There is no information on body reserves of pantothenic 
acid. 
Deficiency 
Pantothenic acid is widely distributed in foods, and it is possible that intestinal 
bacterial synthesis also makes a contribution to intake. Deficiency has not been 
unequivocally reported in human beings except in specific depletion studies, which 
have frequently also used the antagonist methyl pantothenic acid. 
Prisoners of war in the Far East, who were severely malnourished, showed, among 
other signs and symptoms of vitamin deficiency diseases, a new condition of 
paraesthesia and severe pain in the feet and toes, which was called the 'burning foot' 1 18 Reports of the Scientific Committee for Food: 31st series 
syndrome or nutritional melalgia. Although it was attributed to pantothenic acid 
deficiency, no specific trials of pantothenic acid were carried out; rather the subjects 
were given yeast extract and other rich sources of all vitamins as part of an urgent 
programme of nutritional rehabilitation. 
Experimental pantothenic acid depletion, normally together with the administration 
of the antagonist methyl pantothenic acid, results in neuromotor disorders, including 
paraesthesia of the hands and feet, hyperactive deep tendon reflexes and muscle 
weakness, as well as mental depression, gastrointestinal complaints and metabolic 
abnormalities which can be attributed to changes in lipid metabolism
 2. 
Requirements 
From the limited studies which have been performed it is not possible to establish 
requirements for pantothenic acid. Average intakes in adults are about 4-7 mg/d, but 
individuals consume 3-12 mg/d. Such intakes are obviously adequate to prevent 
deficiency; much higher amounts are harmless. There is no evidence on which to 
base estimates of changed pantothenic acid requirements in pregnancy or lactation. Nutrition. Chapter 13: Pantothenic acid 11-12-1992 119 
Summary 
Average intakes of pantothenic acid are adequate to meet requirements. There is no 
information on intakes below which deficiency is likely, nor adequate evidence to 
determine Population Reference Intakes. 
The acceptable range of intakes in adults is the observed range 3-12 mg/d. 
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Physiology and metabolism 
Biotin functions as the coenzyme transferring carbon dioxide in four reactions: 
pyruvate carboxylase, a key step in gluconeogenesis; acetyl CoA carboxylase, the 
first step of fatty acid synthesis; and in propionyl CoA and methylcrotonyl CoA 
carboxylases '. 
Most biotin in foods is present as biocytin, covalently bound to enzymes. This is 
released on proteolysis, and hydrolysed by biotinidase in the pancreatic juice and 
intestinal mucosal secretions to yield the free vitamin. The extent to which bound 
biotin in foods is biologically available is not known. Biotin is absorbed from the 
upper intestinal tract by active transport, although there is also some active uptake 
from the large intestine. Intestinal bacteria synthesise relatively large amounts of 
biotin, and it is assumed that this contributes to the host's nutrition. Biotin circulates 
in the bloodstream both free and tightly bound to a serum glycoprotein. Both free and 
protein-bound biotin are taken up by tissues. In tissues biotin is incorporated 
covalently into biotin-dependent enzymes, and on catabolism of these enzymes, the 
biocytin is hydrolysed by a specific peptidase, biotinidase, permitting reutilisation. 
Biotin may be excreted either unchanged or as the oxidation production bis-norbiotin. 
As a result of both resorption of the vitamin from urine and the protein binding of 
plasma biotin, which reduces excretion, there is very efficient conservation of biotin. 
This, together with the recycling of biotin released by the catabolism of enzymes, 
may be as important as intestinal bacterial synthesis of the vitamin in explaining the 
scarcity of biotin deficiency. There is no information on body reserves of biotin. 
Deficiency 
Biotin deficiency due to simple inadequacy of intake is unknown except in patients 
receiving total parenteral nutrition. 
The activities of biotin-dependent enzymes fall in deficiency. This results in impaired 
gluconeogenesis, with accumulation of lactate, pyruvate and alanine, and impaired 
lipogenesis, with accumulation of acetyl CoA, resulting in ketosis. There is also an 
impairment of protein synthesis. Abnormal organic acids are excreted in deficiency
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The few early reports of human biotin deficiency are all of people who consumed 
large amounts of uncooked eggs, and therefore had a high intake of the protein 
avidin, which binds biotin and renders it unavailable. They developed a fine scaly 
dermatitis and hair loss. Provision of biotin supplements of between 200-
1000μg/day resulted in cure of the skin lesions, and regrowth of hair, despite 
continuing the abnormal diet providing large amounts of avidin. Unfortunately, there 
seem to have been no studies of provision of modest doses of biotin to such patients, 
and none in which their high intake of uncooked eggs was either replaced by an 
equivalent intake of cooked eggs (in which avidin has been denatured by heat, and 
the yolks of which are a good source of biotin) or continued unchanged, so there is no 
information from these case reports of the amounts of biotin which are required for 
normal health. 
In experimental studies of biotin depletion, diets providing up to 30% of energy 
intake from raw egg white have been used. The subjects developed glossitis, 
anorexia, nausea, hallucinations, depression and somnolence, as well as a fine scaly 
desquamating dermatitis. Injection of 150 μg biotin daily reversed all the clinical 
signs. Again there have been no studies of graded intakes of biotin in such 
experiments
 
3·
4. 
Similar signs of biotin deficiency have been observed in patients receiving total 
parenteral nutrition for prolonged periods, e.g. after resection of the gut. The signs 
resolve following the provision of biotin, but there have been no studies of the 
amounts required; curative intakes have ranged between 60 and 200 μg/day
 
5. 
Requirements 
There is little information concerning human biotin requirements, and no evidence on 
which to base recommendations. Average intakes of biotin in the EC are around 28-
42 μg /day, but individuals may consume between 15 and 100 μg/d. Such intakes are 
obviously adequate to prevent deficiency. There is no evidence of adverse effects 
from high intakes of biotin. 
There is no information on which to base estimates on additional requirements in 
pregnancy or lactation. 122 Reports of the Scientific Committee for Food: 31st scries 
Summary 
Average intakes of biotin are adequate to meet requirements. There is no 
information on intakes below which deficiency is likely, nor adequate evidence to 
determine the Population Reference Intakes. 
The acceptable range of intakes for adults is the observed range 15-100 μg /day. 
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Physiology and metabolism 
Vitamin C (L-ascorbic acid) is involved in numerous metabolic reactions in ways not 
yet fully understood '-
2. The most specifically defined biochemical function is as a 
cofactor in hydroxylations using molecular oxygen, notably of proline to 
hydroxyproline, as in the biosynthesis of collagen. Ascorbic acid participates in this 
and other reactions as a reducing agent. It reduces Fe(III) to Fe(II), which helps in 
improving the absorption of non-haem iron. It reduces superoxide radicals to 
hydrogen peroxide, and effectively quenches singlet oxygen, which is the basis of its 
ability to inhibit many destructive photo-dynamic effects, e.g. in the eye, and other 
beneficial effects of vitamin C in the human body have been ascribed to its 
antioxidative capacity. 
Ascorbic acid is one of the main water soluble chain-breaking antioxidants in 
biological systems
 3. Much attention is now being paid to the role of vitamin C in the 
antioxidant defences of the body, but insufficient evidence is currently available to 
enable the antioxidant status of the body to be used as the basis of calculating 
vitamin C requirements. 
At low doses, absorption of vitamin C may be almost complete, but over the range of 
usual intake in food (30-180 mg/d), 80 to 90 % is absorbed. When ingested in 
amounts higher than 100 mg/d, it is mainly excreted as such, while the percentage of 
gastrointestinal absorption decreases with the oral dose of vitamin C to values as 
low as 16 %
 4. 
Total body stores of ascorbic acid in adult man may reach levels up to 3 g at daily 
intakes exceeding 200 mg. The average body pool of vitamin C of healthy male 
subjects consuming a self-selected diet with a daily ingestion of 60-100 mg of 
ascorbate is around 1500 mg, i.e. about 20 mg/kg body weight
 5. 
Levels of deficiency and excess 
Frank vitamin C deficiency appears in the adult as scurvy, in the child as Moeller-
Barlow disease, which has somewhat different signs. 124 Reports of the Scientific Committee for Food: 31st scries 
Scurvy affects primarily the mesenchymal tissues. Because collagen formation is 
impaired, wound healing is delayed. The deficient formation of intercellular substance 
and collagen leads to increased fragility of the capillaries and to bleeding in the skin, 
mucous membranes, internal organs and muscles. 
In childhood scurvy, the bone tissue is most obviously involved, especially in the 
breast cage and the stressed epiphyseal cartilage of the extremities. The disease 
can occur in artificially nourished infants after the 6lh month of life, when the 
transplacental^ transferred reserves of the vitamin have been exhausted. 
Clinical signs of scurvy appear in adult men on a daily intake of less than 10 mg/d, 
when the total body pool falls below 300 mg
 6, and are associated with plasma (or 
serum) and whole blood vitamin C values of less than 2 mg/L (11 μπιοΙ/L plasma) 
and 3 mg/L (17 μπιοΙ/L blood); leukocyte levels of less than 2 μg/10
8 cells (85 
μιτιοΙ/L) are observed. 
A lesser degree of hypovitaminosis C can manifest itself in "prescorbutic" symptoms 
such as weakness, lassitude, fatigue, increased susceptibility to infections, and 
perhaps to other disease conditions
2. Behavioural abnormalities, delayed recovery 
from surgical procedures, weight loss and deficient immune system responses have 
been reported. 
A common feature of vitamin C deficiency is anaemia, due to impaired iron and 
perhaps folic acid metabolism. 
Reports that high intakes may be beneficial have led some individuals to take large 
doses of vitamin C. The only adverse effects consistently reported in apparently 
healthy subjects are transient gastrointestinal disturbances. These can occur after 
ingestion of as little as 1 g, but seem to be caused by the acidity rather than the 
ascorbic acid per se because the symptoms can be largely avoided by taking the 
vitamin as a buffered salt. Ill effects of higher doses have occasionally been reported, 
e.g. an increased urinary excretion of oxalate with a resulting higher risk of kidney 
stones in patients with defects of oxalate metabolism, but in general intakes up to 10 
g/d seem not to be unsafe for healthy individuals
 7. 
Methods for establishing physiological requirements 
Vitamin C status can be evaluated from signs of clinical deficiency (such as follicular 
hyperkeratosis, swollen or bleeding gums, petechial haemorrhages, and joint pain), 
or from its concentration in plasma, blood or leukocytes. It has also been estimated 
from isotopie studies of body stores
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The Sheffield experiment on the vitamin C requirements of human adults
 8 and the 
later Iowa study
 6 indicated that a daily amount of 6.5-10 mg ascorbic acid is 
sufficient to prevent or to cure signs of scurvy. The ultimate lowest physiological 
requirement of adults is presumably in that range. 
It is generally assumed that the amount of vitamin C required for optimal functioning 
of metabolic processes within the body is higher than the amount to prevent classical 
signs of scurvy. However, the optimal tissue levels of vitamin C for these processes 
are not known. Blood levels of vitamin C are often considered, although these levels 
have their limitations. Plasma concentrations above 5 mg/L (28 μιηοΙ/L) are taken as 
indicating an acceptable supply. Such levels are reached at vitamin C intakes from 
about 30 mg per day. Vitamin C levels rise rapidly with increasing daily intake and 
reach a plateau of 12-15 mg/L (68-85 μπιοΙ/L) at intakes far above 80 mg per day
 9. 
The strong relation between plasma vitamin C and recent oral intake limits the value 
of the plasma level as a reliable indicator of vitamin C adequacy. 
The ascorbic acid level in leukocytes approximately reflects that in the tissues. 
However, it may not be a reliable index of vitamin C status as the vitamin rapidly 
moves from plasma into cells, e.g. during infections
 10. 
A priori, the best means of determining vitamin C requirement would seem to be 
determination of the total body pool and its fractional rate of loss or catabolism. The 
appropriate intake would be that needed to replace losses and thus maintain the 
body pool, taking into account the bioavailability of vitamin C from the diet. 
Translation of physiological requirements into dietary intake 
Clinical signs of scurvy appear in adult males when the total body pool of vitamin C 
falls below 300 mg
6. It is desirable to have vitamin C in amounts more generous 
than just to prevent the appearance of scurvy, and psychological abnormalities have 
been reported in men with body pools below 600 mg. There is no convincing evidence 
of extra benefits from a pool in excess of 600 mg, but a pool of 900 mg would provide 
reserves for periods of low intake or temporary higher needs, e.g. stress. 
For a wide range of body pool sizes (12-1700 mg) and vitamin C intakes up to 60 
mg/day, the mean first-order rate of urinary excretion of vitamin C and its 
metabolites in adult men has been calculated as 2.7 ± 0.5 % of the body pool per 
day ". 
During the depletion periods of the Iowa experiments '
2, the body pool was 
catabolized at a rate of 2.9 ± 0.6 % per day. One can derive from this a daily intake of 126 Reports of the Scientific Committee for Food: 31st scries 
vitamin C in adult men by assuming a body pool of 900 mg and an absorption 
efficiency of 85%. In this way the Average Requirement (AR) for an adult man is 
calculated as: 
900 χ 2.9/100 χ 100/85 = 30.7 mg/d, which can be rounded off to 30 mg/d. 
The Population Reference Intake (PRI) for adult men would be 
900 χ (2.9 + 1.2V100 χ 100/85 = 43.4 mg/d, which can be rounded off to 45 mg/d. 
It is difficult to estimate a Lowest Threshold Intake (LTI) for vitamin C. It can be 
argued that it should be the amount that will certainly prevent scurvy - somewhat 
less than 10 mg/d in adult men - but many would consider that a too restricted view 
of the nutritional importance of the vitamin. Maintenance of an adequate body pool 
has been used as the basis for calculating the AR and PRI; a similar approach can be 
employed for estimating the LTI. 
It would be unreasonable to calculate a LTI to maintain a body pool size of 900 mg, 
as failure to do so is unlikely to be harmful. However, it can be derived for a body 
pool of 600 mg as 
600 χ (2.9- 1.2)/100x 100/85= 12 mg/d. 
Women probably have a smaller body pool than men, and might therefore be 
expected to have a lower requirement. No comparable turnover studies have been 
carried out on women, however, and in a depletion experiment the plasma vitamin C 
concentration was reported to fall more rapidly in females than in males '
3. It 
therefore seems prudent to make the same recommendations for non-pregnant, non-
lactating women as for men. 
Requirements of other groups of the population 
Children 
Little information is available beyond that 7 mg/d is sufficient to prevent scorbutic 
signs in infants '
4. The amount of vitamin C in breast milk seems to reflect maternal 
dietary intake, not the infant's needs, and in Europe and USA intake may range down 
to 23 mg/d, while apparently satisfying all the needs of the infant 2.11.14.15 
The PRI for infants 6-12 months is therefore set, somewhat arbitrarily, at 20 mg/d, 
i.e. about three times higher than amounts known to prevent scurvy. Nutrition. Chapter 15: Vitamine 11-12-1992 127 
The PRIs of older children are increased gradually to those for adults. 
Pregnancy 
Plasma and leukocyte vitamin C drop during pregnancy '
4. It is not known whether 
this drop represents a normal physiological adjustment (haemodilution) or indicates 
an increased requirement. It is assumed that the requirement of vitamin C during 
pregnancy is somewhat higher than that of non-pregnant women but by not more 
than 10 mg/d. This increase would allow for the 50 % higher plasma levels and 
probably higher cell concentration of vitamin C in the fetus and the higher catabolic 
rate of the fetus. 
Lactation 
Lactating women should have a vitamin C intake which compensates for at least 20 
mg vitamin C excreted in breast milk. On the assumption of a 85 % bioavailability, 
the dietary intake of lactating women should be 25 mg/d higher than non-lactating 
women for the entire lactating period. 
The elderly 
Conflicting results have been reported on the changes of blood levels of vitamin C as 
a result of ageing. It seems, however, that in the absence of pathological conditions 
that may influence vitamin C metabolism (e.g. digestion or absorption) or renal 
functioning, the vitamin C requirement of the elderly do not deviate from those of 
other adults ". 
Other factors affecting vitamin C requirement 
There are indications that smoking and some other factors and conditions may 
influence the vitamin C requirement. 
Smoking decreases the absorption and blood level of vitamin C and increases its 
catabolism. In heavy smokers (routinely more than 20 cigarettes per day) with a 
vitamin C intake of 60 mg/day, the mean absorption efficiency has been reported as 
9 % lower and the mean half-life significantly reduced (by about 60 %) as compared 
with non-smokers
 16. A direct relationship has been demonstrated between the 
number of cigarettes smoked per day and levels of vitamin C. The daily turnover of 
vitamin C of heavy smokers would be about 40 % higher than that of non-smokers '
6. 128 Reports of the Scientific Committee for Food: 31st scries 
The function of ascorbic acid in the absorption of non-haem iron has been mentioned 
already. The section of this report dealing with iron discusses the difficulty some 
women have in obtaining an adequate supply of iron. The bioavailability of dietary 
non-haem iron can be substantially improved if the meal contains 25 mg or more 
ascorbic acid. 
Some circumstances enhance the requirement for vitamin C, e.g. high physical 
activity, mental stress, alcoholism, drugs, and a number of pathological states, e.g. 
diabetes '
4. Unfortunately, the effects of all these factors have not been quantified 
and results of studies are not concordant. Therefore, the optimal intake of vitamin C 
in such stress conditions is not known. 
Higher recommendations 
There is a school of thought which believes that human requirements for vitamin C 
are considerably higher than the PRIs discussed above, e.g. more than 1 g/d. 
However, this is based on extrapolations to man from observations in animals that 
many consider unjustified. Intakes in excess of about 80-100 mg/d lead to a 
quantitative increase in urinary excretion of unmetabolised vitamin C, indicating that 
at this level tissue reserves are saturated. It is difficult to justify a requirement in 
excess of tissue storage capacity. 
It is hoped that in the near future more information will become available on the 
quantitative role of vitamin C in the body's defences against free radicals and on 
epidemiological evidence that appears to link higher vitamin C intakes with a lower 
level of some diseases
 1·
2·
9·
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Summary 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
mg/d 
30 
45 
12 
Population Reference Intakes of other groups 
Age Group 
6-11 m 
1-3 y 
4-6 y 
7-10 y 
11-14 y 
15-17 y 
Pregnancy 
Lactation 
PRI (mg/d) 
20 
25 
25 
30 
35 
40 
55 
70 130 Reports of the Scientific Committee for Food: 31st series 
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Physiology and metabolism 
The two major forms of vitamin D are the secosteroids cholecalciferol (vitamin D3), 
derived from cholesterol and of animal origin, and ergocalciferol (vitamin D2), derived 
from the plant sterol, ergosterol. Since vitamins D2 and D3 have roughly the same 
activity in man, the term vitamin D will be used here to refer to both D2 and D3. 
Amounts of vitamin D are usually expressed in terms of weight, but the older 
International Unit (IU) is still in use (1 IU = 0.025 μg vitamin D). 
Sources 
Vitamin D is not strictly a vitamin as most of it is formed in the body by the action of 
sunlight converting 7-dehydrocholesterol in the skin to previtamin D3 '. This 
endogenous synthesis depends on the thickness and pigmentation of the skin and on 
the quality (290-315 nm) and intensity of the ultraviolet irradiation; the lowest UVB 
radiation that produces a significant increase in serum vitamin D3 is 18 mJ/cm
2 in 
untanned white subjects
 2. As in North America
 2·
3, this threshold level may not be 
reached in Northern Europe for a large part of the year. For example in Paris (48°N) 
only between late spring and early autumn is there sufficient UVB solar radiation to 
produce vitamin D. Even so, the amount produced during that limited season appears 
to be adequate to cover the needs of healthy adults living at latitudes between 35°N 
and 60°N, provided that the time in sunlight (10-15 min/d) and the amount of skin 
exposed (30%) to optimal UV irradiation are sufficient
 3-
4 and that atmospheric 
pollution is not excessive
 5. Vitamin D synthesis also depends on the age of the 
subject, being decreased in elderly people
 3. 
The diet is a much less important source of vitamin D. Only a few foods (fatty fish, 
eggs, butter, liver and certain types of meat) contain significant amounts of the 
vitamin and average daily intakes are too small to influence vitamin D status 
significantly, unless fortified food products are eaten regularly, e.g. margarine, milk, 
cereals. Dietary practices, such as vegetarianism
 6, macrobiotic diets
 7, or just low 
calcium intakes
 8, may decrease the availability of exogenous vitamin D or increase 
its catabolism. Nutrition. Chapter 16: Vitamin D 11-12-1992 133 
Metabolism 
In the blood vitamin D is bound to a specific vitamin D-binding protein, DBP, and is 
transported to the liver, where it undergoes a first hydroxylation into 25-
hydroxyvitamin D (25-(OH)D). This formation of 25-(OH)D in the liver is not tightly 
regulated and after inadvertent administration of excessive doses of vitamin D 
circulating levels of this metabolite increase up a hundred fold higher than those 
found in healthy populations. In its tum 25-(OH)D is transported, bound to the same 
DBP, to the renal proximal tubule, where it is converted into 1,25-dihydroxyvitamin 
D (l,25-(OH)2D)3. 
The renal proximal tubule is the major contributor to the circulating pool of 1,25-
(OH)2D in healthy non-pregnant subjects, 0.3-1 μ&ά being formed '°. During 
pregnancy, the fetoplacental unit is a second major source of the circulating 1,25-
(OH)2D. Unlike its precursor, 25-(OH)D, the circulating levels of l,25-(OH)2D are 
not influenced by vitamin D status except in situations of severe vitamin D 
deficiency. In contrast, the synthesis of 25-(OH)2D is tightly feedback regulated by 
l,25-(OH)2D itself and depends mainly upon the calcium and phosphate needs of the 
body
9·"·
12. 
Actions 
l,25-(OH)2D is the form of vitamin D responsible for calcium and phosphate 
absorption from the intestine, and for various actions on bone, kidneys, parathyroid 
glands and muscle, leading to the maintenance of phosphate homoeostasis in the 
extracellular fluid, to an increase in the extracellular concentration of calcium and to 
adequate mineralization of the skeleton 'i·
12. In addition, l,25-(OH)2D may be 
directly involved in a variety of different processes unrelated to calcium and 
phosphate homoeostasis, but the physiological relevance, if any, of these latter 
actions remains to be evaluated. 
Deficiency and excess 
The early signs of vitamin D deficiency are infraclinical: decreased serum 
concentrations of calcium and phosphate, resulting from depressed absorption of 
calcium and phosphate from the intestine, secondary hyperparathyroidism and 
increased serum alkaline phosphatase activity. Hypocalcémie convulsions may occur 
at this stage. Later signs are inadequate skeletal mineralization (rickets or 
osteomalacia), bone pains, severe bone deformities, and alterations in muscle 
metabolism and respiratory function. 134 Reports of the Scientific Committee for Food: 31st series 
Signs of acute and chronic vitamin D intoxication include nausea, diarrhoea, polyuria, 
weight loss, hypercalcaemia, hypercalciuria, and eventually nephrocalcinosis, 
decreased renal function, or calcification of soft tissues. Signs of vitamin D 
intoxication have been found after prolonged administration of 250-1250 μg/d '
3, 
although short term administration (7 weeks) of 250 μg/d to healthy adults had no 
detectable effects en the serum and urinary calcium and phosphate concentrations, 
and did not increase 25-(OH)D concentrations above levels spontaneously reached 
after daily total body exposure to UV irradiation '
4. 
Hypercalcaemia has been shown to occur occasionally in infant populations receiving 
periodic administration of very high doses of vitamin D (15 mg, every 6 months) as a 
prophylaxis against rickets, and 25-(OH)D levels in the blood of these infants reach 
values similar to those found in patients with obvious vitamin D intoxication '·
5. 
It was claimed that prolonged daily intakes of 100 μg/d by infants increased the 
incidence of hypercalcaemia '
6, but no reliable assessments of vitamin D intake could 
be made at that time. Doses of 50 μg/d do not appear to be harmful to infants as they 
do not affect statural growth '
7. 
Requirements 
Assessment of vitamin D status 
The most reliable marker of vitamin D status is the circulating level of 25-(OH)D. 
Healthy adults who do not expose themselves to sunshine, or live in countries with 
only a short season of useful UV irradiation, may have 25-(OH)D values as low as 
6-8 ng/ml (15-20 nmol/L). Subclinical signs of vitamin D deficiency have been found 
in some of these otherwise healthy adults with 25-(OH)D levels below 10 ng/ml. At 
the other end of the scale, 25-(OH)D levels as high as 80 ng/ml (200 nmol/L) are 
found in healthy adults living in tropical countries or in southern Europe after 
prolonged sunbathing. Patients with clear signs of vitamin D intoxication usually 
have 25-(OH)D levels above 100 ng/ml. Thus a desirable range for 25-(OH)D could 
be 10-40 ng/ml (25-100 nmol/L). The vitamin D requirement is therefore being 
considered as that necessary to maintain circulating 25-(OH)D concentrations in 
that range. 
Dietary recommendations 
The problem in trying to give a dietary requirement for vitamin D is that many 
individuals maintain their circulating 25-(OH)D concentrations in the desirable range 
by endogenous synthesis of vitamin D, and so need none in the diet Nutriüon. Chapter 16: Vitamin D 11-12-1992 135 
Those that do not produce sufficient vitamin D by endogenous synthesis need some 
dietary supply. The intake necessary will depend on the shortfall of exposure to 
effective UV radiation and perhaps on inadequacy of calcium and phosphate intakes. 
There will thus be considerable variation between different geographical regions in 
Europe (latitude, climate and air pollution) and perhaps between social and ethnic 
groups in a given geographical region (calcium and phosphate intake, exposure to 
sunlight). 
In such circumstances, precise recommendations are hard to give; for some groups it 
would be pointless to try to do so, notably for adults, where most have no dietary 
requirement. 
In all groups of the population however some individuals will need some dietary 
vitamin D, and a range of values is suggested that would meet the needs of all 
members of the group, even those with minimal endogenous production of vitamin D. 
Some population groups may have difficulty in obtaining their needs by endogenous 
synthesis, either because of inadequate exposure to sunlight (e.g. the elderly) or of a 
physiologically raised requirement (e.g. in pregnancy and lactation) or both (e.g. very 
young children). Substantial numbers in these groups will need dietary vitamin D, 
and there is a sizeable risk of an individual becoming deficient. In these groups, as a 
matter of prudence, a minimum value for intake is given, i.e. it is recommended that 
all members of the group receive that amount. In practice this will call for the 
consumption of supplements or fortified foodstuffs. 
Adults 
On the basis of their 25-(OH)D levels, dietary intakes of vitamin D do not appear 
essential for healthy adults, adequately supplied with calcium and phosphate, unless 
they are confined indoors
 
4. 
No information is available on the effects of dietary vitamin D on 25-(OH)D levels of 
non-pregnant younger adults, but from studies on elderly people i
8·'
9, it appears that 
daily intakes of 10 μ&ά would bring 25-(OH)D concentrations into the desired range, 
even if endogenous synthesis were minimal. 
It is suggested that the requirements of all adults would met by dietary intakes of Ο­
ΙΟ μg/d. 
Children 
There is a substantial incidence of rickets in infants not given vitamin D 
supplements. Studies on the 25-(OH)D levels of infants supplemented or not 
supplemented with vitamin D confirm that infants have a high requirement 20.21 136 Reports of the Scientific Committee for Food: 31st scries 
In order to maintain circulating 25-(OH)D levels in the desired range it is 
recommended that the dietary intake of infants 6-1 lm should not be less than 10 
μ&ά. It is possible that the requirement may be higher in some infants, perhaps up to 
25 μg/d
 2'. 
Infants and children are vulnerable to vitamin D deficiency because calcium is being 
laid down in bone at a high rate. As children in the 1-3 y group may not get adequate 
exposure to sunlight it is recommended that their intake should not be less than 
io ng. 
Older children still have a high requirement for vitamin D, and adolescents, who have 
to reach adult bone mass at a time of accelerated skeletal growth, have a particularly 
high requirement for calcium and thus for vitamin D. Most children of 4 years and 
over and most adolescents should however get enough exposure to sunlight to make 
adequate amounts themselves. 
Those belonging to social or ethnic groups with insufficient exposure to the sun, or 
on not wholly satisfactory diets, are at risk of vitamin D deficiency, and attention 
should be paid to adolescents in northern Europe. The ranges of dietary vitamin D 
are 0-10 μg/d for 4-10 y and 0-15 μg/d for 11-17 y. 
Pregnancy and lactation 
Pregnant and lactating women have higher requirements for vitamin D than do non­
pregnant women along with their need for high amounts of calcium and phosphate for 
the mineralization of the growing skeleton of the fetus and infant; lactating women 
also have to provide vitamin D in the milk. Numerous studies on 25-(OH)D levels 
have shown that customary exposure to sunlight in Europe may be insufficient to 
cover the needs for vitamin D, especially during the last trimester of pregnancy, and 
notably at the end of the winter. The ensuing vitamin D deficiency will affect not only 
the mother but also the newborn, whose vitamin D reserves are very dependent on 
those of the mother. To maintain 25-(OH)D levels, 10 μg/d is recommended
 22·
23. 
The elderly and institutionalized individuals 
Because of lack of exposure to sunlight, and the decline with age of the ability to 
synthesize vitamin D3, elderly and institutionalized people are prone to develop D 
deficiency. To maintain circulating 25-(OH)D values between 10 and 20 ng/ml, 
elderly and institutionalized people should receive 10 μg/d
 18·'
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Summary 
Requirements 
A range of values up from zero indicates that all members of the group should be 
able to produce adequate vitamin D for themselves by exposure to sunlight, and 
most will, with no need for a dietary supply. The higher end of the range is the 
estimated dietary requirement of an individual with minimal endogenous synthesis. 
In other groups a single value indicates that it is prudent for the whole group to be 
supplemented to avoid occurrence of vitamin D deficiency. 
Age group 
6- 11 m 
l-3y 
4-6y 
7- 10 y 
11-14 y 
15-17 y 
18-64 y 
65 +y 
Pregnancy 
Lactation 
PRI (^g/d) 
10-25 
10 
0-10 
0-10 
0-15 
0-15 
0-10 
10 
10 
10 
Higher intakes 
Intakes of 250 μg/d have been reported as harmful '
3; the lowest level at which ill 
effects appear is not known. Intakes of 50 μg/d appear safe '
7. There seems no 
benefit to be obtained by healthy individuals from higher regular intakes. It would be 
prudent not to exceed 50 μg/d in habitual intake. 138 Reports of the Scientific Committee for Food: 31st series 
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Physiology 
Vitamin E activity is manifested by two series of compounds. The more important 
are the tocopherols; the tocotrienols, differing in the degree of saturation of the 
phytyl side chain, are less potent biologically and provide only a little of the vitamin 
E activity of the diet. Within each series are four compounds (designated α, β, γ 
and δ) differing in the number and position of the methyl groups on the chromanol 
ring. Synthetic α-tocopherol is a mixture of isomers. The multiple forms differ in 
vitamin E potency, the most active being the natural isomer RRR-a-tocopherol, 
which accounts for about 90% of the vitamin E present in human tissues. The vitamin 
E activity of all is now conventionally summed in terms of the equivalent value of 
RRR-a-tocopherol
1 (1 mg α-tocopherol equivalent = 1.5 international units). 
The biological action of vitamin E results principally and perhaps entirely from its 
antioxidant properties; it prevents propagation of the oxidation of unsaturated fatty 
acids by trapping free radicals. This is believed to be the basic function of vitamin E 
in animal tissues, where tocopherol is found in cellular membranes associated with 
polyunsaturated fatty acids (PUFA) in phospholipids. In vitamin E deficiency, the 
oxidation of PUFA leads to structural and functional damage to cellular membranes. 
Levels of deficiency and excess 
Most diets are an adequate source of vitamin E, and consequently for many years no 
clearly defined deficiency syndrome could be described in man, and no clinical signs 
of deficiency are ever seen in individuals without other metabolic defects. Children 
and adults unable to absorb or utilise vitamin E adequately can develop a 
characteristic and progressive neurological syndrome involving the central and 
peripheral nervous system, retina and skeletal muscles, after a period of years 
during which the plasma tocopherol concentration has been extremely low. 
Appropriate treatment with vitamin E can prevent this if given sufficiently early. 
A specific syndrome comprising haemolytic anaemia, thrombocytosis and oedema 
has been reported in premature infants, but the introduction of milk formulas 
containing adequate vitamin E has resulted in its virtual disappearance. Nutrition. Chapter 17: Vitamin E 11-12-1992 141 
Over the years there have been many claims that vitamin E in quantities much larger 
than those needed to prevent any detectable deficiency may have beneficial effects 
on various disease processes or in promoting better general health. Most have not 
gained wide acceptance. Currently however there is much interest in a postulated 
role of antioxidants in preventing pathological processes in which free radicals have 
been implicated; particular attention has been paid to vitamin E as it can act as a 
free-radical scavenger. It has been suggested that a generous intake of vitamin E 
might protect against, among other things, cancer, atherosclerosis, coronary heart 
disease, cataracts, arthritis, ageing and air pollutants
 2. For example, an inverse 
relationship has been reported between plasma vitamin E concentration and 
coronary heart disease
 3·
4. 
Because of the numerous reports of the beneficial effects of high doses, it is not 
uncommon for individuals to consume large amounts of vitamin E. There have been a 
number of double blind trials to investigate high doses of vitamin E up to 3,200 mg/d. 
Few adverse effects were reported and none consistently but above 2,000 mg 
α-tocopherol equivalents per day some subjects showed intestinal disorders 
(diarrhoea and cramps)
 5. 
Methods of establishing physiological requirements 
Since clinical vitamin E deficiency due to an inadequate supply in the diet does not 
exist, some other marker of E status is necessary, and a commonly used one is the 
plasma tocopherol concentration. This however changes with the concentration of 
serum lipids; as they rise tocopherol appears to partition out of cellular membranes 
into the circulation. The tocopherol concentration is therefore best expressed as the 
serum tocopherol: total lipid ratio, but the serum tocopherolxholesterol ratio is 
almost as good, and is more convenient to measure
 6. 
The major function of vitamin E is believed to be the protection of cellular membrane 
lipids from oxidation and a widely employed test for this is to expose red cells in 
vitro to oxidizing agents such as dilute solutions of hydrogen peroxide. Below a 
plasma tocopherol concentration of 0.5 mg/dl (11.6 μΓΏθΙ/L; tocopherolxholesterol 
ratio 2.25 μΓηοΙ/ΓηιτιοΙ), the erythrocytes tend to haemolyse. A substantial decrease 
below this concentration is necessary to reduce red cell survival time in vivo
 7. 
Nevertheless a plasma tocopherol concentration of 0.5 mg/dl (11.6 μπιοΙ/L) or, better, 
a serum tocopherol: cholesterol ratio of 2.25 μπιοΐ/πιπτιοί, is taken as an indication of 
biochemical abnormality, and it is considered undesirable to have tocopherol 
concentrations fall below that. 142 Reports of the Scientific Committee for Food: 31st scries 
In favourable circumstances the plasma tocopherol concentration can be maintained 
above that on not very large intakes of vitamin E - for some adult males, on not 
much above 3 mg α-tocopherol equivalents per day, provided they have a low intake 
of PUFA
8. 
The requirement for vitamin E is determined to a large extent by the PUFA content 
of the tissues, which is influenced by the PUFA content of the diet. Numerous 
experiments have shown that increasing the PUFA content of a diet low in vitamin E 
has adverse effects on E status
 8·
9 and if there are very large amounts of PUFA, 
substantial quantities of extra vitamin E are needed to restore the plasma tocopherol 
concentration to an adequate level
 9. 
Translation of these physiological requirements into dietary 
intakes 
A major problem in making recommendations arises from the fact that E 
requirements are influenced by the PUFA intake. There are wide variations in PUFA 
consumption; the intakes of individuals are not normally distributed but are skewed 
with some quite high values. In a recent study of adult men in UK
 10the 97.5 centile 
intake of n-6 PUFA was 29 g per day. The amount of vitamin E required for such an 
intake of PUFA would be high. To give such a value as the PRI would have the 
undesirable effect of indicating to people with a much lower, but adequate, intake of 
PUFA that they ought to take substantially more vitamin E when they had no need 
to do so. 
However, widely differing intakes of PUFA are normally not a problem in practical 
vitamin E nutrition. Foods rich in PUFA tend to contain large amounts of vitamin E, 
so high intakes of PUFA are usually accompanied by comparably high intakes of 
vitamin E. This is not always the case with all individual foodstuffs, but taken over a 
mixed diet, the generalization seems to hold. 
The difficulty in making recommendations about dietary intake of vitamin E is that 
there is no good evidence that dietary vitamin E deficiency exists, in part because 
vitamin E is widely distributed in common foodstuffs, and accompanies the PUFA 
that raise requirements. A recent demonstration of this was in a survey in UK
 10. Of 
1,763 adult subjects only 11 (0.6%) had serum tocopherolxholesterol ratios below 
2.25 μιτιοΐ/mmol. 
There are various responses to this problem. One is to declare that, as virtually all 
diets are adequate with respect to vitamin E, recommendations are unnecessary 
except for infant formulas. Nutrition. Chapter 17: Vitamin E 11-12-1992 143 
A second approach is to decide that since the diet as consumed is clearly adequate 
with respect to vitamin E, the recommendation should be based on current intakes. 
In prosperous societies, however, most people seem to ingest more vitamin E than 
they need to maintain apparent biochemical normality. In the recent survey of British 
adults
 10, of which over 99% had acceptable serum tocopherolxholesterol ratios, 
seven-day weighed dietary records (excluding vitamin supplements) showed that 
the 2.5 and 97.5 centile intakes of a group of 1,087 males were 3.5 and 19.5 mg 
α-tocopherol equivalents per day, and of a group of 1,110 females 2.5 and 15.2 mg per 
day. 
Another apparently more logical approach is to make dietary recommendations for 
vitamin E in terms of the dietary PUFA intake. There is however no general 
agreement about what the ratio mg α-tocopherol equivalents:g PUFA should be, but 
about 0.4 seems adequate in a normal American diet 'i·'
2. Furthermore there is 
evidence that even on a very low intake of PUFA, a substantial amount of vitamin E 
is still needed
 9. 
Suggestions have been made that intakes of vitamin E in amounts much larger than 
normally considered essential would raise plasma α-tocopherol concentrations and 
have health benefits. The evidence for this is as yet insufficiently convincing, and 
there is even less certainty on what the effective daily amounts might be. 
The claim should be kept under review as the results of more work, including, it is 
hoped, intervention trials, are published. Should it prove true, the problem could arise 
of distinguishing between true nutrient needs and the use of nutrients as 
prophylactic drugs '
3. 
Children and infants (6-11m) 
A diet containing 0.4 mg α-tocopherol equivalents per g PUFA seems adequate for 
children. It is reasonable to assume that as in adults there is some basic 
requirement for vitamin E on a diet very low in PUFA, but there is no information 
about what the amount might be. In practice, there seems no cause for concern, as 
there is no evidence of E deficiency in metabolically normal children. 
Infant formulae always contain adequate amounts of vitamin E. 144 Reports of the Scientific Committee for Food: 31st series 
Pregnancy and lactation 
Since vitamin E deficiency has never been reported during pregnancy and lactation, 
even on quite low intakes
 14, no recommendations for supplementation are made. 
Summary of proposals 
1. As the vitamin E requirement depends on the dietary PUFA intake, and dietary 
PUFA intakes vary greatly between individuals, it is inexpedient to set a single PRI 
value that would meet the known nutrient needs of practically all healthy persons as 
this would be misleadingly far too large for most of the group. 
2. Similarly there seems little merit in giving an average requirement. 
3. A requirement for vitamin E can be defined in terms of dietary PUFA intake. Vitamin 
E requirement (mg α-tocopherol equivalents) = 0.4 χ (g dietary PUFA). There is no 
evidence that this level would be inadequate for anyone, provided the value did not 
fall below 4 mg/d for adult men and 3 mg/d for adult women (because of their smaller 
body size, women would have less PUFA in their tissues needing protection). 
4. Large doses are usually harmless, but should not exceed 2,000 mg α-tocopherol 
equivalents per day. 
5. Claims that very generous intakes of vitamin E have beneficial effects on health are 
not being taken into account in making the present recommendations. Nutrition. Chapter 17: Vitamin E 11-12-1992 145 
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Physiology 
Vitamin K activity is shown by a number of compounds containing the 2-methyl-l,4-
naphthoquinone structure. They include phylloquinone (the major dietary source), 
which occurs in plants, and the menaquinones, synthesized by bacteria '. 
Knowledge of the physiology of vitamin K has lagged behind that of the other fat-
soluble vitamins mainly because of the difficulty of quantifying the various forms. The 
best dietary sources are green leafy vegetables. Much smaller but nevertheless 
significant amounts are found in other foodstuffs of both plant and animal origin '. It 
is uncertain to what extent the intestinal bacteria contribute vitamin K to the 
body
 2·
3·
4. 
Vitamin K is reasonably well absorbed from the small intestine, but only poorly from 
the colon. Like all fat-soluble vitamins its absorption in substantial amounts depends 
upon normal production of bile acids and pancreatic enzymes. It is enhanced by 
dietary fat. In malabsorption syndromes uptake from the diet is very poor '. 
There is little storage of vitamin K in the body and there appears to be a fairly rapid 
turnover, so a continual supply is necessary in the diet. 
Vitamin K operates as an essential cofactor for a carboxylase enzyme catalysing the 
postranslational carboxylation of specific glutamyl residues in some proteins to the 
γ-carboxyglutamic form
 2. The best known such proteins are prothrombin and at least 
five other proteins involved in blood clotting. More recent work has shown that a 
number of other proteins containing γ-carboxyglutamic acid require vitamin K for their 
biosynthesis, notably osteocalcin in bone
 3. 
Deficiency and excess 
Vitamin K deficiency results in a bleeding syndrome consequent upon a lack of 
clotting factors. No deficiency signs have been reported as a result of inadequate 
production of other vitamin K-dependent proteins. 148 Reports of the Scientific Committee for Food: 31st scries 
Clinical features may range from mild bruising to severe life-threatening 
haemorrhage. Deficiency can occur in infants, who are bom with low reserves and no 
gut flora, as breast milk is not a good source of the vitamin. 
Clinical vitamin K deficiency is never seen after the first few months of life, except as 
a consequence of disease states, e.g. malabsorption, the use of vitamin K 
antagonists as anticoagulant drugs, long-term treatment with some antibiotics, 
parenteral nutrition without vitamin K
 4. 
No adverse signs have ever been reported from large oral doses of vitamin K
 5. 
Menadione, a synthetic water-soluble compound with vitamin K activity, may induce 
haemolytic anaemia, hyperbilirubinaemia and kernicterus in the newborn; these are 
not manifestations of hypervitaminosis K, but are side effects of an unphysiological 
form
 5. 
Requirements 
It is not easy to estimate human requirements because of the difficulty of inducing 
vitamin K deficiency in normal subjects. Vitamin K status has usually been assessed 
from the plasma concentration of prothrombin, measured from the clotting time in 
standardized conditions (prothrombin time). New more sensitive procedures are 
now being used to measure decreased activity of vitamin K-dependent clotting 
factors, lowered serum concentration of vitamin K and decreased urinary excretion of 
γ-carboxyglutamic acid
 6. 
In one experiment young healthy subjects consumed a diet, from which foods rich in 
vitamin K had been removed, to give approximately 50 μg phylloquinone/d. Blood 
clotting appeared normal, but there were signs that prothrombin biosynthesis was 
not optimal, and there was a decrease in γ-carboxyglutamic acid excretion. 
Supplements of 50 μg phylloquinone/d restored these indices to normal
 7. 
These findings are consistent with earlier work indicating that the requirement for 
dietary vitamin K is about 1 μg per kg body weight per day
 2·
7. 
Considering the difficulty of inducing vitamin K deficiency in healthy subjects, the 
problem of monitoring vitamin K status sensitively and reliably, the uncertainty of 
how much might be supplied by intestinal bacteria and the lack of accurate values for 
the amount of dietary K just sufficient to maintain normal function, the Committee 
decided to make no recommendation for vitamin K. An intake of 1 μg per kg body 
weight per day appears adequate and would be provided by a normal mixed diet. Nutrition. Chapter 18: Vitamin K 11-12-1992 149 
References 
1. Suttie JW. (1985). Vitamin K. In: Diplock AT, ed. Fat-Soluble Vitamins, Their 
Biochemistry and Applications. London: Heinemann, 225-311. 
2. Suttie JW. (1987). Recent advances in hepatic vitamin K metabolism and function. 
Hepatology, 7 : 367-376. 
3. Shearer MJ. (1990). Vitamin K and vitamin K-dependent proteins. Br J Haematol, 
75, 156-162. 
4. Carlin A, Walker WA. (1991). Rapid development of vitamin K deficiency in an 
adolescent boy receiving total parenteral nutrition following bone marrow 
transplantation. Nutr Rev, 49 : 179-183. 
5. Miller DR, Hayes KC. (1982). Vitamin excess and toxicity. In: Hathcock JN, ed. 
Nutritional Toxicology, vol. 1. New York: Academic Press, 81-133. 
6. Sadowski JA, Bacon DS, Head S, Davidson KW, Ganter CM, Haroon Y, Shephard 
DC. (1988). The application of methods used for the evaluation of vitamin K 
nutritional status in human and animal studies. In: Suttie JW, ed. Current Advances 
in Vitamin K Research. New York: Elsevier, 453-463. 
7. Suttie JW, Mummah-Schendel LL, Shah DV, Lyle BJ, Greger H. (1988). Vitamin K 
deficiency from dietary vitamin K restriction in humans. Am J Clin Nutr, 47: 475-480. 19. Calcium 
Physiology 
The adult male contains approximately 1.2 kg calcium (i.e. 1.5-2 % of the body 
weight), about 99 % of which is in the skeleton and the teeth; the residual 1 % is 
distributed between soft tissues (0.6 %) and the extracellular fluid (ECF) (0.06 %) 
including plasma (0.03 %). The intracellular concentration of calcium ranges from 15 
mmol/kg in muscle and platelets to as little as 0.02 mmol/kg in erythrocytes. Plasma 
and ECF calcium concentrations are 2.0-2.5 mmol/L; of this approximately 10 % is 
complexed with citrate, phosphate, bicarbonate, and 45 % is bound to circulating 
proteins of which 80-90 % is bound to albumin. About 45 % is present as free calcium 
ions - this is the functionally active pool, and it is far in excess of the intracellular 
activity of free calcium, which is only about 0.1 μπιοΙ/L '-
2. 
Calcium in bone has a structural function as a component of calcium hydroxyapatite, 
the principal bone mineral, which is complexed within the glycosaminoglycan ground 
substance and collagen fibres of the organic matrix. 
Calcium has an important regulatory role; the thousand fold gradient between extra-
and intra-cellular ionic calcium concentrations is fundamental to cellular signal 
transduction and amplification. An induced influx of calcium triggers and activates a 
variety of cellular physical and metabolic events such as enzyme activation, muscle 
contraction, neurotransmission, vesicular secretion, cellular aggregation, 
transformation and cell division. 
Although some calcium is absorbed in the distal bowel most is taken up in the 
proximal intestine via a carrier-mediated pathway and by diffusion which may be 
paracellular. The former involves a calcium-binding protein which transfers the 
element across the enterocyte to the baso-lateral membrane where it is extruded by 
Ca-Mg ATPase. When calcium requirements are increased, circulating 
concentrations of calcitriol (1,25-dihydroxycholecalciferol) increase, upregulating the 
carrier-dependent absorption of calcium. 
Within the intestinal lumen dietary components such as phytate, oxalate, alginate, 
uronate, phosphate, and unabsorbed lipids may bind calcium and reduce its 
absorption. On the other hand the luminal availability and absorption of the element 
is enhanced by lactose, phosphatidic acid, amino acids, sucrose, and increased 
intraluminal pH
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Calcium excretion occurs via both the gastrointestinal tract and the kidneys. The 
urinary content of calcium is related closely to the dietary intake of the element. Up 
to 97 % of the calcium entering the renal glomerular filtrate can be reabsorbed. The 
remaining 3 % may represent an 'obligatory' urinary loss of calcium which is 
considered as a significant determinant of calcium requirements. Urinary calcium loss 
rises with increasing intakes of sodium and protein; however the latter effect may be 
offset by the accompanying high phosphorus intakes in the protein sources. 
Calcium homoeostasis controls and protects the metabolically vital plasma pool of 
ionised calcium by simultaneously modifying its absorption, renal excretion and 
turnover in the mobilisable pool in bone. The principal regulators of these processes 
are parathyroid hormone, calcitonin, and calcitriol
 4. 
The secretion of parathyroid hormone is increased in response to low plasma ionised 
calcium concentrations and, possibly, low plasma magnesium concentrations. 
Initially this increased secretion is effected by increased cellular production of the 
hormone itself but with chronic hypocalcaemia parathyroid hyperplasia sustains the 
increased secretion of hormone. Parathyroid hormone increases renal excretion of 
phosphate and retention of calcium. It also stimulates the 1 a-hydroxylation of 
calcidiol (25-OH cholecalciferol) to calcitriol; thereby having an indirect effect on the 
intestinal absorption of calcium. Parathyroid hormone may also have a direct effect 
on the enterocyte. The hormone increases bone turnover and the release of calcium 
from the freely exchangeable calcium pools. It does this first via the surface 
osteocytes and in the long term by increasing the number of basic multicellular units 
(BMU) which mediate and coordinate bone turnover. 
Calcitriol stimulates intestinal calcium uptake by increasing the enterocytic 
production of calcium-binding protein. It also induces the maturation of osteoblasts 
thereby stimulating calcification of bone matrix, whilst simultaneously blocking bone 
resorption by inhibiting parathyroid hormone production. Calcitonin is secreted by the 
thyroid C cells in response to high plasma ionised calcium activity, which it reduces 
by increasing the renal excretion of calcium and reducing osteoclastic activity. 
Other hormones including the female sex hormones, mineralocorticoids, the thyroid 
hormones, and parathyroid hormone-related protein have a direct or indirect effect via 
the BMU on skeletal mineralisation and calcium metabolism but the precise 
mechanisms are not clear. 152 Reports of the Scientific Committee for Food: 31 si scries 
Deficiency and excess 
Acute calcium deficiency arising from dietary origin is rare, the exception being young 
infants fed infant formulas with an inappropriately low calcium:phosphorus ratio. The 
features are muscular weakness and tetany resulting from reduced ECF ionised 
calcium activity. Thus features of calcium deficiency are commonly seen in severe 
systemic alkalosis in which ionised calcium levels are reduced. 
Chronic calcium deficiency causes a reduction in bone density in children and may 
contribute to an increased fracture rate; it is debatable whether or not it causes 
growth retardation in children. Similarly the role and importance of an inadequate 
calcium intake in the pathogenesis of osteoporosis is not clear. Adequate bone 
formation depends on many nutrients and similarly the aetiology of osteoporosis is 
probably multifactorial
 4. It is uncertain that current calcium intakes play a major role 
in the pathogenesis of osteoporosis
 5·
6. Although calcium supplements (1 g 
calcium/d) slow the loss of bone density in established post-menopausal 
osteoporosis, this needs to be further evaluated in the context of the similar, or 
possibly extra, benefits which can be achieved by exercise, vitamin D or hormone 
replacement therapy
 7·
8·
9·
1011·'
2 0r by changes in lifestyle and calcium intakes in 
earlier life. 
Calcium excess arising from dietary intake is rare because of the effectiveness of the 
homoeostatic mechanisms. In healthy individuals, intakes of 2.5 g (62.5 mmol) are 
tolerated. At intakes above this, as may occur with ingestion of supplements of 
calcium (and sometimes of vitamin D) or of antacids, there is a risk of renal stones, 
hypercalcaemia and impaired renal function. 
Requirements 
Adults 
Since plasma ionised calcium activity is maintained by mobilisation of skeletal 
calcium stores, as well as by increased net intestinal absorption and renal 
conservation of the element, if the dietary intake of calcium is inadequate the plasma 
ionised calcium can be maintained for a long time at the expense of the skeletal pool. 
The approximately thousand fold bigger size of this endogenous resource of calcium 
compared with ingested amounts (500-1000 mg daily) makes it difficult to establish 
reliable conditions under which obligatory losses of calcium can be gauged against 
dietary intakes. Although metabolic balances have been used to analyse the 
adequacy of calcium requirements, experience has shown that few studies allowed Nutrition. Chapter 19: Calcium 11-12-1992 153 
sufficient time for systemic and intestinal adaptation to altered dietary intakes to 
occur or measured simultaneously the systemic hormonal homoeostatic adaptation. 
The prolonged studies of Malm
 9 suggest that with time adult men can adapt to a 
calcium intake of 400 mg/d, but most metabolic studies have used intakes in excess 
of this and extrapolation of the data is limited also by the variable bioavailability 
arising from the various diets used. 
Bone density or the incidence of osteoporosis were not considered suitable 
measurements for determining calcium requirements because they are both subject 
to many physical, genetic and nutritional influences
 4·
5. 
Requirements have been estimated on the assumption that the principal determinant 
is the obligatory loss of the element via skin, faeces and urine, with additional 
estimated increments for skeletal growth and consolidation. In adults the needs for 
bone growth are minimal even though some 10 % of bone consolidation occurs during 
the third decade. No reliable data are available on losses via sweat and the 
integuments although these may not be negligible
 6. A level of such nonfaecal losses 
including 'obligatory urinary loss' has been taken as 160 mg/d. Assuming 
conservatively an absorptive efficiency of 30 % this translates to an average 
requirement of 530 mg/d (rounded to 550 mg/d) which with a 2SD distribution comes 
to 700 mg/d as a PRI with the LTI being set at 400 mg/d. [This may be a generous 
recommendation, and at an alternative, and not unlikely, absorptive efficiency of 40 % 
the average 'systemic need' would be met by an intake of 400 mg (+2SD = 520 mg)]. 
An upper limit of intake of 2.5 g/d is advised. 
Children 
Between the ages of 1 and 10, the average daily calcium retention needed for 
skeletal growth has been estimated to rise from 70 to 150 mg/d 1
3. The PRIs given 
are based on the assumption that there is a net absorption of 35% of dietary calcium, 
with 30% (considered as equivalent to 2SD) being added to the calculated amount to 
allow for individual variation. 
In the absence of reliable information, the PRI for 6-11 months old infants was taken 
as the same as for 1-3 year olds. 
PRIs for adolescents are raised above those for adults to reflect the increased 
requirements for skeletal development. They are derived from a mean retention of 
250 mg/d in girls and 300 mg/d in boys, assuming net absorption of 40% of dietary 
calcium, again with 30% being added to cover individual variation. 154 Reports of the Scientific Committee for Food: 31st series 
Pregnancy 
There appears to be no spontaneous increase in calcium consumption by pregnant 
women. The physiological way of obtaining the calcium required for fetal growth 
includes an increased efficiency of dietary absorption and the mobilization of calcium 
from maternal bone
 14. There seems to be no need to increase the dietary calcium 
intake during pregnancy. 
Lactation 
The calcium required in the milk is normally obtained from the spontaneous increase 
of food intake by lactating women. On the assumption of an absorption efficiency of 
40%, plus an allowance for 2SD, an extra 500 mg/d is proposed for lactating women. Nutrition. Chapter 19: Calcium 11-12-1992 155 
Summary 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
mg/d 
550 
700 
400 
Population Reference Intakes of other groups 
Age Group 
6-11 m 
1-3 y 
4-6 y 
7-lOy 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
Pregnancy 
Lactation 
PRI (mg/d) 
400 
400 
450 
550 
1000 
1000 
800 
800 
700 
1200 156 Reports of the Scientific Committee for Food: 31sl series 
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Physiology 
The adult male contains 20-28 g magnesium; 60-65 % of this is in the skeleton; only 
about 1 % is in the extracellular fluid, and is distributed similarly to calcium in the 
plasma; the rest is intracellular where its activity concentration is tightly regulated '. 
Magnesium is essential for mineralisation and skeletal development and for the 
maintenance of the transmembrane electrical potentials in nerves and muscle. It also 
serves as a cofactor for the phosphorylated purine nucleotides and hence all related 
enzyme activities. It is involved in the structure and replication of nucleic acids, and 
the ribosomal binding of mRNA. Thus magnesium is vital for the regulation of cellular 
metabolism and the synthesis of proteins. 
Magnesium is absorbed by a carrier-mediated mechanism and by a non-specific 
diffusional process
 2. Reported intakes range from 132 to 350 mg for women and 157 
to 595 mg for men with respective means of 234 and 310 mg
 3; in the UK dietary 
survey corresponding means of 237 mg (9.8 mmol) and 323 mg (13.3 mmol) were 
recorded
 4. At such intakes there is great variability in the efficiency of absorption 
and retention: average net absorptions of 21 % and 27 % have been reported in men 
and women respectively
 5. Absorption of magnesium is adaptive; at intakes in 
excess of 2 g/d the element is poorly absorbed. Phytate, calcium phosphate and long 
chain triacylglycerols may impair the intestinal absorption of magnesium but since 
there is very little evidence of magnesium deficiency arising from the diet, there is 
very little definitive information on factors influencing its bioavailability. Systemic 
homoeostasis of magnesium is achieved primarily through renal excretion; at low 
dietary intakes there is increased absorption and renal conservation of the element. 
The endocrine control of magnesium homoeostasis and metabolism is understood 
poorly. The parathyroid hormone responds to acute changes in extracellular (serum) 
concentrations of magnesium in the same way as it does to alterations in ionised 
calcium activity; thus, in response to a sudden drop in serum magnesium, the 
production of parathyroid hormone increases, thereby enhancing both the renal 
conservation of the element and its release from the skeletal pool '. Nutrition. Chapter 20: Magnesium 11-12-1992 159 
Deficiency and excess 
Current dietary intakes of magnesium are adequate but systemic magnesium 
deficiency can result from other conditions such as intestinal and pancreatic 
malabsorption syndromes, the use of diuretic drugs and increased requirements 
arising from rapid tissue synthesis, e.g. during recovery from malnutrition, for which 
as an intracellular cation the element is essential. 
Deficiency is manifested by altered metabolism of calcium, sodium and potassium, 
which is reflected in altered function of skeletal and cardiac muscle, muscle 
weakness, and fits. Tetany may develop with a resistant hypocalcaemia arising from 
reduced secretion of parathyroid hormone and end organ hyporesponsiveness. 
Large intakes (e.g. 3-5 g of the element) induce intestinal secretion and diarrhoea. 
Since renal excretion of excess magnesium is so efficient, such ingestions usually 
have minimal direct systemic effects, but systemic excess, such as may arise from 
large intakes of magnesium salts by individuals with renal insufficiency or from 
intravenous administration, can cause central nervous system depression, with 
muscular paralysis and death
 6. 
Requirements 
Adults 
Magnesium is ubiquitous in the diet; both plants and meats are good dietary 
sources. Early balance studies suggested that adult requirements may be as high as 
700 mg/d
 7 but interpretation of these is difficult because of analytical difficulties and 
the long time needed to achieve equilibrium
 8. Additionally the improved efficiency, 
on restricted intakes, of both intestinal absorption
 9 and increased renal conservation 
of magnesium make it difficult in the absence of more definitive studies to propose 
any PRI with confidence. One study
 1
0 has suggested that normal adults can achieve 
positive balance on 3 mg/kg/d over a 6-9 day period. Evaluation of the variance of 
such balance data suggests that intakes of 3.4 mg/kg would be associated reliably 
with a net balance ". Actual requirements may well be below this; and, in the 
absence of better physiological data with which to establish reliable reference 
intakes, an acceptable range of intakes of 150-500 mg là is proposed on the basis of 
observed intakes. 
This range of intakes will also cover pregnancy and lactation. 160 Reports of the Scientific Committee for Food: 31st scries 
Children 
The difficulties in proposing a reliable PRI for adults are more pronounced in children, 
for whom data are even more scarce. If however some guidance is required, rough 
estimates can be made by calculating average requirements for groups on the basis 
of body weights. Factors can be used ranging from 7 mg/kg body weight/d at 6-11 
months (slightly higher than the intake from breast milk at 6 months) to 4.2 mg/kg 
body weight/d at 15-17 years (slightly higher than the 3.4 mg/kg/d which appears 
adequate for adults). An extra 30% is added to allow for individual variations in 
growth. The quasi - PRIs thus calculated are (mg/d): 6-11 months, 80; 1-3 years, 85; 
4-6 years, 120; 7-10 years, 200; 11-14 years, 280; 15-17 years, 300. These guesses 
should be treated with caution. The amounts would certainly be adequate, and it is 
highly likely that they are over-generous, but the data are too sparse to support good 
estimates. 
Summary 
Acceptable Range of Intakes for Adults: 150-500 mg/d. Nutrition. Chapter 20: Magnesium 11-12-1992 161 
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Physiology 
Between 80 and 85 % (600-900 g) of phosphorus exists as phosphate in the calcium 
salt hydroxyapatite in the skeleton. The residue is in soft tissues as phosphate, 
mainly as a component of proteins, phospholipids and nucleic acids; 5-20 mmol (0.2-
0.6 g) is present intracellularly in a large variety of phosphorylated compounds (e.g. 
adenosine triphosphate (ATP), guanosine triphosphate, etc.) which are needed for 
metabolic energy transfer and storage processes, enzyme activation and control. 
Furthermore via the interconversion of HP04
2" and H2P04" phosphorus contributes 
to extracellular and intracellular acid-base regulation. 
Absorption occurs throughout the gut. At least 60 % of dietary phosphorus is 
absorbed; at least one carrier-mediated process and diffusional component is 
involved. The former mechanism is stimulated by calcitriol. Within the intestinal 
lumen complexes of phosphorus with minerals and amino acids may limit its uptake 
by the gut mucosa. Plasma inorganic phosphate concentration is normally 0.8-1.4 
mmol/L. Homoeostasis is achieved by urinary excretion, and there is a prompt 
increase of urinary phosphate in response to increased dietary intake '. 
Deficiency and excess 
Hypophosphataemia with intracellular depletion of phosphate is associated with 
muscle weakness and altered tissue oxygen tension, perhaps arising from defective 
synthesis of ATP and impaired delivery of oxygen to tissues as a consequence of 
depletion of red cell 2,3-diphosphoglycerate content. Prolonged moderate 
hypophosphataemia leads to osteomalacia. Excessive dietary intake is rare because 
renal excretion is efficient. In diseases prolonged hyperphosphataemia can result in 
abnormal calcification of soft tissues and acute hyperphosphataemia increases 
calcium binding and can precipitate features of hypocalcaemia including tetany. 
Although adults can tolerate varying Ca:P ratios in their diets without gross 
disturbances of their metabolism of calcium, infants cannot. A Ca:P molar ratio of 0.9-
1.7 in diets for infants is considered safe. Nutrition. Chapter 21: Phosphorus 11-12-1992 163 
Requirements 
It is suggested that phosphorus intakes should correspond on a molar basis with 
those for calcium and rounded values are proposed accordingly. 
Summary 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
mg/d 
400 
550 
300 
Population Reference Intakes of other groups 
Age Group 
6-11 m 
1-3 y 
4-6 y 
7-10 y 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
Pregnancy 
Lactation 
PRI (mg/d) 
300 
300 
350 
450 
775 
775 
625 
625 
550 
950 164 Reports of the Scientific Committee for Food: 31st series 
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Physiology  1.2 
Sodium is the principal cation in extracellular fluid. Its physiological roles include the 
maintenance of (i) extracellular fluid volume (ECF), which is related closely to total 
body sodium content, (ii) extracellular fluid oncotic pressure, (iii) acid base balance, 
(iv) electrophysiological phenomena in muscle, neuromuscular and nerve impulse 
transmission, and (v) generation of transmembrane gradients essential for the 
energy-dependent carrier-mediated uptake of nutrients and substrates by cells, 
including hepatocytes and those in the intestinal mucosa and renal tubules. 
A typical adult male has a total body sodium of 4 mol (92 g); of this 0.5 mol (11.5 g) 
is in the intracellular fluid at an activity concentration of 2 mmol/L (46 mg/L), and 1.5 
mol (34.5 g) is sequestered in bone. About 2 mol (46 g) is in the ECF at a 
concentration of 135-145 mmol/L (3.1-3.3 g/L). 
Net intestinal absorption of sodium occurs in the distal small intestine and colon: its 
concentration in the ECF is maintained by the kidneys. Daily 25 mol (575 g) sodium 
enters the glomerular filtrate; since daily dietary intakes (say 50-150 mmol; 1.15-
3.45 g) represent only 0.2-0.6 % of this amount, almost all of this filtered sodium 
must be reabsorbed to maintain sodium homoeostasis. 
Renal sodium reabsorption is highly efficient and adaptable. Regulation of the sodium 
content of the ECF is closely related to the systemic control of the ECF volume. If 
the body sodium burden is increased, water is also retained and ECF volume 
increases; conversely, if the body sodium burden falls the ECF volume decreases. 
The overall regulation of these changes is unclear '. Changes in ECF volume are 
detected by sensors of pressure and distension which are located in the cardiac atria 
and right ventricle, the pulmonary vasculature, the carotid arteries and the aortic 
arch. From these sensors afferent nerve pathways end in the medulla and 
hypothalamus. When ECF or blood volume falls retention is stimulated, sympathetic 
nervous activity increases, stimulating the nerves supplying the afferent renal 
arterioles to induce vasoconstriction and thereby producing a redistribution of renal 
blood flow which, by reducing glomerular filtration, increases sodium and water 
retention. 
Additionally, sympathetic nervous stimulation of the juxtaglomerular apparatus 
increases production of renin. This in turn leads to an increase in circulating 166 Reports of the Scientific Committee for Food: 31st scries 
angiotensin II, adrenal medullary secretion of noradrenaline and adrenaline, and 
pituitary release of adrenocorticotrophin (ACTH) and antidiuretic hormone (ADH). 
ACTH and angiotensin II induce adrenal cortical secretion of aldosterone and other 
mineralocorticoids which stimulate sodium retention and potassium loss by the 
kidneys and the distal bowel. Increased secretion of antidiuretic hormone promotes 
sodium reabsorption from the renal distal tubules and probably the colon. 
Renal sodium excretion is increased by factors which include specific natriuretic 
hormone, and vasodilators, parathyroid hormone, prostaglandins and kinins. The 
adult kidney can regulate sodium excretion at between 0.5 and 10 % of its filtered 
load. Under normal circumstances virtually all dietary sodium is absorbed and daily 
urinary loss matches this amount closely after allowance is made for that which may 
be lost in sweat. 
Deficiency and excess 
The role of higher sodium intakes in the pathogenesis of hypertension has generated 
much interest
 3·
4·
5·
5·
7·
8. However other factors, such as low intakes of potassium 
(see chapter 23), little physical activity, mental stress, alcohol consumption, 
smoking and high body mass index, are contributory to the development of 
hypertension
 4·
5. Indeed obesity is associated with an increased sensitivity to 
sodium-induced hypertension
 9. It has been suggested that absence of these adverse 
factors, rather than lower sodium intakes alone, is responsible for the lower blood 
pressures observed in economically less developed communities compared with 
those seen in developed societies. Nevertheless, after allowance is made for such 
confounders, a relationship still exists between urinary sodium excretion (assumed 
to be a marker of intake) and increasing blood pressure with age
 4. A recent meta-
analysis of studies of the relationship between sodium intake and blood pressure 
strongly implies that the causal association has been underestimated
 6·
7. When 
published epidemiological studies and clinical trials in economically advanced and 
non-advanced populations were analysed separately to minimise the socio-economic 
variables mentioned, there was apparent for both types of community, and amongst 
individuals within such communities, an association between sodium intake, and 
increasing systolic and diastolic blood pressures. This relationship was continuous, 
i.e. there was no threshold of sodium intake below which the effect did not exist: it 
affected all age groups and it increased progressively with age. This reanalysis then 
applied the regression equations of blood pressure against sodium intake derived 
from the initial pooled study to calculate for each age group the potential falls in 
blood pressure which would result from reductions in sodium intakes
 8. Since the 
major source of sodium in the diet is salt these predictions were compared with Nutrition. Chapter 22: Sodium 11-12-1992 167 
observed falls in blood pressure arising from intervention trials of reductions of salt 
intake on blood pressure. For trials lasting five weeks or longer the predicted and 
observed reductions matched closely. From this it was deduced that dietary salt 
reduction would have an appreciable effect on reducing mortality from ischaemic 
heart disease and stroke
 8. 
Requirements 
Adults 
The determination of a meaningful PRI and Average Requirement for sodium intake 
is difficult and a range of intakes is proposed for adults. 
Healthy adults maintain a sodium balance on intakes as low as 3-20 mmol/d (69-460 
mg/d), and some healthy populations have customary daily intakes of less than 40 
mmol (920 mg), possibly even as low as 10 mmol/d (230 mg/d)
3·
4·
6. The latter intake 
requires maximal adaptation to conserve sodium; to allow for changes in physical 
activity and climate it is thought prudent to set a lower intake at 25 mmol/d (575 
mg/d). 
On the basis of current evidence intakes in excess of 200 mmol (4.6 g) sodium daily 
would be associated with a significant risk of high blood pressure, especially in older 
people
 6-
7·
8; ideally intakes should be lower than this to reduce or prevent 
hypertension and the attendant risk of cardiovascular and cerebrovascular disease in 
the population in general. On the basis of the recent analyses, it is proposed that an 
upper limit of 150 mmol/d (3.5 g/d) be set. 
Children 
The evidence is insufficient to give any recommendations for children. 168 Reports of the Scientific Committee for Food: 31st series 
Summary 
Adults: 
Acceptable Range of Intakes 575-3500 mg/d 
(25-150 mmol/d) 
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Physiology 
Potassium is predominantly an intracellular cation. This compartmentalisation is 
maintained by the energy-dependent cellular uptake of the element and simultaneous 
excretion of sodium by the cell membrane bound enzyme Na-K ATPase. This 
process is fundamental to the cellular uptake of molecules against electrochemical 
and concentration gradients, to the electro-physiology of nerves and muscle, and to 
acid-base regulation ''
2·
3. 
An adult male contains approximately 40-50 mmol (1.6-2 g)/kg body weight, on 
which basis a 75 kg adult would contain 3000-3750 mmol (117-147 g) potassium. At 
least 95 % of this is intracellular at an activity concentration of 150 mmol (5.9 g)/L, 
the remainder is in the ECF at a concentration of 3.5-5.5 mmol (137-215 mg)/L. The 
total body potassium reflects lean tissue mass and consequently varies with 
muscularity. 
The systemic homoeostasis of potassium is understood imperfectly. Over 90 % of 
dietary potassium is absorbed in the proximal small intestine, possibly by a 
combination of diffusional mechanisms and solvent drag. The body content is 
regulated by the renal glomerular filtration and tubular secretion but up to 10 % of the 
daily loss of potassium can occur via the distal ileum and colon; additionally a small 
amount is lost in sweat. The glomerular filtration of potassium is approximately 3 % 
of that for sodium, and amounts to only about 680 mmol (26.5 g)/d; however, renal 
tubular secretion of the element, which is regulated predominantly by aldosterone 
and other mineralocorticoids, is highly efficient and the kidney is able to excrete 
potassium considerably in excess of its filtered load. As long as renal function is 
normal, on habitual dietary intakes it is almost impossible to induce potassium 
excess. An additional but usually less important regulation of ECF and plasma 
potassium excess is achieved by the capacity of cells induced by glucose and insulin 
to take up the element. 
Deficiency and excess 
Potassium deficiency arising from inadequate dietary intake is unlikely because of 
the ubiquity of potassium in all foodstuffs. Potassium deficiency alters the Nutrition. Chapter 23: Potassium 11-12-1992 171 
electrophysiological phenomena of cell membranes. This causes weakness of 
skeletal muscles and the effect on cardiac muscle is reflected by electrocardiographic 
changes characteristic of impaired polarisation, which may lead to arrhythmia and 
cardiac arrest. Similar functional changes in intestinal muscle cause intestinal ileus. 
Mental depression and confusion can also develop. 
The reported intakes of potassium by Western populations are 40-150 mmol (1.65-9 
g)/d
 4. An inverse correlation exists between increased blood pressure and urinary 
potassium excretion or urinary Na:K excretion ratios
 4. An adequate potassium 
intake is needed to achieve effective homoeostasis of sodium. Young normotensive 
men on a potassium intake of 10 mmol/d (390 mg/d) were less able to excrete an 
imposed sodium excess than when they had a potassium intake of 90 mmol (3.5 
g)/d
5; simultaneously their blood pressure increased. In the Intersalt study urinary 
potassium excretion, an assumed indicator of potassium intake, was negatively 
related to blood pressure as was the urinary Na:K concentration ratio
 4. Increasing 
potassium intakes to levels achievable with customary diets [i.e. 65 and 100 mmol/d 
(2.5 and 3.9 g/d)] reduced blood pressure in normotensive and hypertensive 
individuals and increased urinary sodium loss
 6·
7. This effect of potassium on blood 
pressure is supported by a recent meta-analysis of published reports
 8. It has been 
calculated that an increase in potassium intakes from 60 to 80 mmol/d (2.3 to 3.1 g/d) 
could induce a fall of 4 mmHg systolic blood pressure and that this could possibly 
achieve a 25 % reduction in deaths related to hypertension
 6. 
Requirements 
Adults 
Renal and faecal losses each amount to about 10 mmol (390 mg)/d and there are also 
integumental losses. However, an intake of 40 mmol/d (1.6 g/d) is needed to avoid 
low plasma potassium concentrations and loss of total body potassium
 9 and on this 
basis a lower intake of 40 mmol/d (1.6 g/d) is suggested. 
An Average Requirement is not set. On the basis of the evidence cited earlier, a PRI 
of 80 mmol/d (3.1 g/d), which would also cover pregnancy and lactation, is proposed. 
This intake could be reliably achieved by an appropriate intake of vegetables, fruit 
and derived juices, rather than by the use of potassium salts as substitutes for 
sodium chloride
 10, because such measures if pursued indiscriminately could result in 
intakes at which toxicity might develop in individuals with undetected renal 
insufficiency and abnormal retention of potassium. Intakes above 450 mmol (17.5g)/d 
induce symptomatic hyperkalaemia in some otherwise normal individuals and can 172 Reports of the Scientific Committee for Food: 31st scries 
thus be used as a threshold for acute toxicity, but such intakes are highly unlikely to 
arise from usual diets. However, for chronic intakes, intakes above 150 mmol (5.9 
g)/d could be dangerous for individuals with undetected renal dysfunction
 10. 
Additionally, since there is no apparent benefit of exceeding an intake of 150 mmol 
(5.9 g)/d, this is proposed as an upper safe level of intake. 
Children 
The basal losses of children are not known reliably. Urinary excretion has been 
reported as 0.7-2.3 mmol (27-90 mg)/d. The amount needed for growth and lean 
tissue synthesis has been taken as 50 mmol (2 g)/kg. With these and other factors 
to allow for faecal losses (which are higher in children) and for integumental losses, 
PRIs for ages up to 17 were estimated factorially. Nutrition. Chapter 23: Potassium 11-12-1992 173 
Summary 
Adults 
Population Reference Intake 
Lowest Threshold Intake 
mg/d 
3100 
1600 
mmol/d 
80 
40 
Population Reference Intakes of other groups 
Age Group 
6-11 m 
1-3 y 
4-6 y 
7-10 y 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
Pregnancy 
Lactation 
mg/d 
800 
800 
1100 
2000 
3100 
3100 
3100 
3100 
3100 
3100 
mmol/d 
20 
20 
28 
50 
80 
80 
80 
80 
80 
80 174 Reports of the Scientific Committee for Food: 31sl series 
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1085. 24. Chloride 
Physiology 
Chloride is the major extracellular and intracellular counter anion to sodium and 
potassium; 70 % is in the ECF, and the remainder is in the intracellular space, 
connective tissue and bone
 x·
2. Total body chloride in adult men is about 33 mmol 
(1.2 g) /kg body weight. Plasma chloride is maintained at 95-107 mmol/L (3.4-3.8 
g/L); its concentration in interstitial fluid is slightly higher, whereas the intracellular 
concentration of chloride has been varyingly reported between 4 and 25 mmol/L. 
Chloride is absorbed passively in the proximal small intestine, where it follows the 
electrochemical gradient created by transport of the major cationic electrolytes. 
Intestinal secretion of chloride occurs proximally but the anion is conserved distally 
by uptake in exchange for bicarbonate. Dietary chloride deficiency has been 
described only once, in healthy infants who were fed an infant formula which, 
accidentally, provided less than 2 mmol/L
 3. It has been suggested that chloride may 
interact with sodium in inducing hypertension
 4·
5. 
Requirements 
Daily chloride intake is derived principally from sodium chloride. Since the dietary 
intake and systemic metabolism of chloride match closely, and are dependent on 
sodium, it is suggested that in the absence of more definitive information the 
requirements of chloride should match those for sodium. 176 Reporis of the Scientific Committee for Food: 31st series 
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Physiology and metabolism 
Iron is present in all cells in the body and has several vital functions: as a carrier of 
oxygen to the tissues from the lungs, in electron transport in cells and as an integral 
part of important enzymes. 
The main part (>65%) of the iron in the body is present in the red cells as 
haemoglobin. In average adult men and women, approaching 3 mg and 2 mg iron 
respectively is in the form of haemoglobin. Myoglobin, the oxygen reserve in muscle, 
amounts to about 10% of the body iron. Iron is the functional portion of the 
cytochromes, essential for harnessing the energy of metabolized foodstuffs, and it is 
present in enzymes which play other key roles, for example, as signal-controlling 
substances, in some neurotransmittor systems in the brain such as the dopamine 
and serotonin systems. The amount of iron in cytochromes and enzymes is small. 
The body has three unique mechanisms for maintaining iron balance and preventing 
iron deficiency and iron overload. 
1. Storage of iron. Ferritin is a protein adapted for the reversible storage of iron. 
Iron stores are especially important for women to meet the excessive iron 
demands in the last trimester of pregnancy. The amount of stored iron is 
about 500-700 mg in 25-30 year old men. In women the amounts are much 
less. In most European countries at least 20-30% of women in the fertile ages 
have no iron stores at all. 
2. Reutilization of iron. Iron is not lost from the body with urine or faeces but 
only with losses of cells, including bleeding. Iron is required to cover such 
losses and to supply the body with the needs for growth, including pregnancy. 
3. Regulation of iron absorption. The body tries to maintain iron balance not by 
regulating the losses of iron but by controlling the absorption of dietary iron. 
This control is not perfect but still of great importance for the prevention of 
iron deficiency and excess '. 178 Reports of lhe Scientific Committee for Food: 31st series 
Deficiency 
When less iron is absorbed than is needed to cover iron losses and demands for 
growth and pregnancy, body iron stores, if present, are first depleted. When the 
stores are exhausted the supply of iron to various tissues is compromised. Iron 
deficiency can thus be defined as a state with an absence of iron stores. This state 
can be recognized clinically by the absence of stainable reticular iron in bone-marrow 
smears or more conveniently by a low serum ferritin (e.g. ^15 g/L). The insufficient 
supply of iron to tissues depresses erythropoiesis. The haemoglobin level is reduced 
and at a certain point falls below the lower normal limit of the population. This is the 
rather arbitrary definition of iron-deficiency anaemia. 
During the depletion of iron stores the absorption of iron increases, but if losses are 
high this compensatory mechanism may not be sufficient to guarantee an adequate 
delivery of iron for the formation of haemoglobin and enzymes. 
A number of adverse effects of iron deficiency are known in man
 2. It was observed 
by early investigators that iron deficiency impaired physical endurance and work 
capacity. In recent years other functional defects have been demonstrated, such as 
disturbances in normal thermoregulation and impairment of certain key steps in the 
immune response. Great interest today is focused on the relationship between mild 
iron deficiency and various brain functions, such as learning. Iron is present in key 
enzymes in several neurotransmittor systems in the brain, for example, the 
dopamine and serotonin systems. Only 10% of the iron content of the brain is present 
at birth, 50% at the age of 10 and it continues to increase up to the age of 20-30 
years. Studies in both children and animals strongly suggest that some of the brain 
symptoms are not reversible by iron treatment, even though all other signs of iron 
deficiency disappear. Emphasis should therefore be put on prevention rather than on 
treatment of iron deficiency
 3"
6. 
Iron deficiency is probably the most frequent deficiency disorder in the world and the 
main remaining nutritional deficiency in Europe. In European countries the 
prevalence of iron deficiency as indicated by absence of iron stores is especially high 
in menstruating women and teenagers (about 20-30%). The prevalence of detectable 
anaemia due to iron deficiency is however much lower in these groups (around 2-
8%). Nutrition. Chapter 25: Iron 11-12-1992 179 
Excess 
The very effective regulation of iron absorption prevents overload of the tissues by 
iron from a normal diet, except in individuals with genetic defects as in idiopathic 
haemochromatosis. 
Side effects of iron supplements 
All iron compounds used therapeutically have side effects. The most disturbing side 
effects (epigastric pain, nausea and diarrhoea) are dose related and more severe if 
tablets are not taken with food. Other side effects such as constipation occur in some 
subjects but are independent of dose. Effects may be seen in adults with doses as 
low as 30 mg of elemental iron but most subjects tolerate well single doses of 100 
mg. 
Acute accidental iron intoxication is mainly seen in children who have mistaken iron 
tablets for sweets. The lowest known lethal dose in infants is 650 mg ferrous iron. 
Physiological requirements (absorbed requirements) 
Iron is needed to cover the basal losses of iron in cells shed from the body, to replace 
that lost by menstruation and to provide the amounts required for growth, including 
pregnancy. 
The basal iron losses with cells from the exterior and interior surfaces of the body 
amount to 14 μg/kg body weight/d and are thus little over 1 mg/d in an average man 
and about 0.9 mg/d in an average woman
 7 (see Table 25.1). The evidence suggests 
that these losses may have an interindividual variation of 15% (coefficient of 
variation). Sweat iron losses amount to only about 23 μg iron per litre of sweat and 
are thus so small that they can be disregarded
 8. 
Adult men and postmenopausal women 
In healthy adult men and postmenopausal women, recommendations are derived 
from the basal iron losses. For an average adult man, the mean basal losses can be 
taken as 1.05 mg/d. The mean + 2SD would be 1.37 mg, which can be rounded off to 
give 1.4 mg/d. For an average postmenopausal woman, the corresponding figures 
will be 0.87 mg/d and 1.1 mg/d (Table 25.1). 180 Reports of the Scientific Committee for Food: 31st scries 
Menstruating women 
For women in the fertile age period the iron required to cover losses from 
menstruation has to be added. Menstrual iron losses vary markedly between 
women but are very constant in an individual woman. The magnitude of the 
menstrual losses is strongly genetically controlled and studies made in different 
countries report very similar figures for average menstrual losses when related to 
body size. An extensive study on menstrual blood losses in women at different ages 
was made in Sweden
 9 (before contraceptive methods known to markedly influence 
the menstrual blood losses were introduced). The observed blood losses were 
transformed to iron losses by "multiplying" them by the distribution of the 
haemoglobin values in healthy women with optimal values. This is done by a 
mathematical-statistical process of convolution. The total iron requirements and their 
variation in menstruating women are then obtained by "adding" basal iron losses and 
their variation to the observed variation in menstrual iron losses by a further 
convolution step. 
By this means the values in Table 25.1 were calculated. Table 25.2 shows the 
percentage of a population of menstruating women whose requirements are satisfied 
by various amounts of absorbed iron
 10. The 90th and 95th centile values of total 
absorbed iron requirements are 2.37 and 2.94 mg respectively. 
Pregnancy and lactation 
Pregnant women need iron to replace the basal iron losses during pregnancy (about 
240 mg), to provide for the fetus and placenta (about 350 mg), and for the expansion 
of the red cell mass of the mother (about 450 mg). In total these requirements have 
been estimated as 1,040 mg
 n. The average blood loss at delivery corresponds to 
250 mg iron. About 200 mg of the iron used for the expansion of the red cell mass is 
thus retained by the mother in her iron stores at delivery. 
In the first trimester the iron requirement of the fetus is negligible. The total iron 
requirements of the mother are thus limited to the basal iron losses, about 0.9 mg/d. 
In the latter half of pregnancy iron requirements increase continuously and 
considerably, especially in the third trimester when the daily iron requirements reach 
the range 8-10 mg'd. Iron absorption is reduced in the first trimester but increases 
during the later half of pregnancy. In this period the iron requirements, however, are 
so great that, in spite of the increase in absorption, even on a diet with a good 
bioavailability there will be a deficit of about 400-500 mg iron. The physiological 
solution for covering the high iron requirements in pregnancy is to use iron from 
stores. The problem, however, is that very few women, if any, have iron stores of Nutrition. Chapter 25: Iron 11-12-1992 181 
this magnitude. Therefore, daily iron supplements are recommended in the latter half 
of pregnancy
 12. Since diet alone cannot cover the iron requirements in most women, 
in their recent report
 1
3 FAO/WHO refrained from giving a value for a recommended 
dietary intake during pregnancy. 
Breast milk contains 0.15-0.3 mg iron/d. As menstruation is usually absent during 
lactation the total iron requirements in a lactating woman are considerably less than 
in an average non-pregnant, menstruating women. 
Adolescent girls 
Menstrual iron losses in teenage girls are about the same as in adult women
 I0. 
Thus in menstruating teenage girls the requirements for growth and their variation 
have to be added to the requirements of adult menstruating women. This addition 
has also to be made using the same mathematical convolution process. There is a 
marked variation in growth rate in girls. The coefficient of variation of the change in 
body weight in the age range 13-16 years is about + 19%. In the present calculations, 
the figures 0.36 + 0.054 mg (mean + SD) have been used as the daily amount of iron 
needed for growth '
4. This corresponds to the situation in 15-16 year old girls. In 
younger teenagers the growth requirements are higher (> 0.5 mg/d) but basal losses 
are then slightly lower. Moreover, some of the younger teenage girls have not 
started to menstruate. The growth figures used are based on a longitudinal study on 
the development of children
 1
4 and on calculations of iron requirements for growth in 
the recent FAO/WHO report
 13. 
Table 25.2 shows the percentages of teenage girls whose needs are satisfied by 
various amounts of absorbed iron
 10. The 90th and 95th centile values for these girls 
are 2.54 and 3.10 mg/d respectively. 
Adolescent boys 
During the age period 12 to 16 years boys gain an average of 5.5 kg/year
 14. At the 
peak year of their growth spurt the average weight gain is about 10 kg. At about the 
same time, in response to sexual maturation, their haemoglobin concentration 
increases between 5-10 g/L per year. The 95th percentile value for total iron 
requirements may thus be considerably higher at the peak growth rate than the value 
given in Table 25.1. It should also be noted in Table 25.1 that the median iron 
requirement in adolescent males is as high as in adult menstruating women. 182 Reports of the Scientific Committee for Food: 31st series 
Children 
Iron requirements in term infants are negligible for the first 4-6 months of life since 
there is a physiological redistribution of iron from the large red cell mass at birth to 
stores. This excess iron covers the needs for growth including expansion of the blood 
volume during this period. In the following months, however, the requirements are 
very considerable and amount to about 0.7 mg/d during the remaining part of the first 
year. This figure is very high in relation to body weight and energy intake. 
The bioavailability of iron in weaning foods consumed during the age period 6-11 m is 
usually lower than that of iron in the adult diet because of an often high content of 
inhibitors of iron absorption such as milk and phytate in infant cereals and a low 
content of enhancers of iron absorption such as meat and ascorbic acid. The figure 
given for bioavailability in Table 25.1 (10%) may thus have a considerable variation. 
Moreover the bioavailability of iron used to fortify infant foods is usually unknown. 
As shown in table 25.1 iron requirements are high in children especially in relation to 
their usual energy requirements and in periods of rapid growth. It is thus important 
that the bioavailable nutrient density for iron
 1
5 is high in the diets of children. 
Dietary iron requirements 
Two main factors need to be considered in the translation of absorbed 
(physiological) iron requirements into dietary iron requirements: body iron status 
and composition of the diet. 
Iron status and iron absorption 
The absorption of iron from the diet is influenced by the iron status of the body: the 
greater the body's need for iron, the higher the percentage of a given dose taken 
up '
6. How this regulation mechanism works is unknown, but it is located in the 
intestinal mucosal cell. There is however an upper limit to this adaptation. 
Dietary iron requirements must therefore be given for a certain iron status, and the 
calculations made here are based on the bioavailability of dietary iron at the 
borderline between normality and iron deficiency. The values given represent the 
amounts of iron needed to be absorbed to prevent an insufficient supply to tissues in 
the body, including the erythron, i.e. to maintain optimal haemoglobin values, but not 
iron stores. Nutrition. Chapter 25: Iron 11-12-1992 183 
Factors influencing dietary iron absorption 
There are two kinds of iron in the diet with different absorption mechanisms: haem 
and non-haem iron
 17. Haem iron in meat and meat products amounts to about 1-2 
mg/d in most EC countries and about 25% of haem iron present in meat is absorbed. 
This absorption is almost independent of meal composition and iron status. 
Non-haem iron (in bread and other cereal products, vegetables and fruits) 
constitutes about 90% of the dietary iron intake. The dietary absorption of non-haem 
iron, however, is very dependent on iron status and the balance between several 
dietary factors influencing absorption. Some substances enhance the absorption of 
non-haem iron (e.g. ascorbic acid, meat, fish) and others inhibit it (e.g. phytate, 
calcium and iron-binding phenolic compounds). There is thus a marked variation in 
the absorption of iron from different meals depending on the meal composition. 
Bioavailability of dietary iron 
The bioavailability of iron from the diet as a whole needs to be known in order to 
translate absorbed iron requirements into dietary requirements. Direct information is 
limited as long-term chemical balance studies on different diets would be required. 
Indirectly, however, it is possible to estimate the bioavailability of iron in the whole 
diet using results obtained in different studies. 
In a recent paper attempts were made using indirect methods to estimate the 
bioavailability of dietary iron in USA and different countries in Europe
 10. The 
calculations were made for iron-replete subjects with no iron stores. The estimated 
upper limit was about 15% of the intake of available iron and the figures were very 
similar in all studies after corrections were made for unavailable fractions of 
fortification iron
 18. This figure may represent "an average European diet" - rather 
varied, and containing meat, fish, bread, vegetables, fruits, etc. Diets with a very 
high meat intake (>250 g/d) may have a slightly higher bioavailability, possibly 
amounting to 17%, whereas diets with little red meat (<50 g/d) and little fruit and 
vegetables with meals, or having a high phytate content due to a high consumption of 
cereal fibre (wholemeal bread, crispbread) may have a lower bioavailability, possibly 
down to 10% or even less. The bioavailability of iron in some vegetarian diets with a 
low content of ascorbic acid is thus probably much lower (5-10%). It is important to 
be aware of the multitude of factors influencing the bioavailability of iron and that 
there may be segments of most populations having diets with a rather poor 
bioavailability. On the other hand, for the European population at large, the error will 
not be great if a single figure of 15% is selected as a basis for the calculations of 
dietary requirements from the physiological requirements. 184 Reports of the Scientific Committee for Food: 31st series 
The present figure for bioavailability of iron from the whole diet (15%) should be 
considered as the upper borderline value associated with maintenance of health (i.e. 
absence of iron stores but normal haemoglobin values). Correction should be made 
for dietary fortification iron that is only partially soluble in the gastrointestinal tract. 
For example, only about 15% of reduced iron, often used for fortification of flour, is 
potentially available
 18. It can then be estimated that 15% of this fraction will finally 
be absorbed. 
Values proposed 
The values given in Table 25.1 are the intakes needed to cover the requirements of 
95% of the various population groups, based on a bioavailability of 15%. 
Menstruating women, both adults and teenagers, have a very skewed distribution of 
their iron requirements. A PRI based on the 95th centile would be unrealistically high 
for the great majority of women, so Table 25.1 gives the requirements of the 90th and 
95th centiles of menstruating women. 
Table 25.2 gives the physiological requirements and dietary intakes needed to cover 
centiles of the population of menstruating women from the 50th to the 95th. 
Strategies to improve iron nutrition 
Modification of dietary composition 
Iron nutrition can be improved by various modifications of the diet. A higher intake of 
foods enhancing iron absorption or a lower intake of foods inhibiting absorption (see 
earlier) will increase the bioavailability of the dietary iron. 
An increased intake of lean meat will not only provide more well-absorbed haem iron 
but also enhance the absorption of non-haem iron. The latter can also be achieved by 
increasing the intake of ascorbic acid-rich foods, especially if the usual intake of 
ascorbic acid is low. 
Iron supplementation 
The iron balance situation for most women is critical during pregnancy. With the 
present type of diet and present low-energy life-style about 500 mg iron would be 
needed in iron stores of mothers to cover iron requirements during pregnancy. About 
25-30% have no iron stores; the average store is about 150 mg; less than 5% reach 
an amount of 400 mg and none the critical amount of 500 mg. This is the background Nulriüon. Chapter 25: Iron 11-12-1992 185 
for the FAO/WHO recommendation
 1
3 that all pregnant women should be given iron 
supplements during the latter half of pregnancy. 
Iron fortification 
The marked skewness of the distribution of iron requirements in menstruating 
women implies that a considerable fraction of them are at risk of developing iron 
deficiency. Personal assessment of individual menstrual losses is unreliable and 
women with physiological but heavy losses usually consider themselves as quite 
healthy and their losses as normal. They would not seek medical advice and thus 
cannot be simply reached and given iron supplementation. Iron fortification is then a 
measure that must be seriously considered, especially as the life style of many 
individuals results in their having low energy needs, and thus reduced food 
consumption, resulting in a lowered iron intake. 186 Reports of the Scientific Committee for Food: 31st series 
References 
1. Bothwell TH, Charlton RW, Cook JD, Finch CA. (1979). Iron Metabolism in Man. 
Blackwell Scientific Publications, Oxford. 
2. Scrimshaw NS. (1984). Functional consequences of iron deficiency in human 
populations. 7 Nutr Sei Vitaminoi, 30: 47-63. 
3. Dallman PR. (1986). Biochemical basis for the manifestations of iron deficiency. Ann 
Rev Nutr, 6:13 - 40. 
4. Lozoff B. (1988). Behavioral alterations in iron deficiency. Adv Pediatr, 35: 331-59. 
5. Walter T, Kovalskys J, Stekel A. (1983). Effect of mild iron deficiency on infant 
mental developmental scores. 7 Pediatr, 102: 519-22. 
6. Youdim MBH. (1988). Brain Iron: Neurochemical and Behavioural Aspects. London: 
Taylor & Francis, 89-114. 
7. Green R, Charlton R, Seftel H, Bothwell T, Mayet F, Adams Β et al. (1968). Body 
iron excretion in man. A collaborative study. Am. J. Med, 45: 336-53. 
8. Brune M, Magnusson Β, Persson Η, Hallberg L. (1986). Iron losses in sweat. Am. J. 
Clin. Nutr, 43: 438-43. 
9. Hallberg L, Högdahl A-M, Nilsson L, Rybo G. (1966). Menstrual blood loss - a 
population study. Variation at different ages and attempts to define normality. Acta 
Obstet Gynaecol Scand, 45: 320-51. 
10. Hallberg L, Rossander-Hultén L. (1991). Iron requirements in menstruating women. 
Am J Clin Nutr, 54: 1047-58. 
11. Hallberg L. (1988). Iron balance in pregnancy. In Berger H, ed. Vitamins and 
Minerals in Pregnancv and Lactation. Raven Press, New York, 115-126. 
12. DeMaeyer EM, Dallman P, Gurney JM, Hallberg L, Sood SK, Srikantia SG. (1989). 
Preventing and controlling iron deficiency anaemia through primary health care. 
World Health Organization, Geneva. Nutrition. Chapter 25: Iron 11-12-1992 187 
13. Food and Agriculture Organization. (1988). Requirements of Vitamin A, Iron, 
Folate, and Vitamin Β¡2- Report of a joint FAO/WHO Expert Consultation. Rome: 
Food and Agriculture Organization. (FAO Food and Nutrition Series, 23). 
14. Karlberg Ρ, Taranger J. Engström I, Lichtenstein Η, Svennberg-Redegren I. (1976). 
The somatic development of children in a Swedish urban community. A prospective 
longitudinal study. Acta Paediat Scand, Suppl 258. 
15. Hallberg L. (1981). Bioavailable nutrient density: a new concept applied in the 
interpretation of food iron absorption data. Am J Clin Nutr, 34: 2242-7. 
16. Rybo E, Bengtsson C, Hallberg L. (1985). The relative importance of various 
laboratory measurements in the diagnosis of iron deficiency. Scand J Haematol, 
Suppl 43: 57-75. 
17. Hallberg L. (1981). Bioavailability of dietary iron in man. Ann Rev Nutr, 1:123-47. 
18. Hallberg L, Brune M, Rossander L. (1986). Low bioavailability of carbonyl iron in 
man: studies on iron fortification of wheat flour. Am J Clin Nutr, 43:59-67 Table 25.1 Absorbed and 
Age 
years 
0.5-1 
1 -3 
4-6 
7- 10 
Males 11-14 
15 - 17 
18+ 
Females 11 - 14
 d 
11-14 
15- 17 
18+ 
Posl-mcnopausal 
women 
Lactating women 
Mean body 
weight 
kg 
9 
13.5 
19.5 
29 
44.5 
62 
75 
45 
45 
54 
62 
62 
62 
dietary iron requirements ". 
Growth requi-
rements 
mg/d 
0.55 
0.27 
0.23 
0.32 
0.55 
0.60 
0.55 
0.55 
0.35 
Basal 
losses 
Median 
mg/d 
0.17 
0.19 
0.27 
0.39 
0.62 
0.90 
1.05 
0.65 
0.65 
0.79 
0.87 
0.87 
1.15 
Menstrual losses 
Median 
mg/d 
0.48
 c 
0.48
 e 
0.48
 e 
95Ui per. 
mg/d 
1.90
 e 
1.90
 e 
1.90
 e 
Total requirements 
Median 
mg/d 
0.72 
0.46 
0.50 
0.71 
1.17 
1.50 
1.05 
1.20 
1.68 
1.62 
1.46 
0.87 
1.15 
95lhpcr. 
mg/d 
0.93 
0.58 
0.63 
0.89 
1.46 
1.88 
1.37 
1.40 
3.27 
3.10 
2.94 
1.13 
1.50 
Dietary iron requirements (assuming 
bioavailability 15%) 
mg/d (rounded to nearest mg/d in brackets) 
90lh centile 
18 
16.9 
15.8 
(18) 
(17) 
(16) 
95th centile 
[6.21 b 
3.9 
4.2 
5.9 
9.7 
12.5 
9.1 
9.3 
21.8 
20.7 
19.6 
7.5 
10 
(6) 
(4) 
(4) 
(6) 
(10) 
(13) 
(9) 
(9) 
(22) 
(21) 
(20) 
(8) 
(10) 
Partly based on an FAO/WHO report '-
1 and partly on new calculations of lhe distribution of iron requirements in menstruating women '°. Because of the very skewed 
distribution of iron requirements in ihesc women, dietary iron requirements are calculated for two levels of coverage, 90% and 95%, in these groups. 
Bioavailability of dietary iron during this period is greatly varying and on average lower than 15%. With a 10% bioavailability, for example, dietary iron requirements will 
be 9.3 mg. 
lïffcct of the normal variation in lib concentration not included in Ulis figure. 
Non-menstruating Table 25.2 The percentages of populations of menstruating adult women and girls aged 15-17 years whose needs will be 
satisfied by various amounts of absorbed iron, and the dietary intakes that would be necessary to provide these 
amounts, assuming 15% bioavailability. 
Probability of 
adequacy 
% 
50 
55 
60 
65 
70 
75 
80 
85 
90 
95 
Absorbed iron 
requirements (mg/d) 
Adult women 
1.46 
1.51 
1.58 
1.65 
1.74 
1.83 
1.96 
2.12 
2.37 
2.94 
Adolescents 
1.62 
1.68 
1.75 
1.81 
1.90 
2.00 
2.12 
2.29 
2.54 
3.10 
Dietary iron intake 
(mg/d) 
Adult women 
9.7 
10.1 
10.5 
11 
11.6 
12.2 
13.2 
14.1 
15.8 
19.6 
Adolescents 
10.8 
11.2 
11.7 
12.1 
12.7 
13.3 
14.1 
15.3 
16.9 
20.7 26. Zinc 
Physiology 
Zinc is ubiquitous in the body. It has essential structural, regulatory or catalytic 
roles in many enzymes '·
2; additionally it maintains the configuration of a number of 
non-enzymic proteins such as pre-secretory granules of insulin, some mammalian 
gene transcription proteins
 3, and thymulin; it facilitates hormone and receptor 
binding at membrane and nuclear levels, and it may maintain integrity of 
biomembranes. Consequently zinc participates in gene expression and in the 
mechanisms and control of major metabolic pathways involving proteins, 
carbohydrates, nucleic acids and lipids. 
An adult human contains about 2 g zinc of which 60 % and 30 % are in skeletal 
muscle and bone respectively, and 4-6 % is present in skin
 2·
4. Zinc turnover in these 
tissues is slow and these depots do not provide a reliable source of zinc at times of 
deprivation. Since zinc is essential for the synthesis of lean tissue, it is whilst this is 
occurring that it may become a limiting nutrient. Although some zinc may be 
available in short term zinc deprivation from a mobile hepatic pool it is generally 
assumed that the body has no specific zinc reserve and is dependent on a regular 
dietary supply of the element. 
Zinc is absorbed throughout the intestine. Proximal intestinal absorption is efficient, 
but since it has a large enteropancreatic circulation, net intestinal absorption of the 
metal is achieved by the distal small intestine. Relatively small amounts of zinc are 
lost in the urine. Homoeostasis at low and customary intakes is achieved by 
adjustments in net intestinal absorption and to a lesser extent by renal 
conservation
 4·
5. With inappropriately high zinc intakes the systemic burden of the 
element is limited by its sequestration in the enterocyte by a cystcine-rich protein, 
metallothionein
 2·
4. The amount of zinc lost in desquamated skin and shed hair and in 
sweat varies with preceding intakes. 
Deficiency and excess 
The classic features of severe zinc deficiency comprise the tetrad of neuropsychiatrie 
disturbances, acrodermatitis and alopecia, diarrhoea, and increased susceptibility to 
infections as a manifestation of defective immune mechanisms (in particular cell-Nutriüon. Chapter 26: Zinc 11-12-1992 191 
mediated immunity). These features by and large represent the dependence on zinc 
of tissues with a high turnover
 2·
6. However, there is currently an increasing interest 
in the occurrence in some children in Western communities, as well as in the Middle 
East, of a mild zinc deficiency syndrome manifest as zinc-responsive growth 
retardation
 7·
8. 
Gross acute zinc toxicity has been described following the drinking of water which 
has been stored in galvanised containers or the use of such water for renal dialysis. 
Symptoms include nausea, vomiting, fever and are apparent after acute ingestion of 2 
g or more of the element
 2. Of more general concern are the effects of supra-
physiological intakes of zinc. Prolonged intakes of 75-300 mg/d have been associated 
with impaired copper utilisation, producing features such as microcytic anaemia and 
neutropenia, but even short term intakes of about 50 mg zinc daily interfere with the 
metabolism of both iron and copper
 9. It is not known if long-term adaptation of the 
metabolism of these metals would compensate for such interactions with zinc, 
however it would be unwise to exceed a daily zinc intake of 30 mg in adults. 
Requirements 
Adults 
The assessment of zinc requirements in adults has been based on factorial analyses 
using measurements of basal losses during periods of extended deprivation, the 
turnover of radio-labelled endogenous zinc pools, and inference from observations in 
patients receiving total parenteral nutrition. None is ideal but all indicate that 
systemic supplies of 2-3 mg/d are adequate to avoid disturbed metabolism of other 
nutrients, and to support optimum nitrogen and carbohydrate metabolism. 
In studies of human volunteers adapted to very low daily intakes of zinc (0.2-0.3 
mg/d), faecal and urinary loss of the element falls to 1.4 and 0.9 mg/d in men and 
women respectively; it is probable that integumental (principally dermal) loss would 
fall similarly
 10. Allowing for losses of zinc in semen and menstruation, it has been 
estimated that basal losses are around 2.2 and 1.63 mg/d in men and women 
respectively
 u. Absorptive efficiency varies with intake
 5·
10; at the levels being 
considered here, a value of 30% can be assumed, giving Average Requirements of 
7.3 and 5.4 mg/d which can be rounded to 7.5 and 5.5 mg/d. Assuming a normal 
population distribution. Population Reference Intakes of 9.5 and 7 mg/d can be 
derived with Lowest Threshold Intakes at 5 and 4 mg/d for men and women 
respectively. 192 Reports of the Scientific Committee for Food: 31st scries 
In reality requirements may be lower; in adult males zinc balance can be maintained 
on intakes of 5.5 mg/d but, since on a prolonged intake of 3.4 mg/d negative balances 
ensue, the above figures would seem prudent and practical on the basis of present 
evidence. 
Children 
Better information not being available, requirements have been calculated 
factorially
 I2. 
In children 6-11 m, average faecal, sweat and urinary losses are estimated to amount 
to about 0.1 mg/kg body weight/d, and a growth increment has been based on a lean 
tissue zinc content of 30 mg/kg. Absorption of dietary zinc is taken as 30%, giving an 
average requirement, and 30% is added for individual variation to give the PRI. 
For children from 1 year of age onwards, similar calculations have been made, 
interpolating values for basal losses between these for adults and infants, plus 
increments for growth, assuming 307c absorption. The values given are probably on 
the generous side. 
Pregnancy 
The extra zinc accumulated during the last trimester amounts to about 0.8 mg
 13. It is 
possible that there is more efficient absorption, but even so it might be thought that 
there would be a need for a raised dietary intake in late pregnancy. In reality this 
appears not to be so; pregnant women do not increase their customary intake, and 
there is no benefit from zinc supplements
 14. Healthy women seem to be able to 
adapt metabolically to transfer an adequate amount of zinc to the fetus. No additional 
recommendation is therefore made for pregnancy. 
Lactation 
It is possible that the absorption of dietary zinc may increase during lactation, but 
there is no good evidence that it does. An extra dietary intake of 5 mg/d is proposed 
to cover the amount of zinc produced in the milk. Nutrition. Chapter 26: Zinc 11-12-1992 193 
Summary 
Population Reference Intakes of other groups (mg/d) 
(mg/d) 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
Males 
7.5 
9.5 
5 
Females 
5.5 
7 
4 
Age Group 
6-11 m 
1-3 y 
4-6 y 
7-lOy 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
Pregnancy 
Lactation 
PRI 
4 
4 
6 
7 
9 
9 
9 
7 
7 
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Physiology 
The two oxidation states of copper enable it to participate in electron-transferring 
(oxidase) enzyme activities such as cytochrome oxidase, Cu/Zn superoxide 
dismutase, thioloxidase, and amine oxidases/ monophenol monooxygenases, e.g. 
DOPA oxidase and lysyl oxidase. Thus it is essential for cellular energy metabolism, 
the production of connective tissue and synthesis of neuroactive peptides 
(catecholamines and enkephalins) '·
2,3. 
The total body copper in adults is 50-120 mg of which approximately 15 %, 10 % and 
40 % are located in liver, brain and muscle respectively. In plasma (copper content 
10-25 μπιοΙ/L) 90-95 % of copper is bound to caeruloplasmin, the remainder is bound 
to albumin, transcuprein and free amino acids. 
The precise function of caeruloplasmin is unknown. It may participate in the 
peripheral distribution of copper as may transcuprein and free amino acids. 
Additionally caeruloplasmin has numerous oxidase activities, substrates for which 
include biogenic amines, adrenaline, serotonin, ascorbate, and sulphydryl groups, and 
its oxidation of Fe(II) to Fe(III) and Mn(II) to Mn(III) may be essential for the 
binding of these metals to transferrin. It may also serve as a plasma free radical 
scavenger. 
Intestinal uptake and transfer of copper occur predominantly in the small intestine, 
where, as with other trace metals, it is probably presented to the mucosa bound to 
low molecular weight ligands. Intestinal absorptive efficiencies of between 35 and 
70% have been reported. 
Systemic homoeostasis of copper is achieved by adjustment of biliary excretion; 0.5-
1.5 mg of the element is lost by this route daily. Intestinal adaptation also 
contributes and with high copper intakes an intestinal block of copper absorption 
mediated by metallothionein may occur
 4. 
Deficiency and excess 
The features of severe copper deficiency can be related to loss of specific 
cuproenzyme activities
 5. The typical syndrome of copper deficiency has occurred in Nutrition. Chapter 27: Copper 11-12-1992 197 
preterm infants, in normal term infants who have been inappropriately fed on 
unmodified cow milk, in children recovering from malnutrition and in adults and 
children receiving parenteral nutrition. Features of copper deficiency in infants and 
young children include neutropenia, leucopenia and skeletal abnormalities, and 
increased susceptibility to respiratory and other infections
 6. Anaemia may develop if 
deficiency is prolonged and severe. 
The occurrence of dietary copper deficiency in adults is far less well documented. 
Some systematic studies of copper deprivation have excited interest that low 
intakes may contribute to cardiovascular diseases
 7·
8. These defects include impaired 
cardiac function and dysrhythmias perhaps secondary to defective metabolism of 
catecholamines and enkephalins
 3; such defects and the contribution of "sub-optimal" 
copper intake to atherogenesis need further metabolic evaluation. 
Copper toxicity arises from deliberate ingestion of copper salts, or accidentally from 
contamination of drinks. In acute toxicity the gastrointestinal tract is affected, 
variable degrees of intravascular haemolysis, heptocellular necrosis and renal 
tubular failure result and death may ensue '·
9. 
With chronic exposure copper accumulates in the liver and toxicity is insidious. 
Eventually hepatic necrosis or cirrhosis with liver failure develops. Some infants and 
young children, at least, are vulnerable to high intakes arising from the use of copper 
containers and conduits
 9. 
Copper taken as copper sulphate induces nausea at intakes of 10 mg and intakes 
above this are increasingly emetic '. However when consumed with foods the 
element is better tolerated and it has been suggested that intakes of 10 to 35 mg/d 
could be tolerated. These suggestions, however, have not been verified and for the 
moment an upper limit of 10 mg/d is proposed. 
Requirements 
There are limited data on which human copper requirements can be based. A review 
of published balance studies suggests that balances can be achieved at intakes 
around 1.2 mg copper daily (CF Mills, personal communication). Copper-responsive 
clinical and biochemical defects have been seen in adults on experimental intakes of 
0.7-1.0 mg/d for four weeks or more. However it is possible that some of these 
abnormalities may have arisen from the nature of the experimental diets
 7, and 
another study using more customary, although still experimental, diets found no 
deterioration of current indices of copper supply in men on intakes of 0.79 mg/d for 42 
days ". This suggests that 0.8 mg Cu/d is an adequate intake although actual 198 Reports of the Scientific Committee for Food: 31st series 
requirements may be lower. For example, for adults on parenteral nutrition 0.3 mg/d 
is adequate
 12; at an absorbability of 50 % this could correspond to a dietary intake of 
0.6 mg/d. Such evidence suggests that an Average Requirement of 0.8 mg/d could be 
set with a LTI of 0.6 mg/d and, with an allowance for possible storage requirements, 
a PRI of 1.1 mg/d. Dietary intakes are generally 1.0-1.5 mg daily. 
Children 
Requirements for infants 6-11 months have been calculated on the basis of a tissue 
content of 1.38 μ^
 13, and an adjustment to allow for a possible loss of endogenous 
copper
 14. An absorption of 50% is assumed, to give a PRI of 36 μg/kg/d. PRIs were 
calculated from the interpolated values of 30 μg/kg/d at 1-6 years, 24 μg/kg/d at 7-10 
years, and 18 μg/kg/d at 15-17 years. 
Pregnancy 
The estimated requirements for the products of conception are 0.033, 0.063 and 0.148 
mg/d for the first, second and third trimesters respectively '
5. It is considered that 
these can probably be met by metabolic adjustment by the mother, so no increment 
is proposed for pregnancy. 
Lactation 
If 750 ml milk is produced with a copper content of 0.22 mg/L
 16, and absorption is 
50%, an increase of 0.33 mg/d would be required in the diet to support lactation. Nutrition. Chapter 27: Copper 11-12-1992 199 
Summary 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
mg/d 
0.8 
1.1 
0.6 
Population Reference Intakes of other groups 
Age Group 
6-1 lm 
1-3 y 
4-6 y 
7-10 y 
Males 11-14 y 
15-17 y 
Females 11-14 y 
15-17 y 
Pregnancy 
Lactation 
PRI (mg/d) 
0.3 
0.4 
0.6 
0.7 
0.8 
1.0 
0.8 
1.0 
1.1 
1.4 200 Reports of the Scientific Committee for Food: 31st scries 
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Physiology 
The total body content of selenium (3-30 mg) varies according to the geochemical 
environment and dietary intakes. Selenium is an integral part of the enzyme 
glutathione peroxidase (GSHpx), one of the mechanisms whereby intracellular 
structures are protected against oxidative damage '. Less than 2 % of selenium in 
plasma exists as glutathione peroxidase. Most is associated with a- and ß-
globulins, and with glycoproteins amongst which one, selenoprotein P, may be 
involved specifically with selenium transport
 2. 
Selenium deficiency (in animal models) has been associated with defective 
microsomal oxidation of xenobiotics and rat hepatic microsomal type 1 iodothyronine 
5'-deiodinase is a seleno-enzyme
 3·
4. Other selenoproteins have been isolated from 
mammalian tissues. One may be essential for normal morphology of mammalian 
sperm
 5 but the roles of the others have not yet been identified. Additionally cellular 
immune functions are disturbed by selenium deficiency
 6. 
Selenium is present in foods mainly as selenomethionine and selenocysteine. 
Selenoamino acids are probably absorbed by energy-dependent and sodium co-
transport mechanisms similar to their sulphur analogues. Although the 
bioavailability of inorganic selenium is less than that of organic forms, this is 
probably of little practical significance because all usual dietary forms are absorbed 
quite efficiently '·
7. 
The pool of selenomethionine in protein is subject to factors influencing methionine 
metabolism, and its constituent selenium is not necessarily available for selenium-
dependent processes. For example, when methionine intake is limiting, 
selenomethionine is incorporated into methionine sites even if there is a concomitant 
selenium deficiency. However if the methionine supply is adequate, selenium 
released from degraded selenomethionine is available to the active selenium pool. 
The biologically active pool of selenium depends on selenocysteine, which can be 
synthesised endogenously. 
Homoeostasis of organic selenium is achieved by adaptations in urinary excretion, 
and to a lesser extent intestinal absorption. Systemically selenoamino acids can be Nutrition. Chapter 28: Selenium 11-12-1992 203 
degraded to yield amino acid residues and selenite. Excess selenium is successively 
reduced to methylated and other derivatives, which are excreted in the urine. 
Deficiency and excess 
In man the most striking selenium-responsive syndrome is that of Keshan disease, a 
selenium-responsive cardiomyopathy which affects predominantly children, 
adolescents and young women in China. Other factors probably contribute to the 
pathogenesis of Keshan disease, but related cardiomyopathies have been observed 
in patients on total parenteral nutrition. Less severe deficiencies, involving skeletal 
myopathy with increased plasma creatine kinase activities, macrocytosis and 
lightening of skin and hair pigmentation, have been documented. An increased 
degree of haemolytic sensitivity of red cells in vitro to peroxide, as evidence of 
significantly reduced GSHpx activity, may be the only detectable feature. 
At excessive intakes of selenium a volatile dimethylated compound [(CH3)2 Se] is 
formed, which when lost via expired air gives a characteristic garlic odour. Dietary 
intakes of 3.2-6.7 mg/d cause severe selenosis, encompassing an erythematous, 
bullous dermatitis, dystrophic nails, alopecia and neurological abnormalities 
involving parasthesia, paralysis and hemiplegia
 9. 
Requirements 
Adults 
Customary adult daily intakes of selenium vary between 20 and 300 μg/d. In China 
dietary intakes range from 11-5000 μ^ΙΑ, at which extremes deficiency and toxicity 
syndromes occur. 
In New Zealand and Finland habitual intakes of 15-40 μg/d have not been associated 
with selenium-responsive disease although whole blood GSHpx activity was below 
its possible peak activity, which occurs with whole blood selenium concentrations 
about 100 μg/L
 7-
8. In China populations with intakes of selenium of less than 12 μg/d 
experience Keshan disease, and those with intakes of 19 μg or more do not
 9·
10. If 
allowance is made for the smaller size of individuals in China, 20 μg/d can be 
proposed as the European LTI ". Studies based on the saturation of GSHpx activity 
suggest that an Average Requirement would be about 40 μg/d
 10, which would give a 
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Disturbed metabolism of selenium occurs at intakes above 750 μg/d and early 
features of nail dystrophy have been described at intakes of 900 μg/d
 12. Since the 
intake beyond which there is no discernible benefit is much lower than this, it is 
suggested that the maximum safe intake from all sources should be 450 μg/d. 
Children 
No extensive investigations have been made on selenium requirements in children. 
Blood concentrations at 1 year of age are about 80% of those of adults, increase to 
adult values by 3 years, and then remain fairly constant
 13. The PRIs have been 
calculated from adult values, on the basis of body weight, and should cover the 
relatively much smaller requirements for growth (0.2 ng/g weight gain). 
Pregnancy and lactation 
Adaptive changes in the metabolism of selenium occur during pregnancy
 14, so no 
recommendation is made for any extra increment 
To maintain the selenium concentration in infants' serum at about 70 ng/ml, a daily 
intake from breast milk of about 8-10 ng/ml is necessary
 15. In the absence of more 
specific information, the extra requirement during lactation has been calculated on 
the basis of 60% absorption from the diet, and milk with a selenium content of 12 
ng/ml, to give an increment of 15 μg. Nutrition. Chapter 28: Selenium 11-12-1992 205 
Summary 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
Maximum safe intake 
μβ/d 
40 
55 
20 
450 
Population Reference Intakes of other groups 
Age Group 
6- 11 m 
l-3y 
4-6y 
7- 10 y 
11-14 y 
15-17 y 
Pregnancy 
Lactation 
PRI (ug/d) 
8 
10 
15 
25 
35 
45 
55 
70 206 Reports of the Scientific Committee for Food: 31st series 
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Physiology 
Iodine is a constituent of thyroxine (T4) and tri-iodothyronine (T3). Adequate 
circulating levels of these thyroid hormones are necessary for optimum cellular 
metabolism, normal growth and development. 
Both inorganic and organic iodine are absorbed efficiently by the small intestine. 
Extracellular fluid contains 10-15 μg iodide/L. The total size of the iodide pool is 
approximately 250-350 μg, but its precise mass varies with iodide intake, which, in 
the absence of specific dietary or exogenous supplementation, corresponds closely to 
the amount of element entering the local food chain from the immediate geochemical 
environment. Thus populations living on heavily leached soils, which are often, but 
not exclusively, mountainous areas are at particular risk of sub-optimal iodine 
intakes. Plasma inorganic iodide is loosely bound to protein. It is cleared principally 
by the thyroid and kidneys but other tissues such as the gastrointestinal mucosa, 
mammary and salivary glands, and ovaries can also concentrate the element. 
Over 75 % of the 10-20 mg iodine present in the normal adult is found in the thyroid 
gland. Iodide is taken up into the thyroid actively by a sodium-dependent carrier-
mediated pathway which is stimulated by thyroid stimulating hormone. The iodide is 
then rapidly oxidised by thyroperoxidase, and 'organified' by iodination of tyrosyl 
residues in thyroglobulin. Pairs of the resultant iodotyrosines link to form 
iodothyronines. The major excretory route of iodide is via the urine, and daily urinary 
excretion of the element is often used as a convenient index of intake. Goitrogenic 
cyanoglucosides in brassicas, cassava, maize, sweet potatoes, lima beans and 
bamboo shoots interfere with the organification of iodide by the thyroid '·
2. 
Decreased circulatory levels of T3 lead to a loss of the inhibitory feed back on the 
release of hypothalamic thyrotrophin releasing hormone, the increased secretion of 
which increases the secretion of pituitary thyroid stimulating hormone, which 
stimulates the uptake of iodide by the gland and can lead to thyroid hyperplasia and 
goitre. Nutrition. Chanter 29: lodine 11-12-1992 209 
Deficiency and excess 
Iodine Deficiency Diseases (IDD) may be widespread in Europe
 3·
4. The spectrum of 
IDD is extensive and subtle, as are their impact on socio-economic development 5.6 
Maternal iodine deficiency causes infertility, increased incidence of abortions and 
stillbirths, increased perinatal and neonatal mortality, congenital abnormalities 
including neurological and myxoedematous cretinism, and, less obviously, degrees of 
psychomotor retardation evident in later childhood resulting from intrauterine iodine 
deficiency. In older children and adults IDD include impaired mental function, 
hypothyroidism with goitre and growth retardation. 
High iodine intakes cause toxic nodular goitre and hyperthyroidism. Such toxicity is 
rare in normal populations or individuals with an intake of less than 5 mg/d but those 
with pre-existent iodine deficiency may be susceptible to developing toxic nodular 
goitre, hyperthyroidism, and thyroid cancer at intakes below this
 7, and transient 
hyperthyroidism has been observed in previously deficient individuals on intakes of 
150-200 μg/d
 s. The incidence of such complications diminishes with time as the 
overall iodine supply of the population is improved and the number of people 
previously exposed to iodine deficiency diminishes. Intakes of 1-2 mg/d appear to be 
safe
 9 but intakes above 10 mg/d in the form of seaweed have been associated with 
an increased incidence of iodine goitre
 10. 
Requirements 
Adults 
Most adults can maintain iodine balance and normal thyroid function on intakes 
between 40 and 100 μg iodine/d. A plateau concentration of iodide in the thyroid 
gland is achieved at an iodine intake of 100 μξ/ά, and increasing intakes to 300 or 500 
μg daily has no further effect on this or on reducing the incidence of goitre "An 
Average Requirement of 100 μg is proposed and a PRI of 130 μg/d. (A daily intake of 
up to 200 μg is being advised by a current WHO initiative designed to eradicate 
iodine deficiency disorders). For the LTI 70 μg/d is proposed, as an intake below 
which thyroid adaptation may become inadequate with a risk of dysfunction or sub-
optimal operation
 6·
7·
12. 210 Reports of the Scientific Committee for Food: 31st series 
Children 
PRIs for younger age groups have been calculated from adult values, on the basis of 
energy requirements. 
Pregnancy and lactation 
Provided the normal prepregnancy iodine intake is adequate, there is no evidence 
that an increased dietary intake is needed during pregnancy, so no increment is 
recommended. 
Lactating women on a normal plane of iodine nutrition produce iodine in their milk in 
amounts more than sufficient for the infant. In order to replace these losses, a PRI of 
160 μg/d is suggested during lactation. The increase is based on the needs of the 
infant rather than the amount actually produced in the milk. Nutrition. Chapter 29: lodine 11-12-1992 211 
Summary 
Adults 
Average Requirement 
Population Reference Intake 
Lowest Threshold Intake 
μ&Α 
100 
130 
70 
Population Reference Intakes of other groups 
Age Group 
6- 11 m 
1- 3y 
4-6y 
7-10y 
11 - 14 y 
15- 17 y 
Pregnancy 
Lactation 
PRI tøg/d) 
50 
70 
90 
100 
120 
130 
130 
160 2 12 Reports of the Scientific Committee for Food: 31st scries 
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Physiology 
Manganese is a component of arginase, pyruvate carboxylase and mitochondrial 
superoxide dismutase. It participates also in various hydrolase, kinase, 
decarboxylase, and phosphotransferase activities. The intestinal absorption of 
manganese occurs throughout the length of the small intestine. Mucosal uptake 
appears to be mediated by two types of mucosal binding, one which is saturable with 
a finite capacity and one which is non-saturable. The efficiency of manganese 
absorption in adults is low (approximately 10 %) but there is some evidence of 
improvement at low intakes. High levels of dietary calcium, phosphorus, and phytate 
impair the intestinal uptake of the element but are probably of limited significance 
because as yet no well documented case of human manganese deficiency has been 
reported. 
Systemic homoeostasis of manganese is maintained principally by hepato-biliary 
excretion. Urinary manganese falls with reduced intake and rises with increased 
intake, suggesting a role of the kidney '. 
Deficiency and excess 
Although it is difficult to characterise the precise biochemical mechanisms that have 
failed, manganese-deprived animals display numerous reproducible phenomena. 
These include growth retardation, impaired cartilage formation and defective 
endochondrial osteogenesis in fetuses leading to impaired development of the 
skeleton and otoliths (with resultant ataxia); impaired glucose tolerance and insulin 
secretion; reduced gluconeogenic response to glucagon and adrenaline; 
hypocholesterolaemia; hepatic and renal accumulation of lipids and ultra-structural 
abnormalities in cellular and sub-cellular membranes and convulsions '. 
Evidence of manganese deficiency in man is poor
 2. Interest in possible manganese 
deprivation in humans has been stimulated by reports of manganese-responsive 
carbohydrate intolerance, and reduced manganese concentration in the hair of some 
mothers whose babies had congenital abnormalities and in the blood or hair of 
children with skeletal abnormalities, osteoporosis, and non-traumatic epilepsy. 214 Reports of the Scientific Committee for Food: 31st scries 
Men fed a low manganese diet (10 μg/d) developed an evanescent skin rash and 
hypocholesterolaemia; however neither feature responded unequivocally to 
manganese repletion
 3. 
Manganese toxicity of dietary origin has not been well documented. Mineworkers in 
Chile exposed to manganese ore dust developed, possibly as a result of inhalation 
rather than ingestion, 'Manganic Madness' manifested by psychosis, hallucinations, 
and extrapyramidal damage with features of Parkinsonism '. 
Requirements 
Manganese is particularly abundant in vegetable-based diets and beverages such as 
tea and it would seem that current population intake is adequate
 2. Most intakes are 
around 2-3 mg/d, but some reach 8.3 mg/d
 u3. No manganese-responsive problems 
were seen in young men on an intake of 0.1 mg
 4 and a basal requirement of 0.74 mg 
daily has been derived from other balance studies
 5. Thus the finding of some 
negative balances on dietary intakes between 1.21 and 2.89 mg/d could represent 
homoeostasis
 5. In the absence of more information an LTI of 0.75 mg daily could 
perhaps be set, but it is considered preferable to give a safe and adequate range of 1-
10 mg/d. 
Summary 
Acceptable Range of Intakes 1-10 mg/d Nutrition. Chapter 30: Manganese 11-12-1992 215 
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Physiology 
Molybdenum has several oxidation states. The redox potential between Mo(V) and 
Mo(VI) is appropriate for electron exchange with flavinmononucleotides and this is 
exploited biochemically in the activities of sulphite oxidase, xanthine oxidase and 
aldehyde dehydrogenase, for which molybdate (Mo4~") linked with a pterin is a 
cofactor. Intestinal absorption of dietary molybdenum is highly efficient 
(approximately 80 %). The element is metabolised as an anion (molybdate) and 
systemic homoeostatic excretion is attained by renal excretion '·
2. 
Molybdenum deficiency in man has occurred with prolonged parenteral feeding
 3, and 
in a fatal autosomal recessive syndrome affecting infants in whom the hepatic-
synthesis of the molybdenum-pterin cofactor is probably defective
 2 With both 
conditions the metabolism of sulphur amino acids and nucleotides was impaired, and 
neurological and encephalopathies developed. The inborn error of metabolism 
presents in neonates: they have abnormal faeces, feeding difficulties, and severe 
neurological and developmental abnormalities leading to encephalopathy and death. 
Requirements 
Molybdenum-responsive defects have been observed in adults fed about 50μg 
daily
 4. Reported dietary intakes in adults are 44-460 μg/d in USA, 48-96 μg/d in New 
Zealand, 44-260 μg/d in Sweden and mean intakes of 128 and 120 μ^/ά in the United 
Kingdom and Finland respectively '. A requirement cannot be established reliably, 
and, in the absence of evidence to the contrary, current intakes appear to be 
adequate and safe. Nutrition. Chapter 31: Molybdenum 11-12-1992 217 
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Physiology 
The precise biological role of chromium has not been established '·
2. It is thought 
that chromium facilitates the activity of insulin, possibly by optimising the number of 
membrane insulin receptors or their interaction with insulin or both. It is reported to 
have been beneficial in the management of both hyperglycaemic and hypoglycaemic 
responses to glucose loads. However, its use in the management of patients with 
diabetes mellitus has produced inconsistent results and this has created scepticism 
about the essentiality of chromium . The element may also have a role in the 
metabolism of lipids and of nucleic acids. It has been suggested that some of these 
effects may arise from a non-specific effect on phosphoglucomutase
 3. 
Chromium (III) absorption is low at 0.5 to 2.0 % of dietary intake. Organic chromium 
is absorbed more efficiently but its bioavailability is low since it is excreted rapidly in 
the urine. 
Deficiency and excess 
Chromium deficiency has been reported in adults and in a child who had received 
prolonged parenteral nutrition. The features involved an insulin-resistant 
hyperglycaemia, elevated serum lipids, weight loss, ataxia, peripheral neuropathy, 
and encephalopathy. The adult patients responded to intravenous chromium chloride 
(C1CI3), but the response in the child was less conclusive
 3·
4. 
Trivalent chromium has a low level of toxicity but hexavalent chromium is more toxic. 
In experimental animals intakes of 50 μg/g diet cause renal and hepatic necrosis and 
tirowth retardation. 
Requirements 
Since data on the essentiality and metabolism of chromium arc so sparse the 
Committee is unable to specify any requirements. Nulriüon. Chapter 32: Chromium 11-12-1992 219 
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Physiology 
The essentiality of fluoride is debatable but since epidemiological studies have 
demonstrated in children an inverse relationship between the incidence of dental 
caries and their calculated intakes of fluoride, the element has been accepted as 
being beneficial to dental health
 l·
2. Both topical and systemic fluoride replace 
hydroxyl moieties in enamel to form calcium fluoroapatite, which is less soluble in 
acid than is calcium hydroxyapatite, thus increasing resistance to déminéralisation 
and improving mineralisation. Additionally, fluoride may have an antimicrobial effect 
on cariogenic oral microflora
 2. Ninety-five percent of systemic fluoride is in the 
skeleton and teeth. The concentration in bone increases with age and it has been 
suggested, but not proven conclusively, that fluoride may have a role in both the 
mineralisation of bone and the maintenance of peak bone mass '. 
Systemic homoeostasis of fluoride is achieved by the kidneys
 3. 
Deficiency and excess 
Apart from an increased risk of susceptibility to dental caries, there are no well 
documented effects arising from low intakes of fluoride. On the other hand fluoride 
excess (fluorosis) is endemic in many parts of the world. An early feature of this is 
patchy déminéralisation (mottling) of the tooth enamel, more usually of the 
permanent dentition. In terms of intake, this affects populations with intakes 
approximating 0.1 mg/kg/d
 4. This problem occurs in 10 % of children in areas with a 
water supply containing 1 mg (50 mol) fluoride/kg. Chronic exposure to high intakes 
(10-25 mg/d, resulting for example from consuming water supplies containing 15 
mg/kg) results :n a sclerotic calcification of bones, ligaments, tendons and 
interosseous membranes. This manifests as debilitating musculoskeletal 
deformities which have been noted particularly in India, East Africa, the Persian Gulf 
and China
 5. However, the overall intake of fluoride, rather than the concentration in 
water is crucial in the pathogenesis of this syndrome and early skeletal features of 
fluorosis have been detected in populations from arid zones with water supplies 
containing less than 15 mg/kg. Nutrition. Chapter 33: Fluoride 11-12-1992 221 
Requirements 
There does not appear to be a specific physiological requirement for fluoride and no 
specific recommendations have been made. Acute toxicity and perhaps death have 
been reported in adults exposed to intakes of 0.5 to 2.6 g/d
 6. 
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Sulphur occurs extensively throughout the body and although a human deficiency 
syndrome has not been demonstrated, there is no doubt that it is essential. The 
sulphate anion is a component of proteoglycans (e.g. keratan sulphate, chondroitin 
sulphate and dermatan sulphate) which are vital constituents of the extracellular 
matrix ', and it is a substrate for the detoxification of various xenobiotics and their 
excretion as sulphate conjugates
 2. The sulphate for these functions is derived by the 
endogenous oxidation of the sulphur in the amino acids methionine and cysteine. 
Thus there does not appear to be any requirement for dietary sulphate. 
Silicon may well be needed for the normal development of the skeleton and 
connective tissue and there does appear to be a differential distribution of the 
element in the body, with high concentrations in the lungs, tendons, trachea and 
aorta. Silica is absorbed poorly but silicic acid is taken up well by the intestine. 
However the significance of these observations is understood imperfectly, as are the 
human requirements for silicon
 3. 
Some studies in animal models suggest that cadmium
 4. lithium
 5, lead
 6 and 
nickel
 7 may be essential, but the current data are not sufficiently conclusive to 
justify setting any recommended intakes. Similarly, evidence supporting the 
essentiality of arsenic, boron and vanadium has yet to be substantiated. Nutrition. Chapter 34: Other minerals 11-12-1992 223 
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to be of nutritional importance 
Certain nutrients are known to be dietary essentials for some higher animals, 
notably choline, taurine, carnitine and inositol. 
It has been suggested that newborn humans may have insufficient biosynthetic 
capacity to produce their full requirement of carnitine, taurine and choline. Any 
possibility of this is usually allowed for in the make up of infant formulas. 
There is no indication of any need for the compounds mentioned to be supplied in the 
diet of healthy individuals above the age of six months. 
Many specific growth factors are known to be required in cell or tissue cultures, e.g. 
ubiquinone (coenzyme Q), lipoic acid, nerve growth factor, p-aminobenzoic acid. 
There is no need for them in human diets as they can be synthesized in the body in 
adequate amounts. 
Over the years there have heen many reports of benefits to be derived from the 
consumption of a wide variety of organic compounds that can occur in foodstuffs, e.g. 
amygdalin (laetrile), pangamic acid, bioflavonoids, chlorophyll, orotic acid. There is 
no persuasive evidence of any need for such compounds in the diet. 36. Values for nutrition labelling 
The Committee has also been asked to advise on a set of nutrient values which 
should be used for nutrition labelling purposes. The nutrient content of a food could 
then be expressed as a percentage of these values as required by the Council 
Directive 90/496/CEE on nutrition labelling. Having derived general recommenda-
tions on scientific grounds the Committee then had to decide on two issues, namely 
(i) the choice of the value for nutrition labelling in itself, and (ii) whether different 
values should be recommended for different groups of the population. 
Choice of a value for nutrition labelling purposes 
The Committee recognises that choosing a value for nutrition labelling purposes 
involves more than strictly scientific considerations; issues related to policy have to 
be taken into account 
This report sets out a range of reference values for each nutrient, and the Committee 
needed to assess whether only one of these values should be used consistently 
throughout the labelling process. The Committee also considered the merit of setting 
an entirely different single value which in some way encompassed the needs of the 
whole European population with its varying national, age and sex structure. To 
choose a single value for labelling seemed sensible from a practical point of view, 
and general consumer understanding was also an important issue, on which there is 
surprisingly little information. The consumers need some simple, coherent, 
understandable and meaningful reference point, should they wish to choose a diet to 
meet their own perceived needs. Consumer organisations and health educators 
support universal, unambiguous labelling. With continuing education and a suitable 
labelling format, an increasing proportion of the population is expected to use 
nutrition labelling in making choices in food purchasing. 
It must be remembered that the value for nutrition labelling will not be used by 
professionals, dieticians or policy makers for assessing the adequacy of the 
population's diet or by those responsible for ensuring that specific population groups 
(e.g. armed forces, schoolchildren taking school meals and those in hospitals, etc.) 
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Nutrition labelling may be of use to the consumer in two respects: (i) providing 
information which would enable consumers to compare different products; (ii) 
providing information to enable consumers to assess the usefulness of a food in the 
overall diet and thus to compose a diet suitable for their individual needs. 
In the first case, the choice of reference value will not affect the comparison of 
different products. Further, products can be compared on the basis of absolute value 
perhaps more effectively. However, it is recognised that there is confusion about the 
use of different units, e.g. μg, mg, g and nutrient equivalents. The use of absolute 
units alone would also fail to provide a perspective on the different quantitative 
needs for the various nutrients. When consumers try to compose their diets on the 
basis of products providing nutritional information as a percentage of a reference 
value or when they try to evaluate the contribution of such products to their daily 
nutrient intake the reference value chosen for nutrition labelling acquires importance. 
The Committee believes that the proportion of the population using nutrition labelling 
reference values to compose their daily diet is at present small, although the media 
may use the values to construct 'model diets'. Labelling values are more likely to be 
used by the consumer as a guide as to which key foods make important or useful 
contributions to overall needs. Further, it is highly unlikely that diets will be 
composed entirely of labelled products which are consumed as purchased. 
Use of the PRI for nutrition labelling 
Traditionally, nutrient information has been presented on the label in relation to a 
recommended daily amount which usually corresponds to the PRI in this report i.e. 
pointe on Figure 1.1. Many would advocate that this should continue. If the 
importance of a product as a contributor to the daily intake of nutrients is to be 
judged, the reference value for nutrition labelling should cover the needs of as great a 
proportion of the population as possible. On this view the reference value for 
nutrition labelling should be the PRI for adult men, except for iron for which the PRI 
for adult women should be selected. 
If consumers were striving to reach 100% of the PRI then an adequate nutrient intake 
for the vast majority of the population would be ensured. Supporters of the male PRI 
as the reference value recognise that this would lead to excess nutrient intake by a 
substantial proportion of the population, and that those unable to reach it would be 
templed to take dietary supplements. They feel however that this is acceptable and 
preferable to the reverse situation, i.e. a proportion of the population possibly not 
covering their needs if a value lower than the PRI were chosen as the reference for 
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Further, this body of opinion believes that opting for a high set of reference values, 
i.e. the male PRIs, will ultimately lead to an upward trend in food quality due to the 
manufacturers' efforts to enhance nutrient value, for example, through better 
processing, nutrient restoration or fortification. There is a risk however that they 
may do this only to improve 'label cosmetics'. The primary aim of reference values 
for nutrition labelling is not to serve as a reference to adjust the composition of 
specific foods but manufacturers may use them in that way. 
Use of the Average Requirement for nutrition labelling 
An opposing opinion argues that the use of a reference value as high as the adult 
male PRI is not appropriate for nutrition labelling. It is more than the needs of most 
men, and women and children are substantially misled about their requirements. It 
makes most peoples' diets appear inadequate when they are not. Despite repeated 
clear statements that the PRI is a value designed to meet very high individual 
requirements, the consumer, the media and even some professionals continue to 
consider anyone eating less to be deficient. 
The use of the adult male PRI for food labelling could lead to a fall in confidence in 
some traditional foods by making them appear to be of low nutritional value. In some 
cases nutritional information could not be given, because nutrients would not be 
present in amounts reaching 15% of the reference value per 100g, a condition for 
labelling in the Community directive. 
Thus the use of the adult male PRI as the basis of nutrition labelling could mislead 
consumers, cause them unnecessary anxiety, encourage them to try to cover their 
needs from sources other than their normal diet and result in unnecessary 
fortification of foods by manufacturers. 
An alternative proposal is to use an average value i.e. point b in the Fig 1.1, which 
should be of more use to consumers than one taken from the end of the range of 
requirements. 
If only one value can be used for labelling purposes, which should be chosen? An 
overall weighted average value could be calculated for Europe, taking account of the 
total population structure. It would however be inappropriately low and lead to 
unwarranted complacency in adult men. A more suitable average value to choose for 
nutrition labelling would be the average requirement for adult men, except for iron, for 
which the average requirement for adult women would be selected. 228 Reports of the Scientific Committee for Food: 31st scries 
Serviceability of the two proposed values 
Table 36.1 gives data on selected micronutrient intakes by women in the EC. The 
intakes by women have been shown because women do most of the shopping and 
they also tend to be more interested than men in nutrition. They are thus more likely 
to read and use nutrition labelling to design or evaluate their own and their family's 
diets. 
Table 36.2 shows that the average EC female diet normally contains less than the 
male PRI of several vitamins and minerals, although it does provide more than the 
male AR, which is also close to the female PRI. So if nutrition labelling is based on 
men's PRI, and women use it to obtain a good diet (or more likely, the media try to 
design "healthy" diets or discuss normal people's intakes) they may find that it is 
difficult for themselves and their children to reach these official targets. Yet there is 
no evidence of thiamin or riboflavin deficiency in Europe, and little or none of 
deficiencies in the other nutrients shown, with the exception of iron where heavy 
menstrual losses can contribute to anaemia, as outlined in chapter 25. 
In table 36.3, the average nutritional value of a number of basic foods is compared 
with ARs and PRIs. This table shows that a number of basic foods barely contain 
15% of the PRI per 100 g, but are important sources for most people because of the 
amounts eaten. Akhough it is not shown in this table, beef, with an average iron 
content of 2 mg/100 g, would provide per 100 g only 12.5% of the PRI for women. If 
the PRI for women were used as the labelling reference value, beef could not be 
labelled as a source of iron, even thoush it is one of the best 
Conclusion 
The Committee has explored a number of options and has sought to identify a 
strategy which would best meet the aims set out in the Council Directive 
90/496/CEE on nutrition labelling. 
The Committee accepted that for practical purposes a single reference value had to 
be chosen, and recognized that the use of any single reference value would 
unavoidably give a potentially misleading message to some of the population. The 
Committee aimed to select the single value that would be of widest benefit. 
The consumer seems to understand the term "average requirement" as implying 
varying individual needs, so the choice of the word "average" for use on the label 
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Inspection of the range of derived reference values shows that the average nutrient 
requirement of adult men is sufficiently similar to the PRI of women to allow a 
rational approach to be developed. The clear exception is iron, which is dealt with 
below. The Committee therefore favours the use of the Average Requirement for 
adult males as the nutrition labelling value, which would cover the needs of the 
majority of the population. This strategy therefore covers the PRI of most groups and 
misleads the least number of consumers. 
The chapter on iron makes it clear that iron needs vary remarkably within the 
population because of the additional needs of women of reproductive age. It is 
difficult therefore to maintain the same rationale set out above unless a special 
allowance is made for women who would be in real danger of deficiency if they simply 
chose foods corresponding to the male average requirement of 7 mg/day. The 
Committee therefore proposes that the iron content of foods should be given two 
labelling reference values. The average male requirement is proposed, together with 
a figure that meets the needs of more than 807c of menstruating women. The two 
values should be used simultaneously on the label, together with an explanatory 
asterisk. In the case of vitamin D, a value of 5 μg is proposed for nutrition labelling 
purposes, being the midpoint of adult requirements. Table 36.4 shows the 
Committee's proposed values for nutrition labelling purposes. 
The Committee has discussed a large number of nutrients, many of them not 
currently permitted by Community legislation to be used in food labelling. The 
Committee does not consider that all the nutrients discussed in this report should 
appear on food labels. Values can be derived only for those nutrients for which an 
Average Requirement for men is given (apart from iron). An exception to this is for 
vitamin D, where no AR has been established, but a labelling value is recommended 
because of documented deficiencies. 
The Committee considered its recommendations in accordance with the Council 
Directive 90/496/CEE. which calls for the amount of nutrient to be given per 100 g or 
100 ml of foodstuff. The Committee also gave some thought to the suggestion that 
nutrition labelling should be in terms of the energy content rather than weight or 
volume. Nevertheless, as a method of nutrition labelling, it would not be so 
serviceable for the consumer to whom this information is directed. 
Special needs of infants and young children 
The Committee is aware that current Community legislation provides for the 
declaration of a single percentage value for the different products. This approach has 
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however like to point out that this presents a problem for products intended solely 
for the nutritional use of infants and young children, whose needs are very different 
from those of adults. 
Since these foods are most unlikely to be eaten by other population groups, the 
Committee is proposing an additional set of reference values which could serve for 
the nutrition labelling of foods intended for the particular nutritional use of infants and 
young children. These are given in table 36.5. They are based on the PRIs for 
children aged between 6 months and 3 years, i.e. they should cover the needs of all 
children under the ace of 4. Table 36.1 Mean daily intake of selected micronutrients by women in the EC from national dietary surveys. 
Thiamin 
(mg) 
Riboflavin 
(mg) 
Vitamin 
B6(mg) 
Iron (mg) 
Zinc (mg) 
Britain 
1.3 
1.6 
1.6 
10.0 
8.2 
Denmark 
1.1 
2.0 
1.2 
13.0 
— 
Ireland 
1.2 
1.7 
1.4 
10.6 
9.2 
Netherlands 
1.0 
1.5 
1.3 
11.4 
— 
Belgium 
1.1 
1.2 
1.3 
13.0 
— 
Germany 
1.1 
1.3 
1.4 
12.1 
9.3 
Portugal 
1.8 
1.1 
1.8 
12.0 
7.6 
EC average 
1.2 
1.5 
1.4 
11.7 
8.6 
Source: Nutriscan EC Food and Nutrition Intake Atlas 
Note: Data for Italy and Spain are at the household level and have not ihcrefore been included Table 36.2 A comparison of the average EC female intake of selected micronutrients against male Average Requirements 
(AR), male Population Reference Intakes (PRI) and female Population Reference Intakes (PRI). 
Thiamin 
(mg) 
Riboflavin 
(mg) 
Vitamin 
B„(mg) 
Iron (mg) 
Zinc (mg) 
Average EC 
female intake 
1.2 
1.5 
1.4 
11.7 
8.6 
Male AR 
0.8 
1.3 
1.3 
7 
7.5 
Intake as % 
of male AR 
150 
115 
108 
167 
114 
Male PRI 
1.1 
1.6 
1.5 
9 
9.5 
Intake as % 
of male PRI 
109 
94 
93 
130 
90 
Female PRI 
0.9 
1.3 
1.1 
16 * 
7 
Intake as % 
of female PRI 
133 
115 
127 
73 
123 
* The intake meeting the requirements of 90% of women of reproductive age Table 36.3 Average content of selected nutrients for a number of basic foods 
Food 
Raw potato 
Baked potato 
White bread 
Spaghetti, boiled 
Milk 
Nutrient 
vitamin C 
folate 
vitamin C 
thiamin 
niacin 
calcium 
ri bollavin 
Amount per 10()g 
of food 
9 mg 
35 μg 
8 mg 
0.21 mg 
0.5 mg 
115 mg 
0.17 mg 
% of male AR 
30 
25 
27 
26 
3 
21 
13 
% of male PRI 
20 
17 
18 
19 
3 
16 
I 1 Table 36.4 Reference values for nutrition labelling for all foods (except those for the particular nutritional use 
of infants and young children) 
Nutrient 
Vitamin A 
Vitamin D 
Vitamin C 
Thiamin 
Riboflavin 
Niacin equivalents 
Vitamin B6 
Folate 
Vitamin B12 
Calcium 
Iron 
Zinc 
Iodine 
Selenium 
Copper 
(Mg) 
(Mg) 
(mg) 
(mg) 
(mg) 
(mg) 
(mg) 
(Mg) 
([ig) 
(mg) 
(mg) 
(mg) 
(Mg) 
(Mg) 
(mg) 
Labelling reference value 
500 
5 
30 
0.8 
1.3 
15 
1.3 
140 
1.0 
550 
7 for men 
14 for women 
7.5 
1(X) 
40 
0.8 Table 36.5 Reference values for nutrition labelling for foods intended solely for infants and young children 
Nutrient 
Vitamin A 
Vitamin D 
Vitamin C 
Thiamin 
Riboflavin 
Niacin equivalents 
Vitamin B6 
Folate 
Vitamin B,2 
Calcium 
Iron 
Zinc 
Iodine 
Selenium 
Copper 
(Mg) 
(Mg) 
(mg) 
(mg) 
(mg) 
(mg) 
(mg) 
(Mg) 
(Mg) 
(mg) 
(mg) 
(mg) 
(Mg) 
(Mg) 
(mg) 
Labelling reference value 
400 
K) 
25 
0.5 
0.8 
9 
0.7 
100 
0.7 
400 
6 
4 
70 
10 
0.4 37. Summary of proposals 
The main proposals of the Committee are summarized in three tables 
Table 37.1 gives Average Requirements, Population Reference Intakes and Lowest 
Threshold Intakes for adults. 
Table 37.2 gives for all groups the Population Reference Intakes expressed in the 
manner chosen by the Committee. 
For those nutrients for which the recommendations are in terms of energy, protein 
intake or body weigh:, Table 37.3 gives examples expressed in weight per day. 
Table 37.1 Multiple values proposed for adults 
(Amounts per day, unless given in other terms. If that for women is different from 
that for men, it is given in parentheses) 
Nutrient 
Protein (g) 
Vitamin A (pg) 
Thiamin (pg) 
Riboflavin (mg) 
Niacin (mg niacin 
equivalents) 
Vitamin Bg (pg ) 
Folate (pg) 
Vitamin B\i (Mg) 
Vitamin C (mg) 
Average 
Requirement 
0.6/kg body wt 
500 (400) 
72/MJ 
1.3 (1.1) 
1.3/MJ 
13/g protein 
140 
1.0 
30 
Population 
Reference Intake 
0.75/kg body wt 
700 (600) 
100/MJ 
1.6 (1.3) 
1.6/MJ 
1 5/g protein 
200 
1.4 
45 
Lowest Threshold 
Intake 
0.45/kg body wt 
300(250) 
50/MJ 
0.6 
1.07MJ 
-
S5 
0.6 
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Nutrient 
Vitamin E (mg 
u-tocopherol equivalents) 
n-6 PUFA (as percentige of 
dietary energy) 
n-3 PUFA (as percentage of 
dietary energy) 
Calcium (mg) 
Phosphorus (mg) 
Potassium (mg) 
Iron (mg) 
Zinc (mg) 
Copper (mg) 
Selenium (pg) 
Iodine (pg) 
Average 
Requirement 
1 
0.2 
550 
400 
-
7(I0.6
a) 
7.5 (5.5) 
0.8 
40 
100 
Population 
Reference Intake 
0.4/g PUFA* 
2 
0.5 
700 
550 
3100 
9 ( 16
 
b. 8
 
a ) 
9.5 (7) 
1.1 
55 
130 
Lowest Threshold 
Intake 
4 (3)/d regardless of 
PUFA intakes 
0.5 
0.1 
400 
300 
1600 
5 (7,4
 
a) 
5(4) 
0.6 
20 
70 
For the following, acceptable ranges of intake are given 
Pantothenic acid (mg) 
Biotin (μ*) 
Vitamin D (^g) 
Sodium (g) 
Magnesium (mg) 
Manganese (mg) 
3-12 
15-100 
0-10 
0.575-3.5 
150-500 
1-10 
PUFA: Polyunsaturated fatty acids 
■' Postmenopausal women 
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Table 37.2 Population Reference Intakes 
Age group 
6- 11m 
1 - 3 y 
4- 6 y 
7- 10 y 
Males 
11-14 y 
15-17 y 
18+ y 
Females 
11-14 y 
15-17 y 
18+ y 
Pregnancy 
Lactation 
Protein 
(g/kg body 
weight/d) 
1.6 
1.1 
1.0 
1.0 
1.0 
0.9 
0.75 
0.95 
0.85 
0.75 
0.75 
(+10 g/d) 
0.75 
(+16 g/d) 
n-6 
PUFA
 a 
<7rOf 
dietary 
energy 
4.5 
3 
2 
-) 
2 
2 
2 
2 
2 
1 
2 
2 
n-3 
PUFA
 a 
<7fof 
dietary 
energy 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
Vitamin 
A 
(pg/d) 
350 
400 
400 
500 
600 
700 
700 
600 
600 
600 
700 
950 
Thiamin 
(pg/MJ) 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
Ribo-
flavin 
(mg/d) 
0.4 
0.8 
1.0 
1.2 
1.4 
1.6 
1.6 
1.2 
1.3 
1.3 
1.6 
1.7 
Niacin 
(mg/MJ) 
1.6 
1.6 
1.6 
1.6 
1.6 
1.6 
1.6 
1.6 
1.6 
1.6 
1.6 
1.6 (+2 
mg/d) 
Vi tun in 
Bf. 
(pg/g 
protein) 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
Folate 
(pg/d) 
50 
100 
130 
150 
180 
200 
200 
180 
200 
200
 b 
400 
350 
Vitamin 
B.2 
(pg/d) 
0.5 
0.7 
0.9 
1.0 
1.3 
1.4 
1.4 
1.3 
1.4 
1.4 
1.6 
1.9 
/itämin 
C 
(mg/d) 
20 
25 
25 
30 
15 
40 
45 
15 
40 
45 
55 
70 
a Polyunsaturated fatly acids. 
" Neural tube defects have been shown to be prevented in offspring by periconceptual ingestion of 400 pg folic 
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Table 37.2 Population Reference Intakes (continued) 
Age group 
6- 11 m 
1 - 3 y 
4- 6y 
7 - 10 y 
Males 
11-14 y 
15-17 y 
18+ y 
Females 
11-14 y 
15-17 y 
18+ y 
Pregnancy 
Lactation 
Calcium 
(mg/d) 
400 
400 
450 
550 
1000 
1000 
700 
800 
800 
700 
700 
1200 
Phosphorus 
(mg/d) 
300 
300 
350 
450 
775 
775 
550 
625 
625 
550 
550 
950 
Potassium 
(mg/d) 
800 
800 
1100 
2000 
3100 
3100 
3100 
3100 
3100 
3100 
3100 
3100 
Iron 
(mg/d) 
6 
4 
4 
6 
10 
B 
9 
22* 
18** 
17** 
20* 
16** 
+ *** 
10 
Zinc 
(mg/d) 
4 
4 
6 
7 
9 
9 
9.5 
9 
7 
7 
7 
12 
Copper 
(mg/d) 
0.3 
0.4 
0.6 
0.7 
0.8 
1.0 
1.1 
0.8 
1.0 
1.1 
1.1 
1.4 
Selenium 
(pg/d) 
8 
10 
15 
25 
35 
45 
55 
15 
45 
55 
55 
70 
Iodine 
(pg/d) 
50 
70 
90 
100 
120 
130 
130 
120 
130 
130 
130 
160 
To cover 95% of population 
** To cover 90% of population 
*** Postmenopausal 
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Table 37.3 Daily intakes of those nutrients for which the recommendations are 
given in relation to body weight, energy or protein intakes " 
Age group 
6- 11m 
1-3 y 
4- 6y 
7-10y 
Males 
11-14 y 
15-17 y 
18+y (PRI) 
(AR) 
Females 
11-14 y 
15-17 y 
18+y (PRI) 
(AR) 
Pregnancy 
Lactation 
Protein 
(g) 
15 
L5 
20 
29 
44 
55 
55 
45 
42 
46 
47 
37 
57 
63 
n-6 PUFA
b 
(g) 
4 
4 
4 
4 
5 
6 
6 
3 
4 
5 
4.5 
2.5 
5
C 
5.5 
n-3 PUFA
b 
(g) 
0.5 
0.7 
1 
1 
1 
1.5 
1.5 
0.6 
1 
1 
1 
0.5 
1 
1 
Thiamin 
(mg) 
0.3 
0.5 
0.7 
0.8 
1.0 
1.2 
1.1 
0.8 
0.9 
0.9 
0.9 
0.6 
1.0
e 
1.1 
Niacin 
(mg) 
5 
9 
11 
13 
L5 
18 
18 
L5 
14 
14 
14 
11 
14 
16 
Vitamin B<> 
(mg) 
0.4 
0.7 
0.9 
1.1 
1.3 
1.5 
1.5 
1.3 
1.1 
1.1 
1.1 
1.0 
1.3" 
1.4<1 
Population Reference Intakes (PRI) except where indicated as Average Requirements (AR), 
(calculated as mean group intake χ PRI or AR) 
Polyunsaturated Fatty Acids 
From 10th week of pregnancy 
Based on protein increments in pregnancy and lactation. Appendix 242 Reports of the Scientific Committee for Food: 31st series 
Table A.1 Equations for predicting the average basal metabolic rate (BMR) 
from body weight (W), expressed in kg, and for children and 
adolescents, from body weight and height (H expressed in m) 
(BMR expressed in M J per day) 
Age in years 
Males < 3 
3-9 
10-17 
18-29 
30-59 
60-74 
>75 
Females < 3 
3-9 
10-17 
18-29 
30-59 
60-74 
>75 
BMR 
(from weight) 
0.249 W-0.13 
0.095 W +2.11 
0.074 W + 2.75 
0.064 W + 2.84 
0.0485 W + 3.67 
0.0499 W + 2.93 
0.035 W + 3.43 
0.244 W-0.13 
0.085 W + 2.03 
0.056 W + 2.90 
0.0615 W +2.08 
0.0364 W + 3.47 
0.0386 W + 2.88 
0.0410 W +2.61 
BMR 
(from weight and height) 
0.0007 W + 6.35 H - 2.58 
0.082 W +0.55 H + 1.74 
0.068 W + 0.57 H+ 2.16 
0.068 W+ 4.28 H - 1.73 
0.071 W + 0.68 H + 1.55 
0.035 W+ 1.95 H+ 0.84 
These values are taken from the WHO/FAO/UNU report on energy and protein 
requirements ' and Schofield et al.
 2 except for the data on the two older groups where 
selected data, taken from Schofield et al.
 2 and used in the report, have been amplified by 
new and more extensive data collected on Scottish elderly men and from both elderly 
men and women in Italv. Nutriüon. Appendix 11-12-1992 243 
Table Α.2 Estimated Energy Requirements (MJ/d) for groups of men and 
women at various ages, weights and activity levels 
Physical Activity Level (PAL) 
Body 
weight (kg) 
Men 18-29 yr 
60 
65 
70 
75 
80 
Men 30-59 yr 
60 
65 
70 
75 
80 
Men 60-74 yr 
60 
65 
70 
75 
80 
Men >75 yr 
60 
65 
70 
75 
80 
BMR 
(MJ/d) 
6.7 
7.0 
7.3 
7.6 
8.0 
6.6 
6.8 
7.1 
7.3 
7.6 
5.9 
6.2 
6.4 
6.7 
6.9 
5.5 
5.7 
5.9 
6 1 
6.2 
1.4 
9.3 
9.8 
10.2 
10.7 
11.2 
9.2 
9.5 
10.0 
10.2 
10.6 
8.3 
8.7 
9.0 
9.4 
9.7 
7.7 
8.0 
8.3 
8.5 
87 
1.5 
10.0 
10.5 
11.0 
11.5 
12.0 
9.9 
10.2 
10.7 
10.9 
11.4 
8.9 
9.3 
9.6 
10.1 
10.4 
8.3 
8.6 
8.9 
9.2 
9.3 
1.6 
10.7 
11.2 
11.7 
12.2 
12.8 
10.6 
10.8 
11.4 
11.6 
12.2 
9.4 
9.9 
10.2 
10.7 
11.0 
8.8 
9.1 
9.4 
9.8 
9.9 
1.7 
11.4 
11.9 
12.5 
13.0 
13.6 
11.2 
11.5 
12.1 
12.4 
12.9 
10.0 
10.5 
10.9 
11.4 
11.7 
9.4 
97 
10.0 
10.4 
10.5 
1.8 
12.0 
12.6 
13.2 
13.7 
14.4 
11.9 
12.2 
12.8 
13.1 
13.7 
10.6 
11.2 
11.5 
12.1 
12.4 
9.9 
10.3 
10.6 
11.0 
11.2 
1.9 
12.7 
13.3 
13.9 
14.5 
15.2 
12.5 
12.9 
13.5 
13.8 
14.4 
11.2 
11.8 
12.2 
12.7 
13.1 
10.5 
10.8 
11.2 
11.6 
11.8 
2.0 
13.4 
14.0 
14.6 
15.2 
16.0 
13.2 
13.5 
14.2 
14.5 
15.2 
11.8 
12.4 
12.8 
13.4 
13.8 
11.0 
11.4 
11.8 
12.2 
12.4 
2.1 
14.1 
14.7 
15.4 
16.0 
16.8 
13.9 
14.2 
14.9 
15.3 
16.0 
12.4 
13.0 
13.4 
14.1 
14.5 
11.6 
12.0 
12.4 
12.8 
13.0 
2.2 
14.7 
15.4 
16.1 
16.8 
17.6 
14.5 
14.9 
15.6 
16.0 
167 
13.0 
13.6 
14.1 
14.7 
152 
12.1 
12.5 
13.0 
13.4 
13.6 244 Reports of the Scientific Committee for Food: 31st series 
(continues Table A.2) 
Physical Activity Level (PAL) 
Body weight 
(kg) 
Women 18-29 yr 
45 
50 
55 
60 
65 
70 
Women 30-59 yr 
45 
50 
55 
60 
65 
70 
Women 60-74 yr 
45 
50 
55 
60 
65 
70 
Women 275 yr 
45 
50 
55 
60 
65 
70 
BMR 
(MJ/d) 
4.8 
5.1 
5.5 
5.8 
6.1 
6.4 
5.1 
5.3 
5.5 
5.7 
5.8 
6.0 
4.6 
4.8 
5.0 
5.2 
5.4 
5.6 
4.5 
4.7 
4.9 
5.1 
5.3 
5.5 
1.4 
6.8 
7.2 
7.7 
8.1 
8.5 
8.9 
7.1 
7.4 
7.7 
8.0 
8.1 
8.4 
6.4 
6.7 
7.0 
7.3 
7.6 
7.8 
6.3 
6.6 
6.9 
7.1 
7.4 
7.7 
1.5 
7.2 
7.7 
8.3 
8.7 
9.1 
9.6 
7.7 
8.0 
8.3 
8.6 
8.7 
9.0 
6.9 
7.2 
7.5 
7.8 
8.1 
8.4 
6.8 
7.1 
7.4 
7.7 
8.0 
8.3 
1.6 
7.7 
8.2 
8.8 
9.2 
9.7 
10.2 
8.2 
8.5 
8.8 
9.1 
9.3 
9.6 
7.4 
7.7 
8.0 
8.3 
8.6 
9.0 
7.2 
7.5 
7.8 
8.2 
8.5 
8.8 
1.7 
8.2 
8.7 
9.4 
9.8 
10.3 
10.8 
8.7 
9.0 
9.4 
9.7 
9.9 
10.2 
7.8 
8.2 
8.5 
8.8 
9.2 
9.5 
7.7 
8.0 
8.3 
8.3 
8.7 
9.4 
1.8 
8.7 
9.2 
9.9 
10.4 
10.9 
11.5 
9.2 
9.5 
9.9 
10.3 
10.4 
10.8 
8.3 
8.6 
9.0 
9.4 
9.7 
10.1 
8.1 
8.5 
8.8 
9.2 
9.5 
9.9 
1.9 
9.2 
9.7 
10.4 
11.0 
11.5 
12.2 
9.7 
10.1 
10.5 
10.8 
11.0 
11.4 
8.7 
9.1 
9.5 
9.9 
10.3 
10.6 
8.6 
8.9 
9.3 
9.7 
10.1 
10.5 
2.0 
9.7 
10.3 
11.0 
11.5 
12.1 
12.8 
10.2 
10.6 
11.0 
11.4 
11.6 
12.0 
9.2 
9.6 
10.0 
10.4 
10.8 
11.2 
9.0 
9.4 
9.8 
10.2 
10.6 
11.0 
2.1 
10.2 
10.8 
11.6 
12.1 
12.7 
13.4 
10.7 
11.1 
11.6 
12.0 
12.2 
12.6 
9.7 
10.1 
10.5 
10.9 
11.3 
11.8 
9.5 
9.9 
10.3 
10.7 
11.1 
11.6 
2.2 
10.6 
11.3 
12.1 
12.7 
13.3 
14.0 
11.2 
11.7 
12.1 
12.5 
12.8 
13.2 
10.1 
10.6 
11.0 
11.4 
11.9 
12.3 
9.9 
10.3 
10.8 
11.2 
11.7 
12.1 Nutrition. Appendix 11-12-1992 245 
Table A.3 Mean body weights (kg) of European children ' 
Age 
years 
-
-
-
-
1 
1 
2 
2 
3 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
months 
1 
3 
6 
9 
0 
6 
0 
6 
0 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
Males 
4.0 
6.0 
8.0 
9.0 
10.0 
11.5 
12.5 
14.0 
15.0 
15.5 
17.5 
19.5 
22.0 
24.5 
27.0 
30.0 
33.0 
36.5 
41.0 
47.0 
53.0 
58.0 
62.5 
64.5 
Females 
4.0 
5.5 
7.5 
8.5 
9.5 
11.0 
12.0 
13.0 
14.0 
15.0 
17.0 
19.5 
21.5 
24.0 
27.0 
30.5 
34.0 
37.5 
43.0 
48.0 
50.5 
52.5 
54.0 
54.5 
Males & 
Females 
4.0 
6.0 
7.5 
9.0 
10.0 
11.0 
12.5 
13.5 
14.5 
15.5 
17.5 
19.5 
22.0 
24.5 
27.0 
30.0 
33.5 
37.0 
42.0 
47.5 
51.5 
55.5 
58.0 
59.5 
' Values, rounded to nearest 0.5 kg, obtained by pooling national data sets from Italy, 
Denmark, France. Spain, UK, The Netherlands. Germany. Belgium and Greece, 
weighted on the basis of each country's population at any given age. Luxemburg, 
Ireland, Portugal not included. 246 Reports of lhe Scientific Committee for Food: ?lst series 
Table A.4 Mean height (cm) of European children ' 
Age 
years 
-
-
-
-
1 
1 
2 
2 
3 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
months 
1 
3 
6 
9 
0 
6 
0 
6 
0 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
Males 
53.0 
60.0 
67.5 
71.5 
75.5 
82.0 
87.5 
92.0 
96.0 
99.0 
106.5 
112.5 
119.0 
124.5 
130.5 
135.5 
140.5 
145.5 
150.5 
158.0 
166.0 
171.0 
174.0 
175.5 
Females 
52.5 
59.0 
66.0 
70.0 
74.0 
80.5 
86.0 
90.5 
95.0 
98.0 
105.5 
111.5 
118.0 
123.5 
129.0 
135.0 
140.5 
146.5 
153.0 
157.5 
160.5 
162.0 
162.5 
163.0 
Males & 
Females 
53.0 
59.5 
66.5 
70.5 
75.0 
81.5 
86.5 
91.0 
95.5 
98.5 
106.0 
112.0 
118.5 
124.0 
129.5 
135.0 
140.5 
146.0 
151.5 
158.0 
163.0 
166.5 
168.0 
169.0 
1 Values, rounded to nearest 0.5 cm, obtained by pooling national data sets from Italy, 
Denmark, France, Spain, UK, The Netherlands, Germany, Belgium and Greece, 
weighted on the basis of each country's population at any given age. Luxemburg, 
Ireland, Portugal not included. Nuiriüon. Appendix 11-12-1992 247 
Table Α.5 Estimated time use and energy cost of activities in older children and 
adolescents aged 10-17 years 
Activity 
Bed 
School 
Light 
Moderate 
High 
Total 
PAL 
Hours 
age yrs 10-13 
9 
5 
4.5 
5 
0.5 
24 
age yrs 14-17 
8 
6 
7 
2.5 
0.5 
24 
Energy Cost (as ratio of BMR) 
Boys 
age yrs 10-13  age yrs 14-17 
1.0 
1.6 
1.6 
2.5 
6.0 
1.65  1.58 
Girls 
age yrs 10-13  age yrs 14-17 
1.0 
1.5 
1.5 
2.2 
6.0 
1.55  1.50 
Based on FAO/WHO/UNU values 248 Reports of the Scientific Committee fur Food: 3 1st serie 
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